General Electric (GE) 10-Q25 Apr 232023 Q1 Quarterly reportFinancial data

Company Profile

COVER

COVER	3 Months Ended
COVER	Mar. 31, 2023 shares
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2023
Document Transition Report	false
Entity File Number	001-00035
Entity Registrant Name	GENERAL ELECTRIC COMPANY
Entity Central Index Key	0000040545
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--12-31
Amendment Flag	false
Entity Incorporation, State or Country Code	NY
Entity Tax Identification Number	14-0689340
Entity Address, Address Line One	5 Necco Street
Entity Address, City or Town	Boston
Entity Address, State or Province	MA
Entity Address, Postal Zip Code	02210
City Area Code	617
Local Phone Number	443-3000
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding	1,088,960,029
Common Stock
Entity Information [Line Items]
Title of 12(b) Security	Common stock, par value $0.01 per share
Trading Symbol	GE
Security Exchange Name	NYSE
1.250% Notes Due 2023
Entity Information [Line Items]
Title of 12(b) Security	1.250% Notes due 2023
Trading Symbol	GE 23E
Security Exchange Name	NYSE
0.875% Notes Due 2025
Entity Information [Line Items]
Title of 12(b) Security	0.875% Notes due 2025
Trading Symbol	GE 25
Security Exchange Name	NYSE
1.875% Notes Due 2027
Entity Information [Line Items]
Title of 12(b) Security	1.875% Notes due 2027
Trading Symbol	GE 27E
Security Exchange Name	NYSE
1.500% Notes Due 2029
Entity Information [Line Items]
Title of 12(b) Security	1.500% Notes due 2029
Trading Symbol	GE 29
Security Exchange Name	NYSE
7.5% Guaranteed Subordinated Notes Due 2035
Entity Information [Line Items]
Title of 12(b) Security	7 1/2% Guaranteed Subordinated Notes due 2035
Trading Symbol	GE /35
Security Exchange Name	NYSE
2.125% Notes Due 2037
Entity Information [Line Items]
Title of 12(b) Security	2.125% Notes due 2037
Trading Symbol	GE 37
Security Exchange Name	NYSE

STATEMENT OF EARNINGS (LOSS) (U

STATEMENT OF EARNINGS (LOSS) (UNAUDITED) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenues
Insurance revenues (Note 13)	$ 791	$ 764
Total revenues	14,486	12,675
Costs and expenses
Selling, general and administrative expenses	2,142	2,725
Separation costs (Note 20)	205	99
Research and development	431	403
Interest and other financial charges	269	387
Insurance losses, annuity benefits and other costs (Note 13)	684	620
Non-operating benefit cost (income)	(385)	(105)
Total costs and expenses	14,075	13,904
Other income (loss) (Note 19)	6,081	49
Earnings (loss) from continuing operations before income taxes	6,492	(1,180)
Provision (benefit) for income taxes	(271)	(29)
Earnings (loss) from continuing operations	6,221	(1,209)
Earnings (loss) from discontinued operations, net of taxes (Note 2)	1,257	101
Net earnings (loss)	7,478	(1,108)
Less net earnings (loss) attributable to noncontrolling interests	(27)	28
Net earnings (loss) attributable to the Company	7,506	(1,136)
Preferred stock dividends and other	(145)	(52)
Net earnings (loss) attributable to GE common shareholders	7,360	(1,188)
Amounts attributable to GE common shareholders
Earnings (loss) from continuing operations	6,221	(1,209)
Less net earnings (loss) attributable to noncontrolling interests, continuing operations	(27)	14
Earnings (loss) from continuing operations attributable to the Company	6,248	(1,224)
Preferred stock dividends and other	(145)	(52)
Earnings (loss) from continuing operations attributable to GE common shareholders	6,103	(1,276)
Earnings (loss) from discontinued operations attributable to GE common shareholders	1,257	88
Net earnings (loss) attributable to GE common shareholders	$ 7,360	$ (1,188)
Earnings (loss) per share from continuing operations (Note 18)
Diluted earnings (loss) per share (in dollars per share)	$ 5.56	$ (1.16)
Basic earnings (loss) per share (in dollars per share)	5.60	(1.16)
Net earnings (loss) per share (Note 18)
Diluted earnings (loss) per share (in dollars per share)	6.71	(1.08)
Basic earnings (loss) per share (in dollars per share)	$ 6.76	$ (1.08)
Equipment
Revenues
Sales	$ 5,287	$ 4,608
Costs and expenses
Cost of sales	5,605	5,148
Services
Revenues
Sales	8,407	7,302
Costs and expenses
Cost of sales	$ 5,124	$ 4,626

STATEMENT OF FINANCIAL POSITION

STATEMENT OF FINANCIAL POSITION (UNAUDITED) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Cash, cash equivalents and restricted cash	$ 12,001	$ 15,810
Investment securities (Note 3)	12,814	7,609
Current receivables (Note 4)	14,212	14,831
Inventories, including deferred inventory costs (Note 5)	16,198	14,891
Current contract assets (Note 9)	2,244	2,467
All other current assets (Note 10)	1,464	1,400
Assets of businesses held for sale (Note 2)	1,353	1,374
Current assets	60,286	58,384
Investment securities (Note 3)	38,262	36,027
Property, plant and equipment – net (Note 6)	12,170	12,192
Goodwill (Note 7)	13,107	12,999
Other intangible assets – net (Note 7)	5,990	6,105
Contract and other deferred assets (Note 9)	5,631	5,776
All other assets (Note 10)	15,888	15,477
Deferred income taxes (Note 16)	10,344	10,001
Assets of discontinued operations (Note 2)	2,793	31,890
Total assets	164,472	188,851
Short-term borrowings (Note 11)	2,262	3,739
Accounts payable and equipment project payables (Note 12)	15,063	15,399
Progress collections and deferred income (Note 9)	16,586	16,216
All other current liabilities (Note 15)	12,313	12,130
Liabilities of businesses held for sale (Note 2)	1,953	1,944
Current liabilities	48,177	49,428
Deferred income (Note 9)	1,500	1,409
Long-term borrowings (Note 11)	20,159	20,320
Insurance liabilities and annuity benefits (Note 13)	39,082	36,845
Non-current compensation and benefits	10,244	10,400
All other liabilities (Note 15)	10,937	11,063
Liabilities of discontinued operations (Note 2)	1,551	24,474
Total liabilities	131,649	153,938
Preferred stock (Note 17)	3	6
Common stock (Note 17)	15	15
Accumulated other comprehensive income (loss) – net attributable to GE (Note 17)	(3,289)	(2,272)
Other capital	30,729	34,173
Retained earnings	84,955	82,983
Less common stock held in treasury	(80,762)	(81,209)
Total GE shareholders’ equity	31,652	33,696
Noncontrolling interests	1,171	1,216
Total equity	32,823	34,912
Total liabilities and equity	$ 164,472	$ 188,851

STATEMENT OF CASH FLOWS (UNAUDI

STATEMENT OF CASH FLOWS (UNAUDITED) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
STATEMENT OF CASH FLOWS (UNAUDITED) - USD ($) $ in Millions	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Cash flows – operating activities
Net earnings (loss)	$ 7,478	$ (1,108)
(Earnings) loss from discontinued operations activities	(1,257)	(101)
Adjustments to reconcile net earnings (loss) to cash from (used for) operating activities
Depreciation and amortization of property, plant and equipment	367	403
Amortization of intangible assets (Note 7)	140	922
(Gains) losses on purchases and sales of business interests	52	(15)
(Gains) losses on equity securities	(5,906)	206
Principal pension plans cost (Note 14)	(271)	94
Principal pension plans employer contributions	(52)	(49)
Other postretirement benefit plans (net)	(181)	(224)
Provision (benefit) for income taxes	271	29
Cash recovered (paid) during the year for income taxes	(172)	(24)
Changes in operating working capital:
Decrease (increase) in current receivables	536	(610)
Decrease (increase) in inventories, including deferred inventory costs	(1,275)	(732)
Decrease (increase) in current contract assets	294	473
Increase (decrease) in accounts payable and equipment project payables	(201)	(293)
Increase (decrease) in progress collections and current deferred income	205	173
Financial services derivatives net collateral/settlement	3	(155)
All other operating activities	125	89
Cash from (used for) operating activities – continuing operations	155	(924)
Cash from (used for) operating activities – discontinued operations	(413)	369
Cash from (used for) operating activities	(259)	(556)
Cash flows – investing activities
Additions to property, plant and equipment	(279)	(239)
Dispositions of property, plant and equipment	7	28
Additions to internal-use software	(20)	(22)
Sales of retained ownership interests	2,025	1,302
Net (purchases) dispositions of insurance investment securities	(1,556)	(1,344)
All other investing activities	1,096	239
Cash from (used for) investing activities – continuing operations	1,273	(37)
Cash from (used for) investing activities – discontinued operations	(3,068)	(407)
Cash from (used for) investing activities	(1,796)	(444)
Cash flows – financing activities
Net increase (decrease) in borrowings (maturities of 90 days or less)	1	45
Newly issued debt (maturities longer than 90 days)	9	0
Repayments and other debt reductions (maturities longer than 90 days)	(1,815)	(1,267)
Dividends paid to shareholders	(203)	(140)
Redemption of GE preferred stock	(3,000)	0
Purchases of GE common stock for treasury	(309)	(39)
All other financing activities	87	(30)
Cash from (used for) financing activities – continuing operations	(5,230)	(1,431)
Cash from (used for) financing activities – discontinued operations	1,999	(28)
Cash from (used for) financing activities	(3,232)	(1,459)
Effect of currency exchange rate changes on cash, cash equivalents and restricted cash	65	(75)
Increase (decrease) in cash, cash equivalents and restricted cash	(5,220)	(2,534)
Cash, cash equivalents and restricted cash at beginning of year	19,092	16,859	$ 16,859
Cash, cash equivalents and restricted cash at March 31	13,871	14,325	$ 19,092
Less cash, cash equivalents and restricted cash of discontinued operations at March 31	1,180	1,223
Cash, cash equivalents and restricted cash of continuing operations at March 31	$ 12,691	$ 13,101

STATEMENT OF COMPREHENSIVE INCO

STATEMENT OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
Statement of Comprehensive Income [Abstract]
Net earnings (loss)		$ 7,478	$ (1,108)
Less: net earnings (loss) attributable to noncontrolling interests		(27)	28
Net earnings (loss) attributable to the Company		7,506	(1,136)
Other comprehensive income (loss)
Currency translation adjustments		2,387	(181)
Benefit plans		(2,319)	240
Investment securities and cash flow hedges		706	(2,998)
Long-duration insurance contracts	[1]	(1,793)	3,682
Less: other comprehensive income (loss) attributable to noncontrolling interests		(3)	(2)
Other comprehensive income (loss) attributable to the Company		(1,017)	745
Comprehensive income (loss)		6,458	(365)
Less: comprehensive income (loss) attributable to noncontrolling interests		(30)	26
Comprehensive income (loss) attributable to the Company		$ 6,489	$ (391)

[1]Represents the net after-tax change in future policy benefit reserves and related reinsurance recoverables from updating the discount rate. See Notes 1 and 13 for further information.

STATEMENT OF CHANGES IN SHAREHO

STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($) $ in Millions		Total	GE shareholders' equity balance	Accumulated other comprehensive income (loss)	Currency translation adjustments	Benefit plans	Investment securities and cash flow hedges	Long-duration insurance contracts	Other capital	Retained earnings	Common stock held in treasury	Noncontrolling interest
Beginning balance at Dec. 31, 2021				$ (4,860)			$ 5,172	$ (9,109)	$ 34,691	$ 83,286	$ (81,093)
Increase (decrease) in shareholders' equity
Other comprehensive income (loss)					$ (177)	$ 238	(2,998)	3,682
Purchases											(39)
Dispositions									(396)		459
Stock-based compensation									91
Other changes	[1]								5
Net earnings (loss) attributable to the Company		$ (1,136)								(1,136)
Dividends and other transactions with shareholders	[2]									(141)
Ending balance at Mar. 31, 2022		32,909	$ 31,631	(4,115)	(4,746)	3,884	2,174	(5,427)	34,391	82,009	(80,673)	$ 1,278
Preferred stock issued		6
Common stock issued		15
Preferred stock issued		6
Common stock issued		15
Beginning balance at Dec. 31, 2022		34,912		(2,272)			(1,927)	(983)	34,173	82,983	(81,209)
Increase (decrease) in shareholders' equity
Other comprehensive income (loss)					2,388	(2,317)	706	(1,793)
Purchases									3,000		(311)
Dispositions									(619)		759
Stock-based compensation									73
Other changes	[1]								(2,898)
Net earnings (loss) attributable to the Company		7,506								7,506
Dividends and other transactions with shareholders	[2]									(5,534)
Ending balance at Mar. 31, 2023		32,823	$ 31,652	$ (3,289)	$ (3,505)	$ 4,214	$ (1,222)	$ (2,776)	$ 30,729	$ 84,955	$ (80,762)	$ 1,171
Preferred stock issued		3
Common stock issued		$ 15

[1]Included $3,000 million decrease substantially all in Other capital related to our redemption of GE Series D preferred stock in the first quarter of 2023.[2]Included $5,300 million decrease in Retained earnings reflecting a pro-rata distribution of approximately 80.1% of the shares of GE HealthCare on January 3, 2023.

STATEMENT OF CHANGES IN SHARE_2

STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED) (Parenthetical) $ in Millions	Jan. 03, 2023 USD ($)
Spinoff \| GE Healthcare
Ownership interest disposed of	80.10%
Retained earnings
Spinoff transaction adjustment	$ 5,300

BASIS OF PRESENTATION AND SUMMA

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 1. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES. Our financial statements are prepared in conformity with U.S. generally accepted accounting principles (GAAP), which requires us to make estimates based on assumptions about current, and for some estimates, future, economic and market conditions which affect reported amounts and related disclosures in our financial statements. Although our current estimates contemplate current and expected future conditions, as applicable, it is reasonably possible that actual conditions could differ from our expectations, which could materially affect our results of operations, financial position and cash flows. Such changes could result in future impairments of goodwill, intangibles, long-lived assets and investment securities, revisions to estimated profitability on long-term product service agreements, incremental credit losses on receivables and debt securities, a change in the carrying amount of our tax assets and liabilities, or a change in our insurance liabilities and pension obligations as of the time of a relevant measurement event. In preparing our Statement of Cash Flows, we make certain adjustments to reflect cash flows that cannot otherwise be calculated by changes in our Statement of Financial Position. These adjustments may include, but are not limited to, the effects of currency exchange, acquisitions and dispositions of businesses, businesses classified as held for sale, the timing of settlements to suppliers for property, plant and equipment, non-cash gains/losses and other balance sheet reclassifications. We have reclassified certain prior-year amounts to conform to the current-year’s presentation. Unless otherwise noted, tables are presented in U.S. dollars in millions. Certain columns and rows may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying numbers in millions. Earnings per share amounts are computed independently for earnings from continuing operations, earnings from discontinued operations and net earnings. As a result, the sum of per-share amounts may not equal the total. Unless otherwise indicated, information in these notes to consolidated financial statements relates to continuing operations. Certain of our operations have been presented as discontinued. We present businesses whose disposal represents a strategic shift that has, or will have, a major effect on our operations and financial results as discontinued operations when the components meet the criteria for held for sale, are sold, or spun-off. See Note 2 for further information. On January 3, 2023, General Electric Company (the Company or GE) completed the previously announced separation (the Separation) of its HealthCare business, into a separate, independent publicly traded company. The historical results of GE HealthCare and certain assets and liabilities included in the spin-off are now reported in GE's consolidated financial statements as discontinued operations. See Note 2 for further information. The accompanying consolidated financial statements and notes are unaudited. The results reported in these financial statements should not be regarded as necessarily indicative of results that may be expected for the entire year. These financial statements should be read in conjunction with the financial statements, notes and significant accounting policies included in our Annual Report on Form 10-K for the year ended December 31, 2022. INSURANCE. Our run-off insurance operations include providing insurance and reinsurance for life and health risks and providing certain annuity products. Primary product types include long-term care, structured settlement annuities, life and disability insurance contracts and investment contracts. Insurance contracts are contracts with significant mortality and/or morbidity risks, while investment contracts are contracts without such risks. Insurance revenues are comprised primarily of premiums and investment income. For traditional long-duration insurance contracts, we report premiums as revenue when due. Premiums received on non-traditional long-duration insurance contracts and investment contracts, including annuities without significant mortality risk, are not reported as revenues but rather as deposit liabilities. We recognize revenues for charges and assessments on these contracts, mostly for mortality, administration and surrender. Interest credited to policyholder accounts is charged to expense. Future policy benefit reserves represent the present value of future benefits to be paid to or on behalf of policyholders and related expenses less the present value of future net premiums. The liability is measured by each group of contracts (i.e., cohorts) using current cash flow assumptions. As a run-off insurance operation consisting substantially all of reinsurance, contracts are grouped into cohorts by legal entity and product type, based on the date the reinsurance contract was consummated. Future policy benefit reserves are adjusted each period as a result of updating lifetime net premium ratios for differences between actual and expected experience with the retroactive effect of those variances recognized in current period earnings. We review at least annually in the third quarter, future policy benefit reserves cash flow assumptions, except related claim expenses which remain locked-in, and if the review concludes that the assumptions need to be updated, future policy benefit reserves are adjusted retroactively based on the revised net premium ratio using actual historical experience, updated cash flow assumptions, and the locked-in discount rate with the effect of those changes recognized in current period earnings. As our insurance operations are in run-off, the locked-in discount rate is the discount rate used for the computation of interest accretion on future policy benefit reserves recognized in earnings. However, cash flows used to estimate future policy benefit reserves are also discounted using an upper-medium grade (i.e., low credit risk) fixed-income instrument yield reflecting the duration characteristics of the liabilities and is updated each reporting period with changes recorded in AOCI. As a result, changes in the current discount rate at each reporting period will be recognized as an adjustment to AOCI and not earnings each period, whereas changes relating to cash flow assumptions will be recognized in the Statement of Earnings (Loss). Reinsurance recoverables are recorded when we cede insurance risk to third parties but are not relieved from our primary obligation to policyholders and cedents. As reinsurance recoverables are recognized in a manner consistent with the future policy benefit reserves relating to the underlying reinsurance contracts, changes in reinsurance recoverables from updating the discount rate in each reporting period are also recognized in AOCI. The allowance for credit losses on reinsurance recoverables is based on the locked-in future policy benefit reserves discount rate for purposes of assessing changes in each reporting period. As such, movements in the gross reinsurance recoverable balance resulting from changes in the discount rate do not impact the allowance for credit losses. Following the recapture transaction effective in the fourth quarter of 2022, the remaining reinsurance recoverables are not material. Liabilities for investment contracts equal the account value, that is, the amount that accrues to the benefit of the contract or policyholder including credited interest and assessments through the financial statement date. See Note 13 for further information. ADOPTIONS OF NEW ACCOUNTING STANDARDS. On January 1, 2023, we adopted Accounting Standards Update No. 2018-12 Financial Services – Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts . The new guidance for measuring the liability for future policy benefits and related reinsurance recoverable asset was adopted on a modified retrospective basis such that those balances were adjusted to conform to the new guidance at the January 1, 2021 transition date. We recognized a $7,285 million after-tax decrease in Total equity at January 1, 2021 from the effect of transition date adjustments due to adoption of the new guidance, as presented in the following table. Retained Earnings AOCI December 31, 2020 $ 92,247 $ (9,749) Liability for future policy benefits, including removal of related balances in AOCI (1,853) (8,806) Reinsurance recoverables, net of allowance for credit losses 48 3,542 Other contracts, including market risk benefits (202) (14) Effect of transition adjustments $ (2,007) $ (5,278) Adjusted balance, January 1, 2021 $ 90,240 $ (15,027) The following table summarizes the balance of and pre-tax changes to total Insurance liabilities and annuity benefits attributable to changes in the liability for future policy benefits and market risk benefits at the transition date, due to adoption of the new guidance. Long-term care Structured settlement annuities Life Other contracts(a) Other adjustments Total December 31, 2020 $ 21,378 $ 9,124 $ 517 $ 3,012 $ 8,160 $ 42,191 Change in discount rate assumptions 14,654 4,369 283 — — 19,306 Change in cash flow assumptions (effect of insufficient gross premiums) and elimination of negative reserves 1,545 39 761 — — 2,345 Adjustment for removal of related balances in AOCI — — — — (8,160) (8,160) Market risk benefits and other — — — 269 — 269 Adjusted balance, January 1, 2021 37,577 13,532 1,561 3,281 — 55,951 Less: reinsurance recoverables, net 7,036 — 15 44 — 7,095 Adjusted balance, January 1, 2021, net of reinsurance recoverables $ 30,541 $ 13,532 $ 1,546 $ 3,237 $ — $ 48,856 (a) As of December 31, 2020, includes investment contracts ($2,049 million), claim reserves related to short-duration contracts at Electric Insurance Company (EIC), net of eliminations ($399 million), and other ($564 million). EIC is a property and casualty insurance company primarily providing insurance to GE and its employees. For the liability for future policy benefits and related reinsurance recoverables, the new guidance transition adjustments are reflected in both AOCI and Retained earnings. The transition adjustment reflected in AOCI is related to the difference in the discount rate used pre-transition and the discount rate required under the new guidance, which is equivalent to an upper-medium grade fixed-income instrument yield reflecting the duration characteristics of our insurance liabilities, at January 1, 2021, and does not represent a change in our ultimate expected cash flows associated with the liability for future policy benefits or related reinsurance recoverables. The transition adjustment in AOCI also reflects removal of certain Other adjustments previously recorded in the liability for future policy benefits related to changes in net unrealized gains on investment securities. Whereas pre-transition, we annually performed premium deficiency testing in the aggregate across our run-off insurance portfolio, the new guidance requires the grouping of contracts (i.e., cohorts) at a more granular level. Due to this lower level of aggregation, combined with the conversion of our long-term care insurance claim cost projection models to first principles models, we identified certain cohorts at transition having insufficient gross premiums in our long-term care insurance portfolio. A first principles model separates morbidity assumptions such as incidence (probability of a claim), continuance (length of a claim) and utilization (percentage of the daily benefit maximum used) into individual assumptions. We also eliminated negative reserves, as required by the new guidance, on certain cohorts in our life portfolio. As a result, we increased the liability for future policy benefits and reflected this transition adjustment in Retained earnings. At the transition date, reinsurance recoverables of $4,062 million increased by $4,483 million upon remeasurement to the updated discount rate, with an offsetting adjustment ($3,542 million after-tax) recognized in AOCI. As reinsurance recoverables are recognized in a manner consistent with the liabilities relating to the underlying reinsurance contracts, adjustments to the liability for future policy benefits due to the change in cash flow assumptions resulted in an increase to reinsurance recoverables of $629 million ($497 million after-tax) and an increase in the related allowance for credit losses of $569 million ($450 million after-tax), which was recorded as an adjustment to Retained earnings at the transition date. As a result, the adjusted balance of reinsurance recoverables at the transition date was $7,095 million, net of the allowance for credit losses of $2,079 million, and substantially all related to our long-term care insurance portfolio. Following the recapture transaction effective in the fourth quarter of 2022, the remaining reinsurance recoverables are not material. The new guidance is only applicable to the measurements of our long-duration insurance liabilities and related reinsurance recoverables under GAAP and does not affect the accounting for our insurance reserves or the levels of capital and surplus under statutory accounting practices. See Note 13 for further information.

BUSINESSES HELD FOR SALE AND DI

BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS	3 Months Ended
BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS	Mar. 31, 2023
Discontinued Operations and Disposal Groups [Abstract]
BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS	NOTE 2. BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS. In the first quarter of 2022, we signed a non-binding memorandum of understanding to sell a portion of our Steam business within our Power segment to Électricité de France S.A. (EDF). In the fourth quarter of 2022, we signed a binding agreement for this transaction, and we expect to complete the sale, subject to regulatory approvals and other customary closing conditions, in the second half of 2023. Closing the transaction is expected to result in a significant gain. In the fourth quarter of 2022, we classified our captive industrial insurance subsidiary, with assets of $596 million and liabilities of $342 million as of March 31, 2023, into held for sale. We expect to complete the sale of this business, subject to regulatory approvals, by the first half of 2024. In connection with the expected sale, in the first quarter of 2023, we recorded a loss of $55 million in Other income (loss) in our Statement of Earnings. ASSETS AND LIABILITIES OF BUSINESSES HELD FOR SALE March 31, 2023 December 31, 2022 Current receivables, inventories and contract assets $ 527 $ 495 Non-current captive insurance investment securities 578 554 Property, plant and equipment and intangible assets - net 240 232 Valuation allowance on disposal group classified as held for sale (72) (17) All other assets 80 111 Assets of businesses held for sale $ 1,353 $ 1,374 Progress collections and deferred income $ 1,101 $ 1,127 Insurance liabilities and annuity benefits 340 358 Accounts payable, equipment project payables and other current liabilities 421 371 All other liabilities 90 87 Liabilities of businesses held for sale $ 1,953 $ 1,944 DISCONTINUED OPERATIONS primarily comprise our former GE HealthCare business, our mortgage portfolio in Poland, our GE Capital Aviation Services (GECAS) business, and other trailing assets and liabilities associated with prior dispositions. Results of operations, financial position and cash flows for these businesses are reported as discontinued operations for all periods presented and the notes to the financial statements have been adjusted on a retrospective basis. GE HealthCare. On January 3, 2023, we completed the previously announced separation of our HealthCare business, into a separate, independent, publicly traded company, GE HealthCare Technologies Inc. (GE HealthCare). The Separation was structured as a tax-free spin-off, and was achieved through GE's pro-rata distribution of approximately 80.1% of the outstanding shares of GE HealthCare to holders of GE common stock. In connection with the Separation, the historical results of GE HealthCare and certain assets and liabilities included in the Separation are reported in GE's consolidated financial statements as discontinued operations. We have continuing involvement with GE HealthCare primarily through trademark license and transition services agreements, through which GE and GE HealthCare will continue to provide certain services to each other for a period of time following the Separation. For the three months ended March 31, 2023, we collected net cash of $160 million related to these activities. Bank BPH . The mortgage portfolio in Poland (Bank BPH) comprises floating rate residential mortgages, 86% of which are indexed to or denominated in foreign currencies (primarily Swiss francs). At March 31, 2023, the total portfolio had a carrying value, net of reserves, of $1,126 million. The portfolio is recorded at the lower of cost or fair value, less cost to sell, which reflects market yields as well as estimates with respect to ongoing litigation in Poland related to foreign currency-denominated mortgages and other factors. Loss from discontinued operations included $175 million and $233 million non-cash pre-tax charges for the three months ended March 31, 2023 and 2022, respectively, reflecting estimates with respect to ongoing litigation as well as market yields. To ensure appropriate capital levels, during the first quarter of 2023, we made a non-cash capital contribution in the form of intercompany loan forgiveness of $198 million. We made a cash capital contribution of $530 million into Bank BPH in the twelve months ended December 31, 2022. Future changes in the estimated legal liabilities or market yields could result in further capital contributions and losses in future reporting periods beyond the amounts that we currently estimate. See Note 23 for further information. GECAS/AerCap. We have continuing involvement with AerCap, primarily through our ownership interest, ongoing sales or leases of products and services, and transition services that we provide to AerCap. For the three months ended March 31, 2023, we had direct and indirect sales of $48 million to AerCap, primarily related to engine services and sales, and purchases of $67 million from AerCap, primarily related to engine leases. We paid net cash of $88 million to AerCap related to this activity. 2023 2022 RESULTS OF DISCONTINUED OPERATIONS Three months ended March 31 GE HealthCare Bank BPH & Other Total GE HealthCare Bank BPH & Other Total Total revenues $ — $ — $ — $ 4,361 $ — $ 4,361 Cost of equipment and services sold — — — (2,679) — (2,679) Other income, costs and expenses (20) (201) (221) (1,146) (250) (1,396) Earnings (loss) of discontinued operations before income taxes (20) (201) (221) 536 (250) 286 Benefit (provision) for income taxes(a) 1,479 (1) 1,478 (150) (18) (167) Earnings (loss) of discontinued operations, net of taxes 1,459 (202) 1,257 387 (268) 119 Gain (loss) on disposal before income taxes — — — — (23) (23) Benefit (provision) for income taxes — — — — 5 5 Gain (loss) on disposal, net of taxes — — — — (18) (18) Earnings (loss) from discontinued operations, net of taxes $ 1,459 $ (202) $ 1,257 $ 387 $ (286) $ 101 (a) The tax benefit for the three months ended March 31, 2023 for GE HealthCare relates to preparatory steps for the spin-off, which resulted in taxable gain offset by a deferred tax asset and the reversal of valuation allowances for capital loss carryovers utilized against a portion of the gain. ASSETS AND LIABILITIES OF DISCONTINUED OPERATIONS March 31, 2023 December 31, 2022 Cash, cash equivalents and restricted cash $ 1,180 $ 2,627 Current receivables 13 3,361 Inventories, including deferred inventory costs — 2,512 Goodwill — 12,799 Other intangible assets - net — 1,520 Contract and other deferred assets — 854 Financing receivables held for sale (Polish mortgage portfolio)(a) 1,126 1,200 Property, plant, and equipment - net 69 2,379 All other assets 344 2,109 Deferred income taxes 62 2,528 Assets of discontinued operations(b) $ 2,793 $ 31,890 Accounts payable and equipment project payables $ 102 $ 3,487 Progress collections and deferred income — 2,499 Long-term borrowings — 8,273 Non-current compensation and benefits 36 5,658 All other liabilities(a) 1,413 4,556 Liabilities of discontinued operations(b) $ 1,551 $ 24,474 (a) Included $889 million of valuation allowance against financing receivables held for sale (including $645 million related to foreign currency-denominated mortgage litigation) and $895 million of litigation reserves recorded in All other liabilities in Poland at March 31, 2023. (b) Included $133 million and $28,998 million of assets and $279 million and $23,337 million of liabilities for GE HealthCare as of March 31, 2023 and December 31, 2022, respectively.

INVESTMENT SECURITIES

INVESTMENT SECURITIES	3 Months Ended
INVESTMENT SECURITIES	Mar. 31, 2023
Investments, Debt and Equity Securities [Abstract]
INVESTMENT SECURITIES	NOTE 3. INVESTMENT SECURITIES. All of our debt securities are classified as available-for-sale and substantially all are investment-grade supporting obligations to annuitants and policyholders in our run-off insurance operations. We manage the investments in our run-off insurance operations under strict investment guidelines, including limitations on asset class concentration, single issuer exposures, asset-liability duration variances, and other factors to meet credit quality, yield, liquidity and diversification requirements associated with servicing our insurance liabilities under reasonable circumstances. This process includes consideration of various asset allocation strategies and incorporates information from several external investment advisors to improve our investment yield subject to maintaining our ability to satisfy insurance liabilities when due, as well as considering our risk-based capital requirements, regulatory constraints, and tolerance for surplus volatility. Asset allocation planning is a dynamic process that considers changes in market conditions, risk appetite, liquidity needs and other factors, which are reviewed on a periodic basis by our investment team. Our investment in GE HealthCare comprised 90.3 million shares (approximately 19.9% ownership interest) at March 31, 2023. Our investment in AerCap comprised 79.7 million ordinary shares (approximately 33% ownership interest) at March 31, 2023 and an AerCap senior note, for which we have adopted the fair value option. We sold our remaining shares in Baker Hughes (BKR) during the first quarter of 2023. Our GE HealthCare, AerCap and BKR investments are recorded as Equity securities with readily determinable fair values. Investment securities held within insurance entities are classified as non-current as they support the long-duration insurance liabilities. March 31, 2023 December 31, 2022 Amortized Gross Gross Estimated Amortized Gross Gross Estimated Equity (GE HealthCare) $ — $ — $ — $ 7,410 $ — $ — $ — $ — Equity and note (AerCap) — — — 5,404 — — — 7,403 Equity (Baker Hughes) — — — — — — — 207 Current investment securities $ — $ — $ — $ 12,814 $ — $ — $ — $ 7,609 Debt U.S. corporate $ 27,760 $ 996 $ (1,781) $ 26,975 $ 26,921 $ 675 $ (2,164) $ 25,432 Non-U.S. corporate 2,585 26 (243) 2,369 2,548 18 (300) 2,266 State and municipal 2,881 106 (184) 2,803 2,898 66 (241) 2,722 Mortgage and asset-backed 4,623 39 (320) 4,341 4,442 21 (290) 4,173 Government and agencies 1,641 3 (139) 1,504 1,172 2 (147) 1,026 Other equity 270 — — 270 408 — — 408 Non-current investment securities $ 39,761 $ 1,169 $ (2,668) $ 38,262 $ 38,388 $ 781 $ (3,143) $ 36,027 The amortized cost of debt securities excludes accrued interest of $490 million and $457 million at March 31, 2023 and December 31, 2022, respectively , which is reported in All other current assets. The estimated fair value of investment securities at March 31, 2023 increased since December 31, 2022, primarily due to the classification of our remaining equity interest in GE HealthCare within investment securities, new insurance investments, lower market yields and tightening credit spreads, partially offset by AerCap and BKR share sales, and the mark-to-market effect on our equity interest in AerCap. Total estimated fair value of debt securities in an unrealized loss position were $20,685 million and $21,482 million, of which $14,044 million and $3,275 million had gross unrealized losses of $(2,344) million and $(835) million and had been in a loss position for 12 months or more at March 31, 2023 and December 31, 2022, respectively. At March 31, 2023, the majority of our U.S. and Non-U.S. corporate securities' gross unrealized losses were in the consumer, electric, technology, energy and insurance industries. In addition, gross unrealized losses on our Mortgage and asset-backed securities included $(194) million related to commercial mortgage-backed securities (CMBS) collateralized by pools of commercial mortgage loans on real estate, and $(125) million related to asset-backed securities. The majority of our CMBS and asset-backed securities in an unrealized loss position have received investment-grade credit ratings from the major rating agencies. For our securities in an unrealized loss position, the losses are not indicative of credit losses, we currently do not intend to sell the investments, and it is not likely that we will be required to sell the investments before recovery of their amortized cost basis. Net unrealized gains (losses) for equity securities with readily determinable fair values, which are recorded in Other income (loss) within continuing operations, were $6,040 million and $(370) million for the three months ended March 31, 2023 and 2022, respectively. Proceeds from debt and equity securities sales and early redemptions by issuers totaled $3,008 million and $1,949 million for the three months ended March 31, 2023 and 2022, respectively. Gross realized gains on debt securities were $11 million and $24 million for the three months ended March 31, 2023 and 2022, respectively. Gross realized losses and impairments on debt securities were $(21) million and an insignificant amount for the three months ended March 31, 2023 and 2022, respectively. Contractual maturities of our debt securities (excluding mortgage and asset-backed securities) at March 31, 2023 are as follows: Amortized cost Estimated fair value Within one year $ 1,057 $ 1,052 After one year through five years 4,762 4,753 After five years through ten years 5,726 5,793 After ten years 23,323 22,052 We expect actual maturities to differ from contractual maturities because borrowers have the right to call or prepay certain obligations. The majority of our equity securities are classified within Level 1 and the majority of our debt securities are classified within Level 2, as their valuation is determined based on significant observable inputs. Investments with a fair value of $6,379 million and $6,421 million are classified within Level 3, as significant inputs to their valuation models are unobservable at March 31, 2023 and December 31, 2022, respectively. During the three months ended March 31, 2023 and 2022, there were no significant transfers into or out of Level 3. In addition to the equity securities described above, we hold $714 million and $614 million of equity securities without readily determinable fair values at March 31, 2023 and December 31, 2022, respectively, that are classified within non-current All other assets in our Statement of Financial Position. Fair value adjustments, including impairments, recorded in earnings were $9 million and $18 million for the three months ended March 31, 2023 and 2022, respectively.

CURRENT AND LONG-TERM RECEIVABL

CURRENT AND LONG-TERM RECEIVABLES	3 Months Ended
CURRENT AND LONG-TERM RECEIVABLES	Mar. 31, 2023
Receivables [Abstract]
CURRENT AND LONG-TERM RECEIVABLES	NOTE 4. CURRENT AND LONG-TERM RECEIVABLES CURRENT RECEIVABLES March 31, 2023 December 31, 2022 Customer receivables $ 11,123 $ 11,803 Revenue sharing program receivables(a) 1,336 1,326 Non-income based tax receivables 1,190 1,146 Supplier advances 711 691 Receivables from disposed businesses 245 115 Other sundry receivables 393 518 Allowance for credit losses(b) (787) (768) Total current receivables $ 14,212 $ 14,831 (a) Revenue sharing program receivables in Aerospace are amounts due from third parties who participate in engine programs by developing and supplying certain engine components through the life of the program. The participants share in program revenues, receive a share of customer progress payments and share costs related to discounts and warranties. (b) Allowance for credit losses increased primarily due to net new provisions of $20 million, partially offset by write-offs, recoveries and foreign currency impact. March 31, 2023 December 31, 2022 Aerospace $ 7,667 $ 7,784 Renewable Energy 2,129 2,415 Power 3,940 4,229 Corporate 477 404 Total current receivables $ 14,212 $ 14,831 Sales of customer receivables. From time to time, the Company sells current or long-term receivables to third parties in response to customer-sponsored requests or programs, to facilitate sales, or for risk mitigation purposes. The Company sold current customer receivables to third parties and subsequently collected $464 million and $347 million in the three months ended March 31, 2023 and 2022, respectively, related primarily to our participation in customer-sponsored supply chain finance programs. Within these programs, primarily in Renewable Energy and Aerospace, the Company has no continuing involvement, fees associated with the transferred receivables are covered by the customer and cash is received at the original invoice due date. Included in the sales of customer receivables in the first quarter of 2023, was $77 million in our Gas Power business, primarily for risk mitigation purposes. LONG-TERM RECEIVABLES March 31, 2023 December 31, 2022 Long-term customer receivables(a) $ 448 $ 457 Supplier advances 279 266 Non-income based tax receivables 236 213 Financing receivables 147 82 Sundry receivables 429 400 Allowance for credit losses (182) (183) Total long-term receivables $ 1,358 $ 1,236 (a) The Company sold zero and $79 million of long-term customer receivables to third parties for the three months ended March 31, 2023 and 2022, respectively, primarily in our Gas Power business for risk mitigation purposes.

INVENTORIES, INCLUDING DEFERRED

INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS	3 Months Ended
INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS	Mar. 31, 2023
Inventory Disclosure [Abstract]
INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS	NOTE 5. INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS March 31, 2023 December 31, 2022 Raw materials and work in process $ 10,000 $ 9,191 Finished goods 4,223 3,937 Deferred inventory costs(a) 1,975 1,764 Inventories, including deferred inventory costs $ 16,198 $ 14,891

PROPERTY, PLANT AND EQUIPMENT A

PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES	3 Months Ended
PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES	Mar. 31, 2023
Property, Plant and Equipment [Abstract]
PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES	NOTE 6. PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES March 31, 2023 December 31, 2022 Original cost $ 26,957 $ 26,641 Less accumulated depreciation and amortization (16,640) (16,303) Right-of-use operating lease assets 1,853 1,854 Property, plant and equipment – net $ 12,170 $ 12,192 Operating Lease Liabilities. Our consolidated operating lease liabilities, included in All other liabilities

GOODWILL AND OTHER INTANGIBLE A

GOODWILL AND OTHER INTANGIBLE ASSETS	3 Months Ended
GOODWILL AND OTHER INTANGIBLE ASSETS	Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL AND OTHER INTANGIBLE ASSETS	NOTE 7. GOODWILL AND OTHER INTANGIBLE ASSETS GOODWILL January 1, 2023 Currency exchange Balance at March 31, 2023 Aerospace $ 8,835 $ 64 $ 8,899 Renewable Energy 3,201 42 3,243 Power 144 — 144 Corporate(a) 818 2 821 Total $ 12,999 $ 108 $ 13,107 (a) Corporate balance comprises our Digital business. We assess the possibility that a reporting unit’s fair value has been reduced below its carrying amount due to the occurrence of events or circumstances between annual impairment testing dates. In the first quarter of 2023, we did not identify any reporting units that required an interim impairment test. However, we continue to monitor the operating results and cash flow forecasts of our Digital reporting unit at Corporate and our Additive reporting unit in our Aerospace segment as the fair value of these reporting units were not significantly in excess of their carrying values based on the results of our most recent annual impairment test, performed in the fourth quarter of 2022. At March 31, 2023, our Digital and Additive reporting units had goodwill of $821 million and $244 million, respectively. Intangible assets decreased $115 million during the three months ended March 31, 2023, primarily as a result of amortization partially offset by changes in foreign exchange rates of $23 million and additions of capitalized software mainly at Aerospace of $20 million. Consolidated amortization expense was $140 million and $922 million in the three months ended March 31, 2023 and 2022, respectively. Included within consolidated amortization expense for the three months ended March 31, 2022 was a non-cash pre-tax impairment charge of $765 million. For further information on this non-cash pre-tax impairment charge, refer to our Annual Report on Form 10-K for the year ended December 31, 2022.

REVENUES

REVENUES	3 Months Ended
REVENUES	Mar. 31, 2023
Revenue from Contract with Customer [Abstract]
REVENUES	NOTE 8. REVENUES EQUIPMENT & SERVICES REVENUES Three months ended March 31 2023 2022 Equipment Services Total Equipment Services Total Aerospace $ 1,974 $ 5,007 $ 6,981 $ 1,654 $ 3,949 $ 5,603 Renewable Energy 2,311 527 2,837 2,173 698 2,871 Power 1,102 2,718 3,820 965 2,536 3,501 Total segment revenues $ 5,387 $ 8,252 $ 13,638 $ 4,792 $ 7,183 $ 11,975 REVENUES Three months ended March 31 2023 2022 Commercial Engines & Services $ 5,194 $ 3,853 Military 1,018 1,036 Systems & Other 770 714 Aerospace $ 6,981 $ 5,603 Onshore Wind $ 1,502 $ 1,906 Grid Solutions equipment and services 824 668 Offshore Wind, Hydro and Hybrid Solutions 511 297 Renewable Energy $ 2,837 $ 2,871 Gas Power $ 2,867 $ 2,489 Steam Power 541 636 Power Conversion, Nuclear and other 412 377 Power $ 3,820 $ 3,501 Total segment revenues $ 13,638 $ 11,975 Corporate $ 848 $ 700 Total revenues $ 14,486 $ 12,675

CONTRACT AND OTHER DEFERRED ASS

CONTRACT AND OTHER DEFERRED ASSETS & PROGRESS COLLECTIONS AND DEFERRED INCOME	3 Months Ended
	Mar. 31, 2023
Contractors [Abstract]
CONTRACT AND OTHER DEFERRED ASSETS & PROGRESS COLLECTIONS AND DEFERRED INCOME	NOTE 9. CONTRACT AND OTHER DEFERRED ASSETS & PROGRESS COLLECTIONS AND DEFERRED INCOME Contract and other deferred assets decreased $368 million in the three months ended March 31, 2023 primarily due to a decrease in long-term service agreements, partially offset by the timing of revenue recognition ahead of billing milestones on long-term equipment contracts. Our long-term service agreements decreased primarily due to billings of $3,155 million, partially offset by revenues recognized of $2,579 million and net favorable changes in estimated profitability of $53 million at Aerospace and net unfavorable changes in estimated profitability of $12 million at Power. March 31, 2023 Aerospace Renewable Energy Power Corporate Total Revenues in excess of billings $ 2,603 $ — $ 5,317 $ — $ 7,920 Billings in excess of revenues (7,288) — (1,807) — (9,095) Long-term service agreements $ (4,685) $ — $ 3,510 $ — $ (1,176) Short-term and other service agreements 456 129 66 277 927 Equipment contract revenues 27 1,009 1,457 — 2,493 Current contract assets $ (4,203) $ 1,138 $ 5,032 $ 277 $ 2,244 Nonrecurring engineering costs(a) 2,521 19 2 — 2,542 Customer advances and other(b) 2,389 — 700 — 3,089 Non-current contract and other deferred assets $ 4,910 $ 19 $ 702 $ — $ 5,631 Total contract and other deferred assets $ 707 $ 1,157 $ 5,734 $ 277 $ 7,875 December 31, 2022 Aerospace Renewable Energy Power Corporate Total Revenues in excess of billings $ 2,363 $ — $ 5,403 $ — $ 7,766 Billings in excess of revenues (6,681) — (1,763) — (8,443) Long-term service agreements $ (4,318) $ — $ 3,640 $ — $ (677) Short-term and other service agreements 391 108 56 245 799 Equipment contract revenues 42 955 1,348 — 2,345 Current contract assets $ (3,884) $ 1,063 $ 5,044 $ 245 $ 2,467 Nonrecurring engineering costs(a) 2,513 17 4 — 2,534 Customer advances and other(b) 2,519 — 724 — 3,243 Non-current contract and other deferred assets $ 5,032 $ 17 $ 728 $ — $ 5,776 Total contract and other deferred assets $ 1,148 $ 1,079 $ 5,772 $ 245 $ 8,244 (a) Included costs incurred prior to production (such as requisition engineering) for equipment production contracts, primarily within our Aerospace segment, which are amortized ratably over each unit produced. (b) Included amounts due from customers at Aerospace for the sales of engines, spare parts and services, and at Power, for the sale of services upgrades, which we collect through incremental fixed or usage-based fees from servicing the equipment under long-term service agreements. Progress collections and deferred income increased $461 million primarily due to new collections received in excess of revenue recognition at Power and Renewable Energy, partially offset by net liquidations at Aerospace. Revenues recognized for contracts included in a liability position at the beginning of the year were $4,468 million and $3,997 million for the three months ended March 31, 2023 and 2022, respectively. March 31, 2023 Aerospace Renewable Energy Power Corporate Total Progress collections on equipment contracts $ 90 $ 2,313 $ 4,349 $ — $ 6,751 Other progress collections 5,631 3,071 451 131 9,284 Current deferred income 216 204 12 119 550 Progress collections and deferred income $ 5,937 $ 5,588 $ 4,812 $ 249 $ 16,586 Non-current deferred income 1,183 206 98 12 1,500 Total Progress collections and deferred income $ 7,120 $ 5,794 $ 4,910 $ 262 $ 18,086 December 31, 2022 Progress collections on equipment contracts $ 74 $ 2,464 $ 3,973 $ — $ 6,511 Other progress collections 5,740 2,731 541 131 9,143 Current deferred income 233 208 13 107 562 Progress collections and deferred income $ 6,047 $ 5,404 $ 4,527 $ 238 $ 16,216 Non-current deferred income 1,110 183 104 12 1,409 Total Progress collections and deferred income $ 7,157 $ 5,586 $ 4,632 $ 250 $ 17,625

ALL OTHER ASSETS

ALL OTHER ASSETS	3 Months Ended
ALL OTHER ASSETS	Mar. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
ALL OTHER ASSETS	NOTE 10. ALL OTHER ASSETS. All other current assets and All other assets primarily include equity method and other investments, long-term customer and sundry receivables (see Note 4), cash and cash equivalents and receivables in our run-off insurance operations and prepaid taxes and other deferred charges. All other non-current assets increased $412 million in the three months ended March 31, 2023, primarily due to an increase in equity method and other investments of $180 million, an increase in long-term receivables of $122 million and an increase in Insurance cash and cash equivalents of $68 million. Insurance cash and cash equivalents was $687 million and $619 million at March 31, 2023 and December 31, 2022, respectively.

BORROWINGS

BORROWINGS	3 Months Ended
BORROWINGS	Mar. 31, 2023
Debt Disclosure [Abstract]
BORROWINGS	NOTE 11. BORROWINGS March 31, 2023 December 31, 2022 Current portion of long-term borrowings Senior notes issued by GE $ 609 $ 464 Senior and subordinated notes assumed by GE 947 1,973 Senior notes issued by GE Capital 592 1,188 Other 114 115 Total short-term borrowings $ 2,262 $ 3,739 Senior notes issued by GE $ 4,653 $ 4,724 Senior and subordinated notes assumed by GE 8,383 8,406 Senior notes issued by GE Capital 6,262 6,289 Other 861 901 Total long-term borrowings $ 20,159 $ 20,320 Total borrowings $ 22,421 $ 24,059

ACCOUNTS PAYABLE AND EQUIPMENT

ACCOUNTS PAYABLE AND EQUIPMENT PROJECT PAYABLES	3 Months Ended
ACCOUNTS PAYABLE AND EQUIPMENT PROJECT PAYABLES	Mar. 31, 2023
Payables and Accruals [Abstract]
ACCOUNTS PAYABLE AND EQUIPMENT PROJECT PAYABLES	NOTE 12. ACCOUNTS PAYABLE AND EQUIPMENT PROJECT PAYABLES March 31, 2023 December 31, 2022 Trade payables $ 10,049 $ 10,033 Supply chain finance programs 3,454 3,689 Equipment project payables(a) 1,109 1,236 Non-income based tax payables 451 441 Accounts payable and equipment project payables $ 15,063 $ 15,399 (a) Primarily related to projects in our Power and Renewable Energy segments. We facilitate voluntary supply chain finance programs with third parties, which provide participating suppliers the opportunity to sell their GE receivables to third parties at the sole discretion of both the suppliers and the third parties. Total supplier invoices paid through these third-party programs were $2,079 million and $1,856 million for the three months ended March 31, 2023 and 2022, respectively.

INSURANCE LIABILITIES AND ANNUI

INSURANCE LIABILITIES AND ANNUITY BENEFITS	3 Months Ended
INSURANCE LIABILITIES AND ANNUITY BENEFITS	Mar. 31, 2023
Insurance [Abstract]
INSURANCE LIABILITIES AND ANNUITY BENEFITS	NOTE 13. INSURANCE LIABILITIES AND ANNUITY BENEFITS. Insurance liabilities and annuity benefits comprise substantially all obligations to annuitants and insureds in our run-off insurance operations. Our insurance operations (net of eliminations) generated revenues of $791 million and $764 million, profit was $70 million and $106 million and net earnings was $54 million and $84 million for the three months ended March 31, 2023 and 2022, respectively. For the years ended December 31, 2022 and 2021 our insurance operations (net of eliminations) generated revenues of $2,957 million and $3,101 million, profit was $205 million and $798 million and net earnings was $159 million and $627 million, respectively. These operations were supported by assets of $47,981 million, $45,031 million and $56,037 million at March 31, 2023, December 31, 2022 and 2021, respectively. A summary of our insurance liabilities and annuity benefits is presented below: March 31, 2023 Long-term care Structured settlement annuities Life Other contracts(a) Total Future policy benefit reserves $ 26,054 $ 9,349 $ 1,045 $ 428 $ 36,876 Investment contracts — 846 — 821 1,667 Other — — 178 361 539 Total $ 26,054 $ 10,194 $ 1,223 $ 1,610 $ 39,082 December 31, 2022 Future policy benefit reserves $ 24,256 $ 8,860 $ 1,040 $ 437 $ 34,593 Investment contracts — 860 — 849 1,708 Other — — 178 365 544 Total $ 24,256 $ 9,720 $ 1,218 $ 1,651 $ 36,845 December 31, 2021 Long-term care Structured settlement annuities Life Other contracts(a) Total Future policy benefit reserves $ 34,644 $ 12,328 $ 1,301 $ 490 $ 48,763 Investment contracts — 950 — 907 1,857 Other — — 189 761 950 Total $ 34,644 $ 13,278 $ 1,490 $ 2,158 $ 51,570 (a) As of December 31, 2021, Other includes reserves of $325 million related to short-duration contracts at EIC, net of eliminations. The following tables summarize balances of and changes in future policy benefits reserves. March 31, 2023 March 31, 2022 Present value of expected net premiums Long-term care Structured settlement annuities Life Long-term care Structured settlement annuities Life Balance, beginning of year $ 4,059 $ — $ 4,828 $ 5,652 $ — $ 6,622 Beginning balance at locked-in discount rate 3,958 — 5,210 4,451 — 5,443 Effect of changes in cash flow assumptions — — — — — — Effect of actual variances from expected experience 29 — (35) (130) — 2 Adjusted beginning of year balance 3,987 — 5,175 4,321 — 5,445 Interest accrual 53 — 50 59 — 52 Net premiums collected (103) — (73) (113) — (83) Effect of foreign currency — — (23) — — 73 Ending balance at locked-in discount rate 3,937 — 5,129 4,267 — 5,487 Effect of changes in discount rate assumptions 281 — (149) 696 — 396 Balance, end of year $ 4,217 $ — $ 4,979 $ 4,963 $ — $ 5,883 Present value of expected future policy benefits Balance, beginning of year $ 28,316 $ 8,860 $ 5,868 $ 40,296 $ 12,328 $ 7,923 Beginning balance at locked-in discount rate 27,026 8,790 6,247 27,465 9,024 6,560 Effect of changes in cash flow assumptions (11) — — — — — Effect of actual variances from expected experience 30 (1) 2 (130) (3) 19 Adjusted beginning of year balance 27,046 8,789 6,250 27,335 9,021 6,579 Interest accrual 363 115 60 365 119 62 Benefit payments (309) (174) (138) (274) (162) (148) Effect of foreign currency — — (24) — — 77 Ending balance at locked-in discount rate 27,100 8,730 6,148 27,425 8,978 6,570 Effect of changes in discount rate assumptions 3,171 619 (123) 7,852 1,870 488 Balance, end of year $ 30,271 $ 9,349 $ 6,025 $ 35,277 $ 10,848 $ 7,058 Net future policy benefit reserves $ 26,054 $ 9,349 $ 1,045 $ 30,314 $ 10,848 $ 1,175 Less: Reinsurance recoverables, net of allowance for credit losses (204) — (57) (5,154) — (81) Net future policy benefit reserves, after reinsurance recoverables $ 25,850 $ 9,349 $ 988 $ 25,160 $ 10,848 $ 1,094 December 31, 2022 December 31, 2021 Present value of expected net premiums Long-term care Structured settlement annuities Life Long-term care Structured settlement annuities Life Balance, beginning of year $ 5,652 $ — $ 6,622 $ 6,397 $ — $ 7,205 Beginning balance at locked-in discount rate 4,451 — 5,443 4,822 — 5,518 Effect of changes in cash flow assumptions (9) — 91 (91) — 191 Effect of actual variances from expected experience (290) — 6 (68) — (69) Adjusted beginning of year balance 4,152 — 5,540 4,663 — 5,640 Interest accrual 223 — 203 241 — 203 Net premiums collected (417) — (357) (453) — (392) Effect of foreign currency — — (176) — — (9) Ending balance at locked-in discount rate 3,958 — 5,210 4,451 — 5,443 Effect of changes in discount rate assumptions 101 — (381) 1,201 — 1,179 Balance, end of year $ 4,059 $ — $ 4,828 $ 5,652 $ — $ 6,622 Present value of expected future policy benefits Balance, beginning of year $ 40,296 $ 12,328 $ 7,923 $ 43,974 $ 13,531 $ 8,767 Beginning balance at locked-in discount rate 27,465 9,024 6,560 27,745 9,163 6,797 Effect of changes in cash flow assumptions (413) (23) 120 (509) 58 207 Effect of actual variances from expected experience (320) (11) 40 (147) (11) (43) Adjusted beginning of year balance 26,732 8,990 6,720 27,089 9,210 6,961 Interest accrual 1,446 471 243 1,435 491 248 Benefit payments (1,152) (671) (531) (1,058) (678) (638) Effect of foreign currency — — (185) — — (10) Ending balance at locked-in discount rate 27,026 8,790 6,247 27,465 9,024 6,560 Effect of changes in discount rate assumptions 1,290 70 (380) 12,831 3,305 1,363 Balance, end of year $ 28,316 $ 8,860 $ 5,868 $ 40,296 $ 12,328 $ 7,923 Net future policy benefit reserves $ 24,256 $ 8,860 $ 1,040 $ 34,644 $ 12,328 $ 1,301 Less: Reinsurance recoverables, net of allowance for credit losses (171) — (67) (6,473) — (87) Net future policy benefit reserves, after reinsurance recoverables $ 24,085 $ 8,860 $ 973 $ 28,171 $ 12,328 $ 1,214 The Statement of Earnings (Loss) for the three months ended March 31, 2023 and 2022, included gross premiums or assessments of $214 million and $229 million and interest accretion of $435 million and $436 million, respectively. For the three months ended March 31, 2023 and 2022, gross premiums or assessments was substantially all related to long-term care of $124 million and $123 million and life of $84 million and $98 million while interest accretion was substantially all related to long-term care of $310 million and $306 million and structured settlement annuities of $115 million and $119 million, respectively. The Statement of Earnings (Loss) for the years ended December 31, 2022 and 2021, included gross premiums or assessments of $935 million and $967 million and interest accretion of $1,735 million and $1,730 million, respectively. For the years ended December 31, 2022 and 2021, gross premiums or assessments was substantially all related to long-term care of $490 million and $487 million and life of $415 million and $448 million while interest accretion was substantially all related to long-term care of $1,224 million and $1,194 million and structured settlement annuities of $471 million and $491 million, respectively. The following table provides the amount of undiscounted and discounted expected future gross premiums and expected future benefits and expenses for nonparticipating traditional contracts. March 31, 2023 March 31, 2022 December 31, 2022 December 31, 2021 Undiscounted Discounted(a) Undiscounted Discounted(a) Undiscounted Discounted(a) Undiscounted Discounted(a) Long-term care Gross premiums $ 7,924 $ 5,105 $ 8,052 $ 5,599 $ 7,985 $ 4,918 $ 8,173 $ 6,187 Benefit payments 64,944 30,271 67,254 35,277 65,217 28,316 67,516 40,296 Structured settlement annuities Benefit payments 19,745 9,349 20,482 10,848 19,936 8,860 20,666 12,328 Life Gross premiums 13,537 6,104 14,676 7,311 13,754 5,916 14,579 8,275 Benefit payments 11,800 6,025 12,709 7,058 12,020 5,868 12,702 7,923 (a) Determined using the current discount rate as of March 31, 2023 and 2022 and December 31, 2022 and 2021. The following table provides the weighted-average durations of and weighted-average interest rates for the liability for future policy benefits. March 31, 2023 March 31, 2022 December 31, 2022 December 31, 2021 Long-term care Structured settlement annuities Life Long-term care Structured settlement annuities Life Long-term care Structured settlement annuities Life Long-term care Structured settlement annuities Life Duration (years)(a) 13.2 11.2 5.3 14.6 12.2 6.1 13.0 10.7 5.0 15.5 13.2 6.3 Interest accretion rate 5.5% 5.4% 5.1% 5.5% 5.4% 5.1% 5.5% 5.4% 4.9% 5.3% 5.5% 4.8% Current discount rate 5.0% 5.0% 4.8% 4.0% 4.0% 3.8% 5.6% 5.5% 5.4% 3.1% 3.1% 2.6% (a) Duration determined using the current discount rate as of March 31, 2023 and 2022 and December 31, 2022 and 2021. We completed our annual review of future policy benefit reserves cash flow assumptions in our run-off insurance portfolio in the third quarter of 2022 and 2021. As a result of our 2022 review, we made changes to assumptions, principally related to assumed moderately higher near-term mortality related to COVID-19. Our 2021 review resulted in changes to our assumptions principally related to favorable adjustments to long-term care claim continuance and utilization, unfavorable emerging lapse experience associated with 20-year level term life policies following the end of their 20-year level premium period, and unfavorable structured settlement annuity mortality at older ages for impaired lives. Included in Insurance losses and annuity benefits in our Statement of Earnings (Loss) for the years ended December 31, 2022 and 2021 are favorable pre-tax adjustments of $404 million and $408 million, respectively, from updating the net premium ratio after updating for actual historical experience each quarter and updating of future cash flow assumptions in the third quarter of each year. Included in these amounts for the years ended December 31, 2022 and 2021, are unfavorable adjustments of $190 million and $58 million, respectively, due to insufficient gross premiums (i.e., net premium ratio exceeded 100%), related to certain cohorts in our long-term care and life insurance portfolios in 2022 and our life portfolio in 2021. These adjustments are primarily attributable to adverse claim experience and delays in premium rate increase approvals in our long-term care insurance portfolio and moderately higher mortality experience and assumption changes related to COVID-19 in our life insurance portfolio. At March 31, 2023 and 2022, policyholders account balances totaled $1,921 million and $2,095 million, respectively. As our insurance operations are in run-off, changes in policyholder account balances for the three months ended March 31, 2023 and 2022, are primarily attributed to surrenders, withdrawals, and benefit payments of $120 million and $115 million, partially offset by net additions from separate accounts and interest credited of $75 million and $81 million, respectively. Interest on policyholder account balances is being credited at minimum guaranteed rates, primarily between 3.0% and 6.0% at both March 31, 2023 and 2022. At December 31, 2022 and 2021, policyholders account balances totaled $1,964 million and $2,124 million. As our insurance operations are in run-off, changes in policyholder account balances for the years ended December 31, 2022 and 2021, are primarily attributed to surrenders, withdrawals, and benefit payments of $441 million and $475 million, partially offset by net additions from separate accounts and interest credited of $271 million and $326 million, respectively. Interest on policyholder account balances is being credited at minimum guaranteed rates, primarily between 3.0% and 6.0% at both December 31, 2022 and 2021. Reinsurance recoverables, net of allowances are included in non-current All other assets in our Statement of Financial Position, and amounted to $277 million, $255 million and $6,596 million at March 31, 2023 and December 31, 2022 and 2021, respectively. Allowances at March 31, 2023 and December 31, 2022 were insignificant and were $2,065 million at December 31, 2021. In the third quarter of 2022, we agreed to terminate substantially all long-term care insurance exposures previously ceded to a single reinsurance company (recapture transaction) and recorded an increase to our allowance for credit losses on such reinsurance recoverables of $350 million (pre-tax) ($276 million (after-tax)) which is unrelated to changes in claim experience or projections of future policy benefit reserves. Upon closing of the recapture transaction in the fourth quarter of 2022, we received a net portfolio of investment securities with an estimated fair value of $2,396 million in complete settlement of reinsurance recoverables previously recognized under retrocession agreements with the reinsurance company, which represented substantially all of our reinsurance recoverables balance as of September 30, 2022 and recorded an incremental loss of $55 million (pre-tax) ($43 million (after-tax)). The recapture transaction reduces both our financial and operational risks by removing the future inherent risk of collectability of reinsurance recoverables, eliminating retrocession contracts having complex terms and conditions, assuming direct control of the portfolio of investment securities held in a trust for our benefit and redeploying those assets consistent with our portfolio realignment strategy and establishing administration service standards intended to enhance claim administration and innovation efforts. The effect of the recapture agreement does not increase our long-term care insurance liabilities as under the existing retrocession agreements we were not previously relieved of our primary obligation to companies from which we originally assumed the liabilities. Statutory accounting practices, not GAAP, determine the required statutory capital levels of our insurance legal entities. Statutory accounting practices are set forth by the National Association of Insurance Commissioners (NAIC) as well as state laws, regulation and general administrative rules and differ in certain respects from GAAP. We annually perform statutory asset adequacy testing, the results of which may affect the amount or timing of capital contributions from GE to the insurance legal entities. Following approval of a statutory permitted accounting practice in 2018 by our primary regulator, the Kansas Insurance Department (KID), we provided a total of $13,215 million of capital contributions to our run-off insurance subsidiaries, including $1,815 million in the first quarter of 2023. In accordance with the terms of the 2018 statutory permitted accounting practice, we expect to provide the final capital contribution of approximately $1,820 million in the first quarter of 2024, pending completion of our December 31, 2023 statutory reporting process, which includes asset adequacy testing, subject to ongoing monitoring by KID. GE is a party to capital maintenance agreements with its run-off insurance subsidiaries under which GE is required to maintain their statutory capital levels at 300% of their year-end Authorized Control Level risk-based capital requirements as defined from time to time by the NAIC. See Notes 1 and 3 for further information related to our run-off insurance operations.

POSTRETIREMENT BENEFIT PLANS

POSTRETIREMENT BENEFIT PLANS	3 Months Ended
POSTRETIREMENT BENEFIT PLANS	Mar. 31, 2023
Retirement Benefits [Abstract]
POSTRETIREMENT BENEFIT PLANS	NOTE 14. POSTRETIREMENT BENEFIT PLANS. We sponsor a number of pension and retiree health and life insurance benefit plans that we present in three categories, principal pension plans, other pension plans and principal retiree benefit plans. Please refer to Note 13 to the consolidated financial statements of our Annual Report on Form 10-K for the year ended December 31, 2022 for further information about our plans before the Separation. In connection with the Separation, certain of these plans were split into three and net liabilities of approximately $4.0 billion associated with GE’s postretirement benefit plans were transferred to GE HealthCare. Information about the plans remaining with GE after the Separation is provided below. DESCRIPTION OF OUR PLANS Plan Category Participants Funding Comments Principal Pension Plans GE Energy Pension Plan and GE Aerospace Pension Plan Covers U.S. participants ~115,000 retirees and beneficiaries, ~50,000 vested former employees and ~16,500 active employees Our funding policy is to contribute amounts sufficient to meet minimum funding requirements under employee benefit and tax laws. We may decide to contribute additional amounts beyond this level. Closed to new participants since 2012. Benefits for employees with salaried benefits were frozen effective January 1, 2021, and thereafter these employees receive increased company contributions in the company sponsored defined contribution plan in lieu of participation in a defined benefit plan (announced October 2019). GE Energy Supplementary Pension Plan GE Aerospace Supplementary Pension Plan Provides supplementary benefits to higher-level, longer-service U.S. employees Unfunded. We pay benefits from company cash. The annuity benefit has been closed to new participants since 2011 and has been replaced by an installment benefit (which was closed to new executives after 2020). Benefits for employees who became executives before 2011 were frozen effective January 1, 2021, and thereafter these employees accrue the installment benefit. Other Pension Plans(a) 35 U.S. and non-U.S. pension plans with pension assets or obligations that have reached $50 million Covers ~42,500 retirees and beneficiaries, ~29,500 vested former employees and ~8,000 active employees Our funding policy is to contribute amounts sufficient to meet minimum funding requirements under employee benefit and tax laws in each country. We may decide to contribute additional amounts beyond this level. We pay benefits for some plans from company cash. In certain countries, benefit accruals have ceased and/or have been closed to new hires as of various dates. Principal Retiree Benefit Plans Provides health and life insurance benefits to certain eligible participants Covers U.S. participants of Power and Renewable Energy (will be part of GE Vernova, GE's portfolio of energy businesses) and Aerospace ~93,500 retirees and dependents and ~15,500 active employees We fund retiree health benefits on a pay-as-you-go basis and the retiree life insurance trust at our discretion. Participants share in the cost of the healthcare benefits. (a) Plans for Power and Renewable Energy (will be part of GE Vernova) and Aerospace that reach $50 million. Plans are not removed from the presentation unless part of a disposition or plan termination. The components of benefit plans cost other than the service cost are included in the caption Non-operating benefit costs in our Statement of Earnings (Loss). PRINCIPAL PENSION PLANS Three months ended March 31 2023 2022 Service cost for benefits earned $ 21 $ 49 Expected return on plan assets (594) (786) Interest cost on benefit obligations 474 517 Net actuarial loss amortization and other (172) 363 Net periodic expense (income) (271) 143 Less discontinued operations $ — $ 49 Continuing operations – net periodic expense (income) $ (271) $ 94 Principal retiree benefit plans income was $36 million for the three months ended March 31, 2023 and $52 million, of which $33 million is from continuing operations, for the three months ended March 31, 2022. Other pension plans income was $29 million for the three months ended March 31, 2023 and $117 million, of which $89 million is from continuing operations, for the three months ended March 31, 2022. We also have a defined contribution plan for eligible U.S. employees that provides employer contributions. Defined contribution plan costs were $77 million for the three months ended March 31, 2023 and $110 million, of which $79 million is from continuing operations, for the three months ended March 31, 2022.

CURRENT AND ALL OTHER LIABILITI

CURRENT AND ALL OTHER LIABILITIES	3 Months Ended
CURRENT AND ALL OTHER LIABILITIES	Mar. 31, 2023
Other Liabilities Disclosure [Abstract]
CURRENT AND ALL OTHER LIABILITIES	NOTE 15. CURRENT AND ALL OTHER LIABILITIES. All other current liabilities and All other liabilities primarily includes liabilities for customer sales allowances, equipment project and commercial liabilities, loss contracts, employee compensation and benefits, income taxes payable and uncertain tax positions, operating lease liabilities (see Note 6), environmental, health and safety remediations and product warranties (see Note 23). All other current liabilities increased $183 million in the three months ended March 31, 2023, primarily due to taxes payable of $175 million, sales discounts and allowances of $135 million and equipment projects and other commercial liabilities of $120 million partially offset by derivative instruments of $195 million. All other liabilities decreased $125 million in the three months ended March 31, 2023, primarily due to decreased equipment projects and other commercial liabilities of $181 million.

INCOME TAXES

INCOME TAXES	3 Months Ended
INCOME TAXES	Mar. 31, 2023
Income Tax Disclosure [Abstract]
INCOME TAXES	NOTE 16. INCOME TAXES. Our income tax rate was 4.2% and (2.5)% for the three months ended March 31, 2023 and 2022, respectively. The low tax rate for 2023 was primarily due to the unrealized gain on our investment in GE HealthCare, which is expected to be recovered tax-free. We intend to dispose of our investment in a manner consistent with the tax-free treatment confirmed in our Internal Revenue Service (IRS) ruling in connection with the spin of GE HealthCare. This was partially offset by separation income tax costs including disallowed expenses and valuation allowances related to the spin of GE HealthCare and by losses in foreign jurisdictions that are not likely to be utilized. The tax rate for 2022 reflects a tax provision on a pre-tax loss. The rate was negative primarily due to non-tax benefited asset impairment charges, losses in foreign jurisdictions that are not likely to be utilized and the net unrealized capital loss on our interest in AerCap and Baker Hughes for which the loss could not be tax benefited. On August 16, 2022, the U.S. enacted the Inflation Reduction Act that includes a new Corporate Alternative Minimum Tax (CAMT) based upon financial statement income, an excise tax on stock buybacks and tax incentives for energy and climate initiatives, among other provisions. The new CAMT is expected to slow but not eliminate the favorable tax impact of our deferred tax assets, resulting in higher cash tax in some years that would generate future tax benefits. The impact of CAMT will depend on our facts in each year and anticipated guidance from the U.S. Department of the Treasury. We currently do not expect to incur CAMT in 2023.

SHAREHOLDERS' EQUITY

SHAREHOLDERS' EQUITY	3 Months Ended
SHAREHOLDERS' EQUITY	Mar. 31, 2023
Equity [Abstract]
SHAREHOLDERS' EQUITY	NOTE 17. SHAREHOLDERS’ EQUITY Three months ended March 31 ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Dividends per share in dollars) 2023 2022 Beginning balance $ (5,893) $ (4,569) AOCI before reclasses – net of taxes of $(5) and $90 152 (181) Reclasses from AOCI – net of taxes of $(626) and $0(a) 2,234 — AOCI 2,387 (181) Less AOCI attributable to noncontrolling interests (1) (4) Currency translation adjustments AOCI $ (3,505) $ (4,746) Beginning balance $ 6,531 $ 3,646 AOCI before reclasses – net of taxes of $(13) and $25 (84) 54 Reclasses from AOCI – net of taxes of $(594) and $55(a) (2,235) 186 AOCI (2,319) 240 Less AOCI attributable to noncontrolling interests (2) 2 Benefit plans AOCI $ 4,214 $ 3,884 Beginning balance $ (1,927) $ 5,172 AOCI before reclasses – net of taxes of $188 and $(801) 718 (2,993) Reclasses from AOCI – net of taxes of $0 and $1(a) (12) (5) AOCI 706 (2,998) Investment securities and cash flow hedges AOCI $ (1,222) $ 2,174 Beginning balance $ (983) $ (9,109) AOCI before reclasses – net of taxes of $(477) and $979 (1,793) 3,682 AOCI (1,793) 3,682 Long-duration insurance contracts AOCI $ (2,776) $ (5,427) AOCI at March 31 $ (3,289) $ (4,115) Dividends declared per common share $ 0.08 $ 0.08 (a) The total reclassification from AOCI included $195 million, including currency translation of $2,234 million and benefit plans of $(2,030) million, net of taxes, in three months ended March 31, 2023 related to the spin-off of GE HealthCare. Preferred stock. GE preferred stock shares outstanding were 2,795,444 and 5,795,444 at March 31, 2023 and December 31, 2022, respectively. We redeemed $3,000 million of GE Series D preferred stock in the first quarter of 2023. Common stock. GE common stock shares outstanding were 1,088,960,029 and 1,089,107,878 at March 31, 2023 and December 31, 2022, respectively. For further information on our common and preferred stock issuances, please refer to our Annual Report on Form 10-K for the year ended December 31, 2022.

EARNINGS PER SHARE INFORMATION

EARNINGS PER SHARE INFORMATION	3 Months Ended
EARNINGS PER SHARE INFORMATION	Mar. 31, 2023
Earnings Per Share [Abstract]
EARNINGS PER SHARE INFORMATION	NOTE 18. EARNINGS PER SHARE INFORMATION Three months ended March 31 2023 2022 (Earnings for per-share calculation, shares in millions, per-share amounts in dollars) Diluted Basic Diluted Basic Earnings (loss) from continuing operations $ 6,242 $ 6,248 $ (1,224) $ (1,224) Preferred stock dividends and other(a) (145) (145) (52) (52) Earnings (loss) from continuing operations attributable to common shareholders 6,097 6,103 (1,276) (1,276) Earnings (loss) from discontinued operations 1,257 1,257 88 88 Net earnings (loss) attributable to GE common shareholders 7,354 7,360 (1,188) (1,188) Shares of GE common stock outstanding 1,089 1,089 1,100 1,100 Employee compensation-related shares (including stock options) 8 — — — Total average equivalent shares 1,097 1,089 1,100 1,100 Earnings (loss) per share from continuing operations $ 5.56 $ 5.60 $ (1.16) $ (1.16) Earnings (loss) per share from discontinued operations 1.15 1.15 0.08 0.08 Net earnings (loss) per share 6.71 6.76 (1.08) (1.08) Potentially dilutive securities(b) 38 43 (a) For the three months ended March 31, 2023, included $(30) million related to excise tax on preferred share redemption. (b) Outstanding stock awards not included in the computation of diluted earnings (loss) per share because their effect was antidilutive. Our unvested restricted stock unit awards that contain non-forfeitable rights to dividends or dividend equivalents are considered participating securities and, therefore, are included in the computation of earnings per share pursuant to the two-class method. For the three months ended March 31, 2023, application of this treatment had an insignificant effect. For the three months ended March 31, 2022, as a result of the loss from continuing operations, losses were not allocated to the participating securities.

OTHER INCOME (LOSS)

OTHER INCOME (LOSS)	3 Months Ended
OTHER INCOME (LOSS)	Mar. 31, 2023
Other Income and Expenses [Abstract]
OTHER INCOME (LOSS)	NOTE 19. OTHER INCOME (LOSS) Three months ended March 31 2023 2022 Licensing and royalty income $ 34 $ 57 Equity method income — 38 Investment in GE HealthCare unrealized gain (loss) 6,093 — Investment in and note with AerCap realized and unrealized gain (loss) (195) (1,736) Investment in Baker Hughes realized and unrealized gain (loss) 10 1,515 Other net interest and investment income (loss) 186 93 Other items (48) 82 Total other income (loss) $ 6,081 $ 49 Our investment in GE HealthCare comprises 90.3 million shares (approximately 19.9% ownership interest) at March 31, 2023. Our investment in AerCap comprises 79.7 million ordinary shares (approximately 33% ownership interest) at March 31, 2023 and an AerCap senior note. During the first quarter of 2023, we received total proceeds of $1,808 million from the sale of AerCap shares. During the first quarter of 2023, we received proceeds of $216 million from the sale of Baker Hughes shares and have now fully monetized our position.

RESTRUCTURING CHARGES AND SEPAR

RESTRUCTURING CHARGES AND SEPARATION COSTS	3 Months Ended
RESTRUCTURING CHARGES AND SEPARATION COSTS	Mar. 31, 2023
Restructuring and Related Activities [Abstract]
RESTRUCTURING CHARGES AND SEPARATION COSTS	NOTE 20. RESTRUCTURING CHARGES AND SEPARATION COSTS RESTRUCTURING AND OTHER CHARGES. This table is inclusive of all restructuring charges in our segments and at Corporate, and the charges are shown below for the business where they originated. Separately, in our reported segment results, significant, higher-cost restructuring programs are excluded from measurement of segment operating performance for internal and external purposes; those excluded amounts are reported in Restructuring and other charges for Corporate. Three months ended March 31 RESTRUCTURING AND OTHER CHARGES 2023 2022 Workforce reductions $ 66 $ 13 Plant closures & associated costs and other asset write-downs 82 26 Acquisition/disposition net charges and other 12 9 Total restructuring and other charges $ 161 $ 48 Cost of equipment/services $ 36 $ 27 Selling, general and administrative expenses 125 25 Other (income) loss — (3) Total restructuring and other charges $ 161 $ 48 Aerospace $ 4 $ 5 Renewable Energy 65 6 Power 19 34 Corporate 72 3 Total restructuring and other charges $ 161 $ 48 Restructuring and other charges cash expenditures $ 137 $ 127 An analysis of changes in the liability for restructuring follows. 2023 2022 Balance at January 1 $ 977 $ 825 Additions 86 9 Payments (87) (115) Effect of foreign currency and other — (9) Balance at March 31(a) $ 976 $ 710 (a) Includes actuarial determined post-employment severance benefits reserve of $353 million and $322 million as of March 31, 2023 and 2022, respectively. Also includes $64 million reserve in discontinued operations related to a GE technology contract which is indemnified by GE HealthCare as of March 31, 2023. For the three months ended March 31, 2023, restructuring and other initiatives primarily included exit activities related to the restructuring program announced in the fourth quarter of 2022 reflecting lower Corporate shared-service and footprint needs as a result of the GE HealthCare spin-off. It also includes exit activities associated with the plan announced in the fourth quarter of 2022 to undertake a restructuring program across our businesses planned to be part of GE Vernova, primarily reflecting the selectivity strategy to operate in fewer markets and to simplify and standardize product variants at Renewable Energy. We recorded total charges of $161 million, consisting of $75 million primarily in non-cash impairment, accelerated depreciation and other charges, not reflected in the table above, and $86 million primarily in employee workforce reduction and contract related charges, which are reflected in the table above. We incurred $137 million in cash outflows related to restructuring actions, primarily for employee severance payments. For the three months ended March 31, 2022, restructuring and other initiatives primarily included exit activities at our Power business related to our new coal build wind-down actions announced in the third quarter of 2021, which included the exit of certain product lines, closing certain manufacturing and office facilities, and workforce reduction programs. We recorded total charges of $48 million, consisting of $39 million primarily in non-cash impairment, accelerated depreciation and other charges, not reflected in the table above, and $9 million primarily in employee workforce reduction charges, which are reflected in the table above. We incurred $127 million in cash outflows related to restructuring actions, primarily for employee severance payments. SEPARATION COSTS. In November 2021, the company announced its plan to form three industry-leading, global public companies focused on the growth sectors of aviation, healthcare, and energy. As a result of this plan, we expect to incur separation, transition, and operational costs, which will depend on specifics of the transactions. For the three months ended March 31, 2023, we incurred pre-tax separation expense of $205 million and paid $204 million in cash primarily related to employee costs, professional fees, costs to establish certain stand-alone functions and information technology systems, and other transformation and transaction costs to transition to three stand-alone public companies. These costs are presented as separation costs in our consolidated Statement of Earnings (Loss). In addition, we incurred $56 million of net tax expense, including taxes associated with planned legal entity restructuring and changes to indefinite reinvestment of foreign earnings. For the three months ended March 31, 2022, we incurred pre-tax separation costs of $99 million, spent $3 million in cash, and recognized $24 million of net tax expense related to separation activities. As discussed in Note 2, GE completed the previously announced separation of its HealthCare business into a separate, independent publicly traded company, GE HealthCare Technologies Inc. (GE HealthCare). As a result, pre-tax separation costs specifically identifiable to GE HealthCare are now reflected in discontinued operations. We incurred $20 million in pre-tax costs and recognized $4 million of tax benefits for both the three months ended March 31, 2023 and 2022, and spent $85 million in cash related to GE HealthCare for the three months ended March 31, 2023.

FINANCIAL INSTRUMENTS

FINANCIAL INSTRUMENTS	3 Months Ended
FINANCIAL INSTRUMENTS	Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
FINANCIAL INSTRUMENTS	NOTE 21. FINANCIAL INSTRUMENTS. The following table provides information about assets and liabilities not carried at fair value and excludes finance leases, equity securities without readily determinable fair value and non-financial assets and liabilities. Substantially all of these assets are considered to be Level 3 and the vast majority of our liabilities’ fair value are considered Level 2. March 31, 2023 December 31, 2022 Carrying Estimated Carrying Estimated Assets Loans and other receivables $ 2,427 $ 2,275 $ 2,557 $ 2,418 Liabilities Borrowings (Note 11) $ 22,421 $ 21,586 $ 24,059 $ 22,849 Investment contracts (Note 13) 1,667 1,736 1,708 1,758 Assets and liabilities that are reflected in the accompanying financial statements at fair value are not included in the above disclosures; such items include cash and equivalents, investment securities and derivative financial instruments. DERIVATIVES AND HEDGING. Our policy requires that derivatives are used solely for managing risks and not for speculative purposes. We use derivatives to manage currency risks related to foreign exchange, and interest rate and currency risk between financial assets and liabilities, and certain equity investments and commodity prices. FAIR VALUE OF DERIVATIVES March 31, 2023 December 31, 2022 Gross Notional All other assets All other liabilities Gross Notional All other assets All other liabilities Currency exchange contracts $ 4,648 $ 138 $ 100 $ 5,112 $ 132 $ 146 Derivatives accounted for as hedges $ 4,648 $ 138 $ 100 $ 5,112 $ 132 $ 146 Currency exchange contracts $ 58,595 $ 917 $ 871 $ 51,885 $ 946 $ 1,082 Interest rate contracts 30 — — 43 — 1 Other contracts 652 154 9 858 197 13 Derivatives not accounted for as hedges $ 59,277 $ 1,071 $ 880 $ 52,786 $ 1,143 $ 1,095 Gross derivatives $ 63,925 $ 1,208 $ 980 $ 57,898 $ 1,275 $ 1,241 Netting and credit adjustments $ (756) $ (755) $ (821) $ (820) Net derivatives recognized in statement of financial position $ 452 $ 225 $ 454 $ 420 FAIR VALUE HEDGES. As of March 31, 2023, all fair value hedges were terminated due to exposure management actions, including debt maturities. Gains (losses) associated with the terminated hedging relationships will continue to amortize into interest expense until the hedged borrowings mature. The cumulative amount of hedging adjustments of $1,226 million (all on discontinued hedging relationships) was included in the carrying amount of the previously hedged liability of $8,817 million. At March 31, 2022, the cumulative amount of hedging adjustments of $1,931 million (including $2,011 million on discontinued hedging relationships) was included in the carrying amount of the previously hedged liability of $15,636 million. The cumulative amount of hedging adjustments was primarily recorded in long-term borrowings. CASH FLOW HEDGES AND NET INVESTMENT HEDGES Gain (loss) recognized in AOCI Three months ended March 31 2023 2022 Cash flow hedges(a) $ 28 $ (47) Net investment hedges(b) (62) 112 (a) Primarily related to currency exchange contracts. (b) The carrying value of foreign currency debt designated as net investment hedges was $3,398 million and $3,934 million as of March 31, 2023 and 2022, respectively. The total reclassified from AOCI into earnings was zero for both the three months ended March 31, 2023 and 2022. Changes in the fair value of cash flow hedges are recorded in AOCI and recorded in earnings in the period in which the hedged transaction occurs. The total amount in AOCI related to cash flow hedges of forecasted transactions was a $25 million loss as of March 31, 2023. We expect to reclassify $8 million of loss to earnings in the next 12 months contemporaneously with the earnings effects of the related forecasted transactions. As of March 31, 2023, the maximum term of derivative instruments that hedge forecasted transactions was approximately 12 years. The table below presents the gains (losses) of our derivative financial instruments in the Statement of Earnings (Loss): Three months ended March 31, 2023 Three months ended March 31, 2022 Revenues Interest Expense SG&A Other(a) Revenues Interest Expense SG&A Other(a) $ 14,486 $ 269 $ 2,142 $ 16,810 $ 12,675 $ 387 $ 2,725 $ 9,823 Effect of cash flow hedges $ 1 $ (2) $ — $ (2) $ 3 $ (7) $ — $ (32) Hedged items 78 Derivatives designated as hedging instruments (87) Effect of fair value hedges $ (9) Currency exchange contracts $ 2 $ — $ 76 $ (47) $ 1 $ (68) $ (81) Interest rate, commodity — 39 (11) 1 (37) 15 Effect of derivatives not designated as hedges $ 2 $ — $ 115 $ (58) $ 1 $ — $ (105) $ (66) (a) Amounts are inclusive of cost of sales and other income (loss). (b) SG&A was primarily driven by hedges of deferred incentive compensation, and hedges of remeasurement of monetary assets and liabilities. These hedging programs were to offset the earnings impact of the underlying. COUNTERPARTY CREDIT RISK. Our exposures to counterparties were $325 million and $306 million at March 31, 2023 and December 31, 2022, respectively. Counterparties' exposures to our derivative liability were $170 million and $365 million at March 31, 2023 and December 31, 2022, respectively.

VARIABLE INTEREST ENTITIES

VARIABLE INTEREST ENTITIES	3 Months Ended
VARIABLE INTEREST ENTITIES	Mar. 31, 2023
Variable Interest Entities [Abstract]
VARIABLE INTEREST ENTITIES	NOTE 22. VARIABLE INTEREST ENTITIES. In our Statement of Financial Position, we have assets of $404 million and $401 million and liabilities of $192 million and $206 million at March 31, 2023 and December 31, 2022, respectively, in consolidated Variable Interest Entities (VIEs). These entities were created to help our customers facilitate or finance the purchase of GE equipment and services and have no features that could expose us to losses that would significantly exceed the difference between the consolidated assets and liabilities.

COMMITMENTS, GUARANTEES, PRODUC

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES	NOTE 23. COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES COMMITMENTS. We had total investment commitments of $3,966 million at March 31, 2023. The commitments primarily comprise investments by our run-off insurance operations in investment securities and other assets of $3,868 million and included within these commitments are obligations to make investments in unconsolidated VIEs of $3,761 million. See Note 22 for further information. As of March 31, 2023, in our Aerospace segment, we have committed to provide financing assistance of $2,390 million of future customer acquisitions of aircraft equipped with our engines. GUARANTEES. Indemnification agreements - Discontinued Operations. Following the Separation of GE HealthCare on January 3, 2023, GE has remaining performance and bank guarantees on behalf of its former HealthCare business. Under the Separation Distribution Agreement (SDA) entered into by the Company and GE HealthCare in connection with the Separation, GE HealthCare is obligated to use reasonable best efforts to replace GE as the guarantor on or terminate all such credit support instruments. Until such termination or replacement, in the event of non-fulfillment of contractual obligations by the relevant obligor(s), GE could be obligated to make payments under the applicable instruments. Under the SDA, GE HealthCare is obligated to reimburse and indemnify GE for any such payments. As of March 31, 2023, GE’s maximum aggregate exposure under such credit support instruments was $76 million. Most of these guarantees are not expected to remain in effect as of December 31, 2023. GE also has obligations under the Transition Services Agreement to indemnify GE HealthCare for certain of its technology costs of $70 million, which are expected to be incurred by GE HealthCare within the first year following the Separation and are fully reserved, and under the Tax Matters Agreement to indemnify GE HealthCare for certain tax costs of $47 million, which are fully reserved. In addition, we have provided specific indemnities to other buyers of assets of our business that, in the aggregate, represent a maximum potential claim of $706 million with related reserves of $76 million. Indemnification agreements – Continuing Operations. GE has obligations under the Tax Matters Agreement to indemnify GE HealthCare for certain tax costs and other indemnifications of $49 million, which are fully reserved. In addition, we have $520 million of other indemnification commitments, including representations and warranties in sales of business assets, for which we recorded a liability of $78 million. For information on credit support agreements, see our Annual Report on Form 10-K for the year ended December 31, 2022. PRODUCT WARRANTIES. We provide for estimated product warranty expenses when we sell the related products. Because warranty estimates are forecasts that are based on the best available information, mostly historical claims experience, claims costs may differ from amounts provided. The liability for product warranties was $1,932 million and $1,960 million at March 31, 2023 and December 31, 2022, respectively. LEGAL MATTERS. The following information supplements and amends the discussion of Legal Matters in Note 24 to the consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2022; refer to that discussion for information about previously reported legal matters that are not updated below. In the normal course of our business, we are involved from time to time in various arbitrations, class actions, commercial litigation, investigations and other legal, regulatory or governmental actions, including the significant matters described below that could have a material impact on our results of operations. In many proceedings, including the specific matters described below, it is inherently difficult to determine whether any loss is probable or even reasonably possible or to estimate the size or range of the possible loss, and accruals for legal matters are not recorded until a loss for a particular matter is considered probable and reasonably estimable. Given the nature of legal matters and the complexities involved, it is often difficult to predict and determine a meaningful estimate of loss or range of loss until we know, among other factors, the particular claims involved, the likelihood of success of our defenses to those claims, the damages or other relief sought, how discovery or other procedural considerations will affect the outcome, the settlement posture of other parties and other factors that may have a material effect on the outcome. For these matters, unless otherwise specified, we do not believe it is possible to provide a meaningful estimate of loss at this time. Moreover, it is not uncommon for legal matters to be resolved over many years, during which time relevant developments and new information must be continuously evaluated. Alstom legacy legal matters. In 2015, we acquired the Steam Power, Renewables and Grid businesses from Alstom, which prior to our acquisition were the subject of significant cases involving anti-competitive activities and improper payments. We had reserves of $420 million and $455 million at March 31, 2023 and December 31, 2022, respectively, for legal and compliance matters related to the legacy business practices that were the subject of cases in various jurisdictions. Allegations in these cases relate to claimed anti-competitive conduct or improper payments in the pre-acquisition period as the source of legal violations or damages. Given the significant litigation and compliance activity related to these matters and our ongoing efforts to resolve them, it is difficult to assess whether the disbursements will ultimately be consistent with the reserve established. The estimation of this reserve may not reflect the full range of uncertainties and unpredictable outcomes inherent in litigation and investigations of this nature, and at this time we are unable to develop a meaningful estimate of the range of reasonably possible additional losses beyond the amount of this reserve. Factors that can affect the ultimate amount of losses associated with these and related matters include the way cooperation is assessed and valued, prosecutorial discretion in the determination of damages, formulas for determining disgorgement, fines or penalties, the duration and amount of legal and investigative resources applied, political and social influences within each jurisdiction, and tax consequences of any settlements or previous deductions, among other considerations. Actual losses arising from claims in these and related matters could exceed the amount provided. Bank BPH . As previously reported, Bank BPH, along with other Polish banks, has been subject to ongoing litigation in Poland related to its portfolio of floating rate residential mortgage loans, with cases brought by individual borrowers seeking relief related to their foreign currency indexed or denominated mortgage loans in various courts throughout Poland. At March 31, 2023, approximately 86% of the Bank BPH portfolio is indexed to or denominated in foreign currencies (primarily Swiss francs), and the total portfolio had a carrying value, net of reserves, of $1,126 million. We continue to observe an increase in the number of lawsuits being brought against Bank BPH and other banks in Poland by current and former borrowers, and we expect this to continue in future reporting periods. We estimate potential losses for Bank BPH in connection with borrower litigation cases that are pending by recording legal reserves, as well as in connection with potential future cases or other adverse developments as part of our ongoing valuation of the Bank BPH portfolio, which we record at the lower of cost or fair value, less cost to sell. At March 31, 2023, the total amount of estimated losses was $1,540 million. We update our assumptions underlying the amount of estimated losses based primarily on the number of lawsuits filed and estimated to be filed in the future, whether liability will be established in lawsuits and the nature of the remedy ordered by courts if liability is established. The increase in the amount of estimated losses during the first quarter of 2023 was driven primarily by increased findings of liability and increases in the number of lawsuits filed. We expect the trends we have previously reported of an increasing number of lawsuits being filed and estimated to be filed in the future, more findings of liability and more severe remedies being ordered against Polish banks (including Bank BPH) to continue in future reporting periods, although Bank BPH is unable at this time to develop a meaningful estimate of reasonably possible losses associated with active and inactive Bank BPH mortgage loans beyond the amounts currently recorded. Additional factors may also affect our estimated losses over time, including: potentially significant judicial decisions or binding resolutions by the European Court of Justice (ECJ) or the Polish Supreme Court; the impact of any of these or other future or recent decisions or resolutions (including an expected ECJ ruling that could adversely impact the remedy cost to Polish banks upon a finding of liability and encourage more borrower lawsuits) on how Polish courts will interpret and apply the law in particular cases and how borrower behavior may change in response, neither of which are known immediately upon the issuance of a decision or resolution; financial, economic and other conditions in Poland that may adversely affect borrowers; uncertainty related to a proposal by the Chairman of the Polish Financial Supervisory Authority in December 2020 that banks voluntarily offer borrowers an opportunity to convert their foreign currency indexed or denominated mortgage loans to Polish zlotys using an exchange rate applicable at the date of loan origination, and about the success of the various settlement strategies or other approaches that Polish banks have increasingly adopted or will adopt, or that Bank BPH may adopt in the future, in response to this proposal, regulatory encouragement or other factors, the approaches that regulators and other government authorities will adopt in response, the receptivity of borrowers to settlement offers; the financial and capital impact on banks that adopt settlement programs; the ability of banks, including Bank BPH, to continue collecting installment payments under existing loans, including principal, interest and foreign exchange margins; the ability of banks, including Bank BPH, to recover from borrowers the original principal amount of loans invalidated by Polish courts; and any potential legislation that may be passed in Poland relating to foreign exchange indexed or denominated mortgage loans. In addition, there is continued uncertainty arising from investigations of the Polish Office of Competition and Consumer Protection (UOKiK), including existing or anticipated UOKiK and court decisions resulting from those investigations, particularly UOKiK's investigation into the adequacy of disclosure of foreign exchange risk by banks (including Bank BPH) and the legality under Polish law of unlimited foreign exchange risk on customers. Future changes related to any of the foregoing or in Bank BPH's approach, or other adverse developments such as actions by regulators, legislators or other governmental authorities (including UOKiK), likely would have a material adverse effect on Bank BPH as well as result in additional required capital contributions to Bank BPH or significant losses beyond the amounts that we currently estimate. ENVIRONMENTAL, HEALTH AND SAFETY MATTERS . For further information about environmental, health and safety matters, see our Annual Report on Form 10-K for the year ended December 31, 2022.

SEGMENT OPERATIONS

SEGMENT OPERATIONS	3 Months Ended
SEGMENT OPERATIONS	Mar. 31, 2023
Segment Reporting [Abstract]
SEGMENT OPERATIONS	SEGMENT OPERATIONS. Refer to our Annual Report on Form 10-K for the year ended December 31, 2022 for further information regarding our determination of segment profit for continuing operations and for our allocations of corporate costs to our segments. SUMMARY OF REPORTABLE SEGMENTS Three months ended March 31 2023 2022 V % Aerospace $ 6,981 $ 5,603 25 % Renewable Energy 2,837 2,871 (1) % Power 3,820 3,501 9 % Total segment revenues 13,638 11,975 14 % Corporate 848 700 21 % Total revenues $ 14,486 $ 12,675 14 % Aerospace $ 1,326 $ 908 46 % Renewable Energy (414) (434) 5 % Power 75 63 19 % Total segment profit (loss) 987 538 83 % Corporate(a) 5,456 (1,419) F Interest and other financial charges (257) (371) 31 % Non-operating benefit income (cost) 385 105 F Benefit (provision) for income taxes (322) (76) U Preferred stock dividends (145) (52) U Earnings (loss) from continuing operations attributable to GE common shareholders 6,103 (1,276) F Earnings (loss) from discontinued operations attributable to GE common shareholders 1,257 88 F Net earnings (loss) attributable to GE common shareholders $ 7,360 $ (1,188) F (a) Includes interest and other financial charges of $12 million and $16 million and benefit for income taxes of $51 million and $47 million related to EFS within Corporate for the three months ended March 31, 2023 and 2022, respectively.

BASIS OF PRESENTATION AND SUM_2

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
FINANCIAL STATEMENT PRESENTATION	Our financial statements are prepared in conformity with U.S. generally accepted accounting principles (GAAP), which requires us to make estimates based on assumptions about current, and for some estimates, future, economic and market conditions which affect reported amounts and related disclosures in our financial statements. Although our current estimates contemplate current and expected future conditions, as applicable, it is reasonably possible that actual conditions could differ from our expectations, which could materially affect our results of operations, financial position and cash flows. Such changes could result in future impairments of goodwill, intangibles, long-lived assets and investment securities, revisions to estimated profitability on long-term product service agreements, incremental credit losses on receivables and debt securities, a change in the carrying amount of our tax assets and liabilities, or a change in our insurance liabilities and pension obligations as of the time of a relevant measurement event.In preparing our Statement of Cash Flows, we make certain adjustments to reflect cash flows that cannot otherwise be calculated by changes in our Statement of Financial Position. These adjustments may include, but are not limited to, the effects of currency exchange, acquisitions and dispositions of businesses, businesses classified as held for sale, the timing of settlements to suppliers for property, plant and equipment, non-cash gains/losses and other balance sheet reclassifications.
RECLASSIFICATIONS	We have reclassified certain prior-year amounts to conform to the current-year’s presentation. Unless otherwise noted, tables are presented in U.S. dollars in millions. Certain columns and rows may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying numbers in millions. Earnings per share amounts are computed independently for earnings from continuing operations, earnings from discontinued operations and net earnings. As a result, the sum of per-share amounts may not equal the total. Unless otherwise indicated, information in these notes to consolidated financial statements relates to continuing operations. Certain of our operations have been presented as discontinued. We present businesses whose disposal represents a strategic shift that has, or will have, a major effect on our operations and financial results as discontinued operations when the components meet the criteria for held for sale, are sold, or spun-off.
INSURANCE	INSURANCE. Our run-off insurance operations include providing insurance and reinsurance for life and health risks and providing certain annuity products. Primary product types include long-term care, structured settlement annuities, life and disability insurance contracts and investment contracts. Insurance contracts are contracts with significant mortality and/or morbidity risks, while investment contracts are contracts without such risks. Insurance revenues are comprised primarily of premiums and investment income. For traditional long-duration insurance contracts, we report premiums as revenue when due. Premiums received on non-traditional long-duration insurance contracts and investment contracts, including annuities without significant mortality risk, are not reported as revenues but rather as deposit liabilities. We recognize revenues for charges and assessments on these contracts, mostly for mortality, administration and surrender. Interest credited to policyholder accounts is charged to expense. Future policy benefit reserves represent the present value of future benefits to be paid to or on behalf of policyholders and related expenses less the present value of future net premiums. The liability is measured by each group of contracts (i.e., cohorts) using current cash flow assumptions. As a run-off insurance operation consisting substantially all of reinsurance, contracts are grouped into cohorts by legal entity and product type, based on the date the reinsurance contract was consummated. Future policy benefit reserves are adjusted each period as a result of updating lifetime net premium ratios for differences between actual and expected experience with the retroactive effect of those variances recognized in current period earnings. We review at least annually in the third quarter, future policy benefit reserves cash flow assumptions, except related claim expenses which remain locked-in, and if the review concludes that the assumptions need to be updated, future policy benefit reserves are adjusted retroactively based on the revised net premium ratio using actual historical experience, updated cash flow assumptions, and the locked-in discount rate with the effect of those changes recognized in current period earnings. As our insurance operations are in run-off, the locked-in discount rate is the discount rate used for the computation of interest accretion on future policy benefit reserves recognized in earnings. However, cash flows used to estimate future policy benefit reserves are also discounted using an upper-medium grade (i.e., low credit risk) fixed-income instrument yield reflecting the duration characteristics of the liabilities and is updated each reporting period with changes recorded in AOCI. As a result, changes in the current discount rate at each reporting period will be recognized as an adjustment to AOCI and not earnings each period, whereas changes relating to cash flow assumptions will be recognized in the Statement of Earnings (Loss).
ADOPTIONS OF NEW ACCOUNTING STANDARDS	ADOPTIONS OF NEW ACCOUNTING STANDARDS. On January 1, 2023, we adopted Accounting Standards Update No. 2018-12 Financial Services – Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts . The new guidance for measuring the liability for future policy benefits and related reinsurance recoverable asset was adopted on a modified retrospective basis such that those balances were adjusted to conform to the new guidance at the January 1, 2021 transition date. We recognized a $7,285 million after-tax decrease in Total equity at January 1, 2021 from the effect of transition date adjustments due to adoption of the new guidance, as presented in the following table. Retained Earnings AOCI December 31, 2020 $ 92,247 $ (9,749) Liability for future policy benefits, including removal of related balances in AOCI (1,853) (8,806) Reinsurance recoverables, net of allowance for credit losses 48 3,542 Other contracts, including market risk benefits (202) (14) Effect of transition adjustments $ (2,007) $ (5,278) Adjusted balance, January 1, 2021 $ 90,240 $ (15,027) The following table summarizes the balance of and pre-tax changes to total Insurance liabilities and annuity benefits attributable to changes in the liability for future policy benefits and market risk benefits at the transition date, due to adoption of the new guidance. Long-term care Structured settlement annuities Life Other contracts(a) Other adjustments Total December 31, 2020 $ 21,378 $ 9,124 $ 517 $ 3,012 $ 8,160 $ 42,191 Change in discount rate assumptions 14,654 4,369 283 — — 19,306 Change in cash flow assumptions (effect of insufficient gross premiums) and elimination of negative reserves 1,545 39 761 — — 2,345 Adjustment for removal of related balances in AOCI — — — — (8,160) (8,160) Market risk benefits and other — — — 269 — 269 Adjusted balance, January 1, 2021 37,577 13,532 1,561 3,281 — 55,951 Less: reinsurance recoverables, net 7,036 — 15 44 — 7,095 Adjusted balance, January 1, 2021, net of reinsurance recoverables $ 30,541 $ 13,532 $ 1,546 $ 3,237 $ — $ 48,856 (a) As of December 31, 2020, includes investment contracts ($2,049 million), claim reserves related to short-duration contracts at Electric Insurance Company (EIC), net of eliminations ($399 million), and other ($564 million). EIC is a property and casualty insurance company primarily providing insurance to GE and its employees. For the liability for future policy benefits and related reinsurance recoverables, the new guidance transition adjustments are reflected in both AOCI and Retained earnings. The transition adjustment reflected in AOCI is related to the difference in the discount rate used pre-transition and the discount rate required under the new guidance, which is equivalent to an upper-medium grade fixed-income instrument yield reflecting the duration characteristics of our insurance liabilities, at January 1, 2021, and does not represent a change in our ultimate expected cash flows associated with the liability for future policy benefits or related reinsurance recoverables. The transition adjustment in AOCI also reflects removal of certain Other adjustments previously recorded in the liability for future policy benefits related to changes in net unrealized gains on investment securities. Whereas pre-transition, we annually performed premium deficiency testing in the aggregate across our run-off insurance portfolio, the new guidance requires the grouping of contracts (i.e., cohorts) at a more granular level. Due to this lower level of aggregation, combined with the conversion of our long-term care insurance claim cost projection models to first principles models, we identified certain cohorts at transition having insufficient gross premiums in our long-term care insurance portfolio. A first principles model separates morbidity assumptions such as incidence (probability of a claim), continuance (length of a claim) and utilization (percentage of the daily benefit maximum used) into individual assumptions. We also eliminated negative reserves, as required by the new guidance, on certain cohorts in our life portfolio. As a result, we increased the liability for future policy benefits and reflected this transition adjustment in Retained earnings. At the transition date, reinsurance recoverables of $4,062 million increased by $4,483 million upon remeasurement to the updated discount rate, with an offsetting adjustment ($3,542 million after-tax) recognized in AOCI. As reinsurance recoverables are recognized in a manner consistent with the liabilities relating to the underlying reinsurance contracts, adjustments to the liability for future policy benefits due to the change in cash flow assumptions resulted in an increase to reinsurance recoverables of $629 million ($497 million after-tax) and an increase in the related allowance for credit losses of $569 million ($450 million after-tax), which was recorded as an adjustment to Retained earnings at the transition date. As a result, the adjusted balance of reinsurance recoverables at the transition date was $7,095 million, net of the allowance for credit losses of $2,079 million, and substantially all related to our long-term care insurance portfolio. Following the recapture transaction effective in the fourth quarter of 2022, the remaining reinsurance recoverables are not material. The new guidance is only applicable to the measurements of our long-duration insurance liabilities and related reinsurance recoverables under GAAP and does not affect the accounting for our insurance reserves or the levels of capital and surplus under statutory accounting practices. See Note 13 for further information.

BASIS OF PRESENTATION AND SUM_3

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Schedule of New Accounting Standards	We recognized a $7,285 million after-tax decrease in Total equity at January 1, 2021 from the effect of transition date adjustments due to adoption of the new guidance, as presented in the following table. Retained Earnings AOCI December 31, 2020 $ 92,247 $ (9,749) Liability for future policy benefits, including removal of related balances in AOCI (1,853) (8,806) Reinsurance recoverables, net of allowance for credit losses 48 3,542 Other contracts, including market risk benefits (202) (14) Effect of transition adjustments $ (2,007) $ (5,278) Adjusted balance, January 1, 2021 $ 90,240 $ (15,027) The following table summarizes the balance of and pre-tax changes to total Insurance liabilities and annuity benefits attributable to changes in the liability for future policy benefits and market risk benefits at the transition date, due to adoption of the new guidance. Long-term care Structured settlement annuities Life Other contracts(a) Other adjustments Total December 31, 2020 $ 21,378 $ 9,124 $ 517 $ 3,012 $ 8,160 $ 42,191 Change in discount rate assumptions 14,654 4,369 283 — — 19,306 Change in cash flow assumptions (effect of insufficient gross premiums) and elimination of negative reserves 1,545 39 761 — — 2,345 Adjustment for removal of related balances in AOCI — — — — (8,160) (8,160) Market risk benefits and other — — — 269 — 269 Adjusted balance, January 1, 2021 37,577 13,532 1,561 3,281 — 55,951 Less: reinsurance recoverables, net 7,036 — 15 44 — 7,095 Adjusted balance, January 1, 2021, net of reinsurance recoverables $ 30,541 $ 13,532 $ 1,546 $ 3,237 $ — $ 48,856 (a) As of December 31, 2020, includes investment contracts ($2,049 million), claim reserves related to short-duration contracts at Electric Insurance Company (EIC), net of eliminations ($399 million), and other ($564 million). EIC is a property and casualty insurance company primarily providing insurance to GE and its employees.

BUSINESSES HELD FOR SALE AND _2

BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS (Tables)	3 Months Ended
	Mar. 31, 2023
Discontinued Operations and Disposal Groups [Abstract]
Financial Information for Assets and Liabilities of Businesses Held for Sale	ASSETS AND LIABILITIES OF BUSINESSES HELD FOR SALE March 31, 2023 December 31, 2022 Current receivables, inventories and contract assets $ 527 $ 495 Non-current captive insurance investment securities 578 554 Property, plant and equipment and intangible assets - net 240 232 Valuation allowance on disposal group classified as held for sale (72) (17) All other assets 80 111 Assets of businesses held for sale $ 1,353 $ 1,374 Progress collections and deferred income $ 1,101 $ 1,127 Insurance liabilities and annuity benefits 340 358 Accounts payable, equipment project payables and other current liabilities 421 371 All other liabilities 90 87 Liabilities of businesses held for sale $ 1,953 $ 1,944
Financial Information for Discontinued Operations	2023 2022 RESULTS OF DISCONTINUED OPERATIONS Three months ended March 31 GE HealthCare Bank BPH & Other Total GE HealthCare Bank BPH & Other Total Total revenues $ — $ — $ — $ 4,361 $ — $ 4,361 Cost of equipment and services sold — — — (2,679) — (2,679) Other income, costs and expenses (20) (201) (221) (1,146) (250) (1,396) Earnings (loss) of discontinued operations before income taxes (20) (201) (221) 536 (250) 286 Benefit (provision) for income taxes(a) 1,479 (1) 1,478 (150) (18) (167) Earnings (loss) of discontinued operations, net of taxes 1,459 (202) 1,257 387 (268) 119 Gain (loss) on disposal before income taxes — — — — (23) (23) Benefit (provision) for income taxes — — — — 5 5 Gain (loss) on disposal, net of taxes — — — — (18) (18) Earnings (loss) from discontinued operations, net of taxes $ 1,459 $ (202) $ 1,257 $ 387 $ (286) $ 101 (a) The tax benefit for the three months ended March 31, 2023 for GE HealthCare relates to preparatory steps for the spin-off, which resulted in taxable gain offset by a deferred tax asset and the reversal of valuation allowances for capital loss carryovers utilized against a portion of the gain. ASSETS AND LIABILITIES OF DISCONTINUED OPERATIONS March 31, 2023 December 31, 2022 Cash, cash equivalents and restricted cash $ 1,180 $ 2,627 Current receivables 13 3,361 Inventories, including deferred inventory costs — 2,512 Goodwill — 12,799 Other intangible assets - net — 1,520 Contract and other deferred assets — 854 Financing receivables held for sale (Polish mortgage portfolio)(a) 1,126 1,200 Property, plant, and equipment - net 69 2,379 All other assets 344 2,109 Deferred income taxes 62 2,528 Assets of discontinued operations(b) $ 2,793 $ 31,890 Accounts payable and equipment project payables $ 102 $ 3,487 Progress collections and deferred income — 2,499 Long-term borrowings — 8,273 Non-current compensation and benefits 36 5,658 All other liabilities(a) 1,413 4,556 Liabilities of discontinued operations(b) $ 1,551 $ 24,474 (a) Included $889 million of valuation allowance against financing receivables held for sale (including $645 million related to foreign currency-denominated mortgage litigation) and $895 million of litigation reserves recorded in All other liabilities in Poland at March 31, 2023. (b) Included $133 million and $28,998 million of assets and $279 million and $23,337 million of liabilities for GE HealthCare as of March 31, 2023 and December 31, 2022, respectively.

INVESTMENT SECURITIES (Tables)

INVESTMENT SECURITIES (Tables)	3 Months Ended
INVESTMENT SECURITIES (Tables)	Mar. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Schedule of Investment Securities	March 31, 2023 December 31, 2022 Amortized Gross Gross Estimated Amortized Gross Gross Estimated Equity (GE HealthCare) $ — $ — $ — $ 7,410 $ — $ — $ — $ — Equity and note (AerCap) — — — 5,404 — — — 7,403 Equity (Baker Hughes) — — — — — — — 207 Current investment securities $ — $ — $ — $ 12,814 $ — $ — $ — $ 7,609 Debt U.S. corporate $ 27,760 $ 996 $ (1,781) $ 26,975 $ 26,921 $ 675 $ (2,164) $ 25,432 Non-U.S. corporate 2,585 26 (243) 2,369 2,548 18 (300) 2,266 State and municipal 2,881 106 (184) 2,803 2,898 66 (241) 2,722 Mortgage and asset-backed 4,623 39 (320) 4,341 4,442 21 (290) 4,173 Government and agencies 1,641 3 (139) 1,504 1,172 2 (147) 1,026 Other equity 270 — — 270 408 — — 408 Non-current investment securities $ 39,761 $ 1,169 $ (2,668) $ 38,262 $ 38,388 $ 781 $ (3,143) $ 36,027
Contractual Maturities of Debt Securities (Excluding Mortgage and Asset-Backed Securities)	Contractual maturities of our debt securities (excluding mortgage and asset-backed securities) at March 31, 2023 are as follows: Amortized cost Estimated fair value Within one year $ 1,057 $ 1,052 After one year through five years 4,762 4,753 After five years through ten years 5,726 5,793 After ten years 23,323 22,052

CURRENT AND LONG-TERM RECEIVA_2

CURRENT AND LONG-TERM RECEIVABLES (Tables)	3 Months Ended
CURRENT AND LONG-TERM RECEIVABLES (Tables)	Mar. 31, 2023
Receivables [Abstract]
Schedule of Receivables	CURRENT RECEIVABLES March 31, 2023 December 31, 2022 Customer receivables $ 11,123 $ 11,803 Revenue sharing program receivables(a) 1,336 1,326 Non-income based tax receivables 1,190 1,146 Supplier advances 711 691 Receivables from disposed businesses 245 115 Other sundry receivables 393 518 Allowance for credit losses(b) (787) (768) Total current receivables $ 14,212 $ 14,831 (a) Revenue sharing program receivables in Aerospace are amounts due from third parties who participate in engine programs by developing and supplying certain engine components through the life of the program. The participants share in program revenues, receive a share of customer progress payments and share costs related to discounts and warranties. (b) Allowance for credit losses increased primarily due to net new provisions of $20 million, partially offset by write-offs, recoveries and foreign currency impact. March 31, 2023 December 31, 2022 Aerospace $ 7,667 $ 7,784 Renewable Energy 2,129 2,415 Power 3,940 4,229 Corporate 477 404 Total current receivables $ 14,212 $ 14,831 LONG-TERM RECEIVABLES March 31, 2023 December 31, 2022 Long-term customer receivables(a) $ 448 $ 457 Supplier advances 279 266 Non-income based tax receivables 236 213 Financing receivables 147 82 Sundry receivables 429 400 Allowance for credit losses (182) (183) Total long-term receivables $ 1,358 $ 1,236 (a) The Company sold zero and $79 million of long-term customer receivables to third parties for the three months ended March 31, 2023 and 2022, respectively, primarily in our Gas Power business for risk mitigation purposes.

INVENTORIES, INCLUDING DEFERR_2

INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS (Tables)	3 Months Ended
INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS (Tables)	Mar. 31, 2023
Inventory Disclosure [Abstract]
Schedule of Inventories	March 31, 2023 December 31, 2022 Raw materials and work in process $ 10,000 $ 9,191 Finished goods 4,223 3,937 Deferred inventory costs(a) 1,975 1,764 Inventories, including deferred inventory costs $ 16,198 $ 14,891

PROPERTY, PLANT AND EQUIPMENT_2

PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES (Tables)	3 Months Ended
PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES (Tables)	Mar. 31, 2023
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment	March 31, 2023 December 31, 2022 Original cost $ 26,957 $ 26,641 Less accumulated depreciation and amortization (16,640) (16,303) Right-of-use operating lease assets 1,853 1,854 Property, plant and equipment – net $ 12,170 $ 12,192

GOODWILL AND OTHER INTANGIBLE_2

GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)	3 Months Ended
GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)	Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Changes in Goodwill Balances	GOODWILL January 1, 2023 Currency exchange Balance at March 31, 2023 Aerospace $ 8,835 $ 64 $ 8,899 Renewable Energy 3,201 42 3,243 Power 144 — 144 Corporate(a) 818 2 821 Total $ 12,999 $ 108 $ 13,107

REVENUES (Tables)

REVENUES (Tables)	3 Months Ended
REVENUES (Tables)	Mar. 31, 2023
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregated Revenues	EQUIPMENT & SERVICES REVENUES Three months ended March 31 2023 2022 Equipment Services Total Equipment Services Total Aerospace $ 1,974 $ 5,007 $ 6,981 $ 1,654 $ 3,949 $ 5,603 Renewable Energy 2,311 527 2,837 2,173 698 2,871 Power 1,102 2,718 3,820 965 2,536 3,501 Total segment revenues $ 5,387 $ 8,252 $ 13,638 $ 4,792 $ 7,183 $ 11,975 REVENUES Three months ended March 31 2023 2022 Commercial Engines & Services $ 5,194 $ 3,853 Military 1,018 1,036 Systems & Other 770 714 Aerospace $ 6,981 $ 5,603 Onshore Wind $ 1,502 $ 1,906 Grid Solutions equipment and services 824 668 Offshore Wind, Hydro and Hybrid Solutions 511 297 Renewable Energy $ 2,837 $ 2,871 Gas Power $ 2,867 $ 2,489 Steam Power 541 636 Power Conversion, Nuclear and other 412 377 Power $ 3,820 $ 3,501 Total segment revenues $ 13,638 $ 11,975 Corporate $ 848 $ 700 Total revenues $ 14,486 $ 12,675

CONTRACT AND OTHER DEFERRED A_2

CONTRACT AND OTHER DEFERRED ASSETS & PROGRESS COLLECTIONS AND DEFERRED INCOME (Tables)	3 Months Ended
	Mar. 31, 2023
Contractors [Abstract]
Contract with Customer, Asset and Liability	March 31, 2023 Aerospace Renewable Energy Power Corporate Total Revenues in excess of billings $ 2,603 $ — $ 5,317 $ — $ 7,920 Billings in excess of revenues (7,288) — (1,807) — (9,095) Long-term service agreements $ (4,685) $ — $ 3,510 $ — $ (1,176) Short-term and other service agreements 456 129 66 277 927 Equipment contract revenues 27 1,009 1,457 — 2,493 Current contract assets $ (4,203) $ 1,138 $ 5,032 $ 277 $ 2,244 Nonrecurring engineering costs(a) 2,521 19 2 — 2,542 Customer advances and other(b) 2,389 — 700 — 3,089 Non-current contract and other deferred assets $ 4,910 $ 19 $ 702 $ — $ 5,631 Total contract and other deferred assets $ 707 $ 1,157 $ 5,734 $ 277 $ 7,875 December 31, 2022 Aerospace Renewable Energy Power Corporate Total Revenues in excess of billings $ 2,363 $ — $ 5,403 $ — $ 7,766 Billings in excess of revenues (6,681) — (1,763) — (8,443) Long-term service agreements $ (4,318) $ — $ 3,640 $ — $ (677) Short-term and other service agreements 391 108 56 245 799 Equipment contract revenues 42 955 1,348 — 2,345 Current contract assets $ (3,884) $ 1,063 $ 5,044 $ 245 $ 2,467 Nonrecurring engineering costs(a) 2,513 17 4 — 2,534 Customer advances and other(b) 2,519 — 724 — 3,243 Non-current contract and other deferred assets $ 5,032 $ 17 $ 728 $ — $ 5,776 Total contract and other deferred assets $ 1,148 $ 1,079 $ 5,772 $ 245 $ 8,244 (a) Included costs incurred prior to production (such as requisition engineering) for equipment production contracts, primarily within our Aerospace segment, which are amortized ratably over each unit produced. (b) Included amounts due from customers at Aerospace for the sales of engines, spare parts and services, and at Power, for the sale of services upgrades, which we collect through incremental fixed or usage-based fees from servicing the equipment under long-term service agreements. March 31, 2023 Aerospace Renewable Energy Power Corporate Total Progress collections on equipment contracts $ 90 $ 2,313 $ 4,349 $ — $ 6,751 Other progress collections 5,631 3,071 451 131 9,284 Current deferred income 216 204 12 119 550 Progress collections and deferred income $ 5,937 $ 5,588 $ 4,812 $ 249 $ 16,586 Non-current deferred income 1,183 206 98 12 1,500 Total Progress collections and deferred income $ 7,120 $ 5,794 $ 4,910 $ 262 $ 18,086 December 31, 2022 Progress collections on equipment contracts $ 74 $ 2,464 $ 3,973 $ — $ 6,511 Other progress collections 5,740 2,731 541 131 9,143 Current deferred income 233 208 13 107 562 Progress collections and deferred income $ 6,047 $ 5,404 $ 4,527 $ 238 $ 16,216 Non-current deferred income 1,110 183 104 12 1,409 Total Progress collections and deferred income $ 7,157 $ 5,586 $ 4,632 $ 250 $ 17,625

BORROWINGS (Tables)

BORROWINGS (Tables)	3 Months Ended
BORROWINGS (Tables)	Mar. 31, 2023
Debt Disclosure [Abstract]
Schedule of Borrowings	March 31, 2023 December 31, 2022 Current portion of long-term borrowings Senior notes issued by GE $ 609 $ 464 Senior and subordinated notes assumed by GE 947 1,973 Senior notes issued by GE Capital 592 1,188 Other 114 115 Total short-term borrowings $ 2,262 $ 3,739 Senior notes issued by GE $ 4,653 $ 4,724 Senior and subordinated notes assumed by GE 8,383 8,406 Senior notes issued by GE Capital 6,262 6,289 Other 861 901 Total long-term borrowings $ 20,159 $ 20,320 Total borrowings $ 22,421 $ 24,059

ACCOUNTS PAYABLE AND EQUIPMEN_2

ACCOUNTS PAYABLE AND EQUIPMENT PROJECT PAYABLES (Tables)	3 Months Ended
ACCOUNTS PAYABLE AND EQUIPMENT PROJECT PAYABLES (Tables)	Mar. 31, 2023
Payables and Accruals [Abstract]
Schedule of Accounts Payable and Accruals	March 31, 2023 December 31, 2022 Trade payables $ 10,049 $ 10,033 Supply chain finance programs 3,454 3,689 Equipment project payables(a) 1,109 1,236 Non-income based tax payables 451 441 Accounts payable and equipment project payables $ 15,063 $ 15,399 (a) Primarily related to projects in our Power and Renewable Energy segments.

INSURANCE LIABILITIES AND ANN_2

INSURANCE LIABILITIES AND ANNUITY BENEFITS (Tables)	3 Months Ended
INSURANCE LIABILITIES AND ANNUITY BENEFITS (Tables)	Mar. 31, 2023
Insurance [Abstract]
Schedule of Insurance and Investment Contract Liabilities	A summary of our insurance liabilities and annuity benefits is presented below: March 31, 2023 Long-term care Structured settlement annuities Life Other contracts(a) Total Future policy benefit reserves $ 26,054 $ 9,349 $ 1,045 $ 428 $ 36,876 Investment contracts — 846 — 821 1,667 Other — — 178 361 539 Total $ 26,054 $ 10,194 $ 1,223 $ 1,610 $ 39,082 December 31, 2022 Future policy benefit reserves $ 24,256 $ 8,860 $ 1,040 $ 437 $ 34,593 Investment contracts — 860 — 849 1,708 Other — — 178 365 544 Total $ 24,256 $ 9,720 $ 1,218 $ 1,651 $ 36,845 December 31, 2021 Long-term care Structured settlement annuities Life Other contracts(a) Total Future policy benefit reserves $ 34,644 $ 12,328 $ 1,301 $ 490 $ 48,763 Investment contracts — 950 — 907 1,857 Other — — 189 761 950 Total $ 34,644 $ 13,278 $ 1,490 $ 2,158 $ 51,570 (a) As of December 31, 2021, Other includes reserves of $325 million related to short-duration contracts at EIC, net of eliminations.
Summary of Future Policy Benefits	The following tables summarize balances of and changes in future policy benefits reserves. March 31, 2023 March 31, 2022 Present value of expected net premiums Long-term care Structured settlement annuities Life Long-term care Structured settlement annuities Life Balance, beginning of year $ 4,059 $ — $ 4,828 $ 5,652 $ — $ 6,622 Beginning balance at locked-in discount rate 3,958 — 5,210 4,451 — 5,443 Effect of changes in cash flow assumptions — — — — — — Effect of actual variances from expected experience 29 — (35) (130) — 2 Adjusted beginning of year balance 3,987 — 5,175 4,321 — 5,445 Interest accrual 53 — 50 59 — 52 Net premiums collected (103) — (73) (113) — (83) Effect of foreign currency — — (23) — — 73 Ending balance at locked-in discount rate 3,937 — 5,129 4,267 — 5,487 Effect of changes in discount rate assumptions 281 — (149) 696 — 396 Balance, end of year $ 4,217 $ — $ 4,979 $ 4,963 $ — $ 5,883 Present value of expected future policy benefits Balance, beginning of year $ 28,316 $ 8,860 $ 5,868 $ 40,296 $ 12,328 $ 7,923 Beginning balance at locked-in discount rate 27,026 8,790 6,247 27,465 9,024 6,560 Effect of changes in cash flow assumptions (11) — — — — — Effect of actual variances from expected experience 30 (1) 2 (130) (3) 19 Adjusted beginning of year balance 27,046 8,789 6,250 27,335 9,021 6,579 Interest accrual 363 115 60 365 119 62 Benefit payments (309) (174) (138) (274) (162) (148) Effect of foreign currency — — (24) — — 77 Ending balance at locked-in discount rate 27,100 8,730 6,148 27,425 8,978 6,570 Effect of changes in discount rate assumptions 3,171 619 (123) 7,852 1,870 488 Balance, end of year $ 30,271 $ 9,349 $ 6,025 $ 35,277 $ 10,848 $ 7,058 Net future policy benefit reserves $ 26,054 $ 9,349 $ 1,045 $ 30,314 $ 10,848 $ 1,175 Less: Reinsurance recoverables, net of allowance for credit losses (204) — (57) (5,154) — (81) Net future policy benefit reserves, after reinsurance recoverables $ 25,850 $ 9,349 $ 988 $ 25,160 $ 10,848 $ 1,094 The following table provides the amount of undiscounted and discounted expected future gross premiums and expected future benefits and expenses for nonparticipating traditional contracts. March 31, 2023 March 31, 2022 December 31, 2022 December 31, 2021 Undiscounted Discounted(a) Undiscounted Discounted(a) Undiscounted Discounted(a) Undiscounted Discounted(a) Long-term care Gross premiums $ 7,924 $ 5,105 $ 8,052 $ 5,599 $ 7,985 $ 4,918 $ 8,173 $ 6,187 Benefit payments 64,944 30,271 67,254 35,277 65,217 28,316 67,516 40,296 Structured settlement annuities Benefit payments 19,745 9,349 20,482 10,848 19,936 8,860 20,666 12,328 Life Gross premiums 13,537 6,104 14,676 7,311 13,754 5,916 14,579 8,275 Benefit payments 11,800 6,025 12,709 7,058 12,020 5,868 12,702 7,923 (a) Determined using the current discount rate as of March 31, 2023 and 2022 and December 31, 2022 and 2021. The following table provides the weighted-average durations of and weighted-average interest rates for the liability for future policy benefits. March 31, 2023 March 31, 2022 December 31, 2022 December 31, 2021 Long-term care Structured settlement annuities Life Long-term care Structured settlement annuities Life Long-term care Structured settlement annuities Life Long-term care Structured settlement annuities Life Duration (years)(a) 13.2 11.2 5.3 14.6 12.2 6.1 13.0 10.7 5.0 15.5 13.2 6.3 Interest accretion rate 5.5% 5.4% 5.1% 5.5% 5.4% 5.1% 5.5% 5.4% 4.9% 5.3% 5.5% 4.8% Current discount rate 5.0% 5.0% 4.8% 4.0% 4.0% 3.8% 5.6% 5.5% 5.4% 3.1% 3.1% 2.6%

POSTRETIREMENT BENEFIT PLANS (T

POSTRETIREMENT BENEFIT PLANS (Tables)	3 Months Ended
POSTRETIREMENT BENEFIT PLANS (Tables)	Mar. 31, 2023
Retirement Benefits [Abstract]
Description Postretirement Benefit Plans	DESCRIPTION OF OUR PLANS Plan Category Participants Funding Comments Principal Pension Plans GE Energy Pension Plan and GE Aerospace Pension Plan Covers U.S. participants ~115,000 retirees and beneficiaries, ~50,000 vested former employees and ~16,500 active employees Our funding policy is to contribute amounts sufficient to meet minimum funding requirements under employee benefit and tax laws. We may decide to contribute additional amounts beyond this level. Closed to new participants since 2012. Benefits for employees with salaried benefits were frozen effective January 1, 2021, and thereafter these employees receive increased company contributions in the company sponsored defined contribution plan in lieu of participation in a defined benefit plan (announced October 2019). GE Energy Supplementary Pension Plan GE Aerospace Supplementary Pension Plan Provides supplementary benefits to higher-level, longer-service U.S. employees Unfunded. We pay benefits from company cash. The annuity benefit has been closed to new participants since 2011 and has been replaced by an installment benefit (which was closed to new executives after 2020). Benefits for employees who became executives before 2011 were frozen effective January 1, 2021, and thereafter these employees accrue the installment benefit. Other Pension Plans(a) 35 U.S. and non-U.S. pension plans with pension assets or obligations that have reached $50 million Covers ~42,500 retirees and beneficiaries, ~29,500 vested former employees and ~8,000 active employees Our funding policy is to contribute amounts sufficient to meet minimum funding requirements under employee benefit and tax laws in each country. We may decide to contribute additional amounts beyond this level. We pay benefits for some plans from company cash. In certain countries, benefit accruals have ceased and/or have been closed to new hires as of various dates. Principal Retiree Benefit Plans Provides health and life insurance benefits to certain eligible participants Covers U.S. participants of Power and Renewable Energy (will be part of GE Vernova, GE's portfolio of energy businesses) and Aerospace ~93,500 retirees and dependents and ~15,500 active employees We fund retiree health benefits on a pay-as-you-go basis and the retiree life insurance trust at our discretion. Participants share in the cost of the healthcare benefits.
Schedule of Net Benefit Costs	The components of benefit plans cost other than the service cost are included in the caption Non-operating benefit costs in our Statement of Earnings (Loss). PRINCIPAL PENSION PLANS Three months ended March 31 2023 2022 Service cost for benefits earned $ 21 $ 49 Expected return on plan assets (594) (786) Interest cost on benefit obligations 474 517 Net actuarial loss amortization and other (172) 363 Net periodic expense (income) (271) 143 Less discontinued operations $ — $ 49 Continuing operations – net periodic expense (income) $ (271) $ 94

SHAREHOLDERS' EQUITY (Tables)

SHAREHOLDERS' EQUITY (Tables)	3 Months Ended
SHAREHOLDERS' EQUITY (Tables)	Mar. 31, 2023
Equity [Abstract]
Schedule of Shareholders' Equity	Three months ended March 31 ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Dividends per share in dollars) 2023 2022 Beginning balance $ (5,893) $ (4,569) AOCI before reclasses – net of taxes of $(5) and $90 152 (181) Reclasses from AOCI – net of taxes of $(626) and $0(a) 2,234 — AOCI 2,387 (181) Less AOCI attributable to noncontrolling interests (1) (4) Currency translation adjustments AOCI $ (3,505) $ (4,746) Beginning balance $ 6,531 $ 3,646 AOCI before reclasses – net of taxes of $(13) and $25 (84) 54 Reclasses from AOCI – net of taxes of $(594) and $55(a) (2,235) 186 AOCI (2,319) 240 Less AOCI attributable to noncontrolling interests (2) 2 Benefit plans AOCI $ 4,214 $ 3,884 Beginning balance $ (1,927) $ 5,172 AOCI before reclasses – net of taxes of $188 and $(801) 718 (2,993) Reclasses from AOCI – net of taxes of $0 and $1(a) (12) (5) AOCI 706 (2,998) Investment securities and cash flow hedges AOCI $ (1,222) $ 2,174 Beginning balance $ (983) $ (9,109) AOCI before reclasses – net of taxes of $(477) and $979 (1,793) 3,682 AOCI (1,793) 3,682 Long-duration insurance contracts AOCI $ (2,776) $ (5,427) AOCI at March 31 $ (3,289) $ (4,115) Dividends declared per common share $ 0.08 $ 0.08 (a) The total reclassification from AOCI included $195 million, including currency translation of $2,234 million and benefit plans of $(2,030) million, net of taxes, in three months ended March 31, 2023 related to the spin-off of GE HealthCare.

EARNINGS PER SHARE INFORMATION

EARNINGS PER SHARE INFORMATION (Tables)	3 Months Ended
EARNINGS PER SHARE INFORMATION (Tables)	Mar. 31, 2023
Earnings Per Share [Abstract]
Schedule of Earnings Per Share	Three months ended March 31 2023 2022 (Earnings for per-share calculation, shares in millions, per-share amounts in dollars) Diluted Basic Diluted Basic Earnings (loss) from continuing operations $ 6,242 $ 6,248 $ (1,224) $ (1,224) Preferred stock dividends and other(a) (145) (145) (52) (52) Earnings (loss) from continuing operations attributable to common shareholders 6,097 6,103 (1,276) (1,276) Earnings (loss) from discontinued operations 1,257 1,257 88 88 Net earnings (loss) attributable to GE common shareholders 7,354 7,360 (1,188) (1,188) Shares of GE common stock outstanding 1,089 1,089 1,100 1,100 Employee compensation-related shares (including stock options) 8 — — — Total average equivalent shares 1,097 1,089 1,100 1,100 Earnings (loss) per share from continuing operations $ 5.56 $ 5.60 $ (1.16) $ (1.16) Earnings (loss) per share from discontinued operations 1.15 1.15 0.08 0.08 Net earnings (loss) per share 6.71 6.76 (1.08) (1.08) Potentially dilutive securities(b) 38 43 (a) For the three months ended March 31, 2023, included $(30) million related to excise tax on preferred share redemption. (b) Outstanding stock awards not included in the computation of diluted earnings (loss) per share because their effect was antidilutive.

OTHER INCOME (LOSS) (Tables)

OTHER INCOME (LOSS) (Tables)	3 Months Ended
OTHER INCOME (LOSS) (Tables)	Mar. 31, 2023
Other Income and Expenses [Abstract]
Schedule of Other Income (Loss)	Three months ended March 31 2023 2022 Licensing and royalty income $ 34 $ 57 Equity method income — 38 Investment in GE HealthCare unrealized gain (loss) 6,093 — Investment in and note with AerCap realized and unrealized gain (loss) (195) (1,736) Investment in Baker Hughes realized and unrealized gain (loss) 10 1,515 Other net interest and investment income (loss) 186 93 Other items (48) 82 Total other income (loss) $ 6,081 $ 49

RESTRUCTURING CHARGES AND SEP_2

RESTRUCTURING CHARGES AND SEPARATION COSTS (Tables)	3 Months Ended
RESTRUCTURING CHARGES AND SEPARATION COSTS (Tables)	Mar. 31, 2023
Restructuring and Related Activities [Abstract]
Schedule of Restructuring and Related Costs	This table is inclusive of all restructuring charges in our segments and at Corporate, and the charges are shown below for the business where they originated. Separately, in our reported segment results, significant, higher-cost restructuring programs are excluded from measurement of segment operating performance for internal and external purposes; those excluded amounts are reported in Restructuring and other charges for Corporate. Three months ended March 31 RESTRUCTURING AND OTHER CHARGES 2023 2022 Workforce reductions $ 66 $ 13 Plant closures & associated costs and other asset write-downs 82 26 Acquisition/disposition net charges and other 12 9 Total restructuring and other charges $ 161 $ 48 Cost of equipment/services $ 36 $ 27 Selling, general and administrative expenses 125 25 Other (income) loss — (3) Total restructuring and other charges $ 161 $ 48 Aerospace $ 4 $ 5 Renewable Energy 65 6 Power 19 34 Corporate 72 3 Total restructuring and other charges $ 161 $ 48 Restructuring and other charges cash expenditures $ 137 $ 127 An analysis of changes in the liability for restructuring follows. 2023 2022 Balance at January 1 $ 977 $ 825 Additions 86 9 Payments (87) (115) Effect of foreign currency and other — (9) Balance at March 31(a) $ 976 $ 710 (a) Includes actuarial determined post-employment severance benefits reserve of $353 million and $322 million as of March 31, 2023 and 2022, respectively. Also includes $64 million reserve in discontinued operations related to a GE technology contract which is indemnified by GE HealthCare as of March 31, 2023.

FINANCIAL INSTRUMENTS (Tables)

FINANCIAL INSTRUMENTS (Tables)	3 Months Ended
FINANCIAL INSTRUMENTS (Tables)	Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Estimated Fair Value of Assets and Liabilities	The following table provides information about assets and liabilities not carried at fair value and excludes finance leases, equity securities without readily determinable fair value and non-financial assets and liabilities. Substantially all of these assets are considered to be Level 3 and the vast majority of our liabilities’ fair value are considered Level 2. March 31, 2023 December 31, 2022 Carrying Estimated Carrying Estimated Assets Loans and other receivables $ 2,427 $ 2,275 $ 2,557 $ 2,418 Liabilities Borrowings (Note 11) $ 22,421 $ 21,586 $ 24,059 $ 22,849 Investment contracts (Note 13) 1,667 1,736 1,708 1,758
Fair Value of Derivative Assets	FAIR VALUE OF DERIVATIVES March 31, 2023 December 31, 2022 Gross Notional All other assets All other liabilities Gross Notional All other assets All other liabilities Currency exchange contracts $ 4,648 $ 138 $ 100 $ 5,112 $ 132 $ 146 Derivatives accounted for as hedges $ 4,648 $ 138 $ 100 $ 5,112 $ 132 $ 146 Currency exchange contracts $ 58,595 $ 917 $ 871 $ 51,885 $ 946 $ 1,082 Interest rate contracts 30 — — 43 — 1 Other contracts 652 154 9 858 197 13 Derivatives not accounted for as hedges $ 59,277 $ 1,071 $ 880 $ 52,786 $ 1,143 $ 1,095 Gross derivatives $ 63,925 $ 1,208 $ 980 $ 57,898 $ 1,275 $ 1,241 Netting and credit adjustments $ (756) $ (755) $ (821) $ (820) Net derivatives recognized in statement of financial position $ 452 $ 225 $ 454 $ 420
Fair Value of Derivative Liabilities	FAIR VALUE OF DERIVATIVES March 31, 2023 December 31, 2022 Gross Notional All other assets All other liabilities Gross Notional All other assets All other liabilities Currency exchange contracts $ 4,648 $ 138 $ 100 $ 5,112 $ 132 $ 146 Derivatives accounted for as hedges $ 4,648 $ 138 $ 100 $ 5,112 $ 132 $ 146 Currency exchange contracts $ 58,595 $ 917 $ 871 $ 51,885 $ 946 $ 1,082 Interest rate contracts 30 — — 43 — 1 Other contracts 652 154 9 858 197 13 Derivatives not accounted for as hedges $ 59,277 $ 1,071 $ 880 $ 52,786 $ 1,143 $ 1,095 Gross derivatives $ 63,925 $ 1,208 $ 980 $ 57,898 $ 1,275 $ 1,241 Netting and credit adjustments $ (756) $ (755) $ (821) $ (820) Net derivatives recognized in statement of financial position $ 452 $ 225 $ 454 $ 420
Effects of Derivatives on AOCI	Gain (loss) recognized in AOCI Three months ended March 31 2023 2022 Cash flow hedges(a) $ 28 $ (47) Net investment hedges(b) (62) 112 (a) Primarily related to currency exchange contracts. (b) The carrying value of foreign currency debt designated as net investment hedges was $3,398 million and $3,934 million as of March 31, 2023 and 2022, respectively. The total reclassified from AOCI into earnings was zero for both the three months ended March 31, 2023 and 2022.
Effects of Derivatives on Earnings	The table below presents the gains (losses) of our derivative financial instruments in the Statement of Earnings (Loss): Three months ended March 31, 2023 Three months ended March 31, 2022 Revenues Interest Expense SG&A Other(a) Revenues Interest Expense SG&A Other(a) $ 14,486 $ 269 $ 2,142 $ 16,810 $ 12,675 $ 387 $ 2,725 $ 9,823 Effect of cash flow hedges $ 1 $ (2) $ — $ (2) $ 3 $ (7) $ — $ (32) Hedged items 78 Derivatives designated as hedging instruments (87) Effect of fair value hedges $ (9) Currency exchange contracts $ 2 $ — $ 76 $ (47) $ 1 $ (68) $ (81) Interest rate, commodity — 39 (11) 1 (37) 15 Effect of derivatives not designated as hedges $ 2 $ — $ 115 $ (58) $ 1 $ — $ (105) $ (66) (a) Amounts are inclusive of cost of sales and other income (loss).

SEGMENT OPERATIONS (Tables)

SEGMENT OPERATIONS (Tables)	3 Months Ended
SEGMENT OPERATIONS (Tables)	Mar. 31, 2023
Segment Reporting [Abstract]
Summary of Operating Segments	SUMMARY OF REPORTABLE SEGMENTS Three months ended March 31 2023 2022 V % Aerospace $ 6,981 $ 5,603 25 % Renewable Energy 2,837 2,871 (1) % Power 3,820 3,501 9 % Total segment revenues 13,638 11,975 14 % Corporate 848 700 21 % Total revenues $ 14,486 $ 12,675 14 % Aerospace $ 1,326 $ 908 46 % Renewable Energy (414) (434) 5 % Power 75 63 19 % Total segment profit (loss) 987 538 83 % Corporate(a) 5,456 (1,419) F Interest and other financial charges (257) (371) 31 % Non-operating benefit income (cost) 385 105 F Benefit (provision) for income taxes (322) (76) U Preferred stock dividends (145) (52) U Earnings (loss) from continuing operations attributable to GE common shareholders 6,103 (1,276) F Earnings (loss) from discontinued operations attributable to GE common shareholders 1,257 88 F Net earnings (loss) attributable to GE common shareholders $ 7,360 $ (1,188) F (a) Includes interest and other financial charges of $12 million and $16 million and benefit for income taxes of $51 million and $47 million related to EFS within Corporate for the three months ended March 31, 2023 and 2022, respectively.

BASIS OF PRESENTATION AND SUM_4

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - New Accounting Standards Narrative (Details) - USD ($) $ in Millions	Jan. 01, 2023	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022	Dec. 31, 2021	Jan. 01, 2021	Dec. 31, 2020
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Accounting Standards Update [Extensible List]	Accounting Standards Update 2018-12 [Member]
Decrease in equity		$ (32,823)	$ (34,912)	$ (32,909)
Reinsurance recoverables, allowances					$ 2,065	$ 2,079
Reinsurance recoverables, net of allowance for credit losses						7,095
Adoption of new accounting standards
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Decrease in equity						7,285
Previously reported
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Reinsurance recoverables						4,062
Change in discount rate assumptions
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Reinsurance recoverables						4,483
Adjustment for removal of related balances in AOCI
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Reinsurance recoverables						(3,542)
Change in cash flow assumptions (effect of insufficient gross premiums) and elimination of negative reserves
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Reinsurance recoverables						629
Reinsurance recoverables, allowances						569
Change in cash flow assumptions, after-tax
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Reinsurance recoverables						497
Reinsurance recoverables, allowances						450
Accumulated other comprehensive income (loss)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Decrease in equity		$ 3,289	$ 2,272	$ 4,115	$ 4,860	15,027
Accumulated other comprehensive income (loss) \| Adoption of new accounting standards
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Decrease in equity						5,278
Reinsurance recoverables, net of allowance for credit losses						$ 3,542
Accumulated other comprehensive income (loss) \| Previously reported
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Decrease in equity							$ 9,749

BASIS OF PRESENTATION AND SUM_5

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of New Accounting Standards (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022	Dec. 31, 2021	Jan. 01, 2021	Dec. 31, 2020
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity	$ 32,823	$ 34,912	$ 32,909
Future policy benefit reserves	36,876	34,593		$ 48,763
Reinsurance recoverables, net of allowance for credit losses					$ 7,095
Other	539	544		950
Adoption of new accounting standards
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity					(7,285)
Retained earnings
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity	84,955	82,983	82,009	83,286	90,240
Retained earnings \| Previously reported
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity						$ 92,247
Retained earnings \| Adoption of new accounting standards
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity					(2,007)
Future policy benefit reserves					(1,853)
Reinsurance recoverables, net of allowance for credit losses					48
Other					(202)
Accumulated other comprehensive income (loss)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity	$ (3,289)	$ (2,272)	$ (4,115)	$ (4,860)	(15,027)
Accumulated other comprehensive income (loss) \| Previously reported
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity						$ (9,749)
Accumulated other comprehensive income (loss) \| Adoption of new accounting standards
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity					(5,278)
Future policy benefit reserves					(8,806)
Reinsurance recoverables, net of allowance for credit losses					3,542
Other					$ (14)

BASIS OF PRESENTATION AND SUM_6

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Summary of Changes in Future Policy Benefits (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022	Dec. 31, 2021	Jan. 01, 2021	Dec. 31, 2020
Liability for Future Policy Benefit, by Product Segment [Line Items]
Liability for future policy benefits and market risk benefits					$ 55,951
Other adjustments					0
Reinsurance recoverables, net of allowance for credit losses					7,095
Net future policy benefit reserves, after reinsurance recoverables					48,856
Investment contracts	$ (1,667)	$ (1,708)		$ (1,857)
Other	(539)	(544)		(950)
Previously reported
Liability for Future Policy Benefit, by Product Segment [Line Items]
Liability for future policy benefits and market risk benefits						$ 42,191
Other adjustments						8,160
Change in discount rate assumptions
Liability for Future Policy Benefit, by Product Segment [Line Items]
Effect of changes in cash flow assumptions					19,306
Change in cash flow assumptions (effect of insufficient gross premiums) and elimination of negative reserves
Liability for Future Policy Benefit, by Product Segment [Line Items]
Effect of changes in cash flow assumptions					2,345
Adjustment for removal of related balances in AOCI
Liability for Future Policy Benefit, by Product Segment [Line Items]
Effect of changes in cash flow assumptions					(8,160)
Market risk benefits and other
Liability for Future Policy Benefit, by Product Segment [Line Items]
Effect of changes in cash flow assumptions					269
Long-term care
Liability for Future Policy Benefit, by Product Segment [Line Items]
Liability for future policy benefits and market risk benefits	30,271	28,316	$ 35,277	40,296	37,577	43,974
Reinsurance recoverables, net of allowance for credit losses	204	171	5,154	6,473	7,036
Net future policy benefit reserves, after reinsurance recoverables	25,850	24,085	25,160	28,171	30,541
Investment contracts	0	0		0
Other	0	0		0
Long-term care \| Previously reported
Liability for Future Policy Benefit, by Product Segment [Line Items]
Liability for future policy benefits and market risk benefits						21,378
Long-term care \| Change in discount rate assumptions
Liability for Future Policy Benefit, by Product Segment [Line Items]
Effect of changes in cash flow assumptions					14,654
Long-term care \| Change in cash flow assumptions (effect of insufficient gross premiums) and elimination of negative reserves
Liability for Future Policy Benefit, by Product Segment [Line Items]
Effect of changes in cash flow assumptions					1,545
Long-term care \| Market risk benefits and other
Liability for Future Policy Benefit, by Product Segment [Line Items]
Effect of changes in cash flow assumptions					0
Structured settlement annuities
Liability for Future Policy Benefit, by Product Segment [Line Items]
Liability for future policy benefits and market risk benefits	9,349	8,860	10,848	12,328	13,532	13,531
Reinsurance recoverables, net of allowance for credit losses	0	0	0	0	0
Net future policy benefit reserves, after reinsurance recoverables	9,349	8,860	10,848	12,328	13,532
Investment contracts	(846)	(860)		(950)
Other	0	0		0
Structured settlement annuities \| Previously reported
Liability for Future Policy Benefit, by Product Segment [Line Items]
Liability for future policy benefits and market risk benefits						9,124
Structured settlement annuities \| Change in discount rate assumptions
Liability for Future Policy Benefit, by Product Segment [Line Items]
Effect of changes in cash flow assumptions					4,369
Structured settlement annuities \| Change in cash flow assumptions (effect of insufficient gross premiums) and elimination of negative reserves
Liability for Future Policy Benefit, by Product Segment [Line Items]
Effect of changes in cash flow assumptions					39
Structured settlement annuities \| Market risk benefits and other
Liability for Future Policy Benefit, by Product Segment [Line Items]
Effect of changes in cash flow assumptions					0
Life
Liability for Future Policy Benefit, by Product Segment [Line Items]
Liability for future policy benefits and market risk benefits	6,025	5,868	7,058	7,923	1,561	8,767
Reinsurance recoverables, net of allowance for credit losses	57	67	81	87	15
Net future policy benefit reserves, after reinsurance recoverables	988	973	$ 1,094	1,214	1,546
Investment contracts	0	0		0
Other	(178)	(178)		(189)
Life \| Previously reported
Liability for Future Policy Benefit, by Product Segment [Line Items]
Liability for future policy benefits and market risk benefits						517
Life \| Change in discount rate assumptions
Liability for Future Policy Benefit, by Product Segment [Line Items]
Effect of changes in cash flow assumptions					283
Life \| Change in cash flow assumptions (effect of insufficient gross premiums) and elimination of negative reserves
Liability for Future Policy Benefit, by Product Segment [Line Items]
Effect of changes in cash flow assumptions					761
Life \| Market risk benefits and other
Liability for Future Policy Benefit, by Product Segment [Line Items]
Effect of changes in cash flow assumptions					0
Other contracts
Liability for Future Policy Benefit, by Product Segment [Line Items]
Liability for future policy benefits and market risk benefits					3,281
Reinsurance recoverables, net of allowance for credit losses					44
Net future policy benefit reserves, after reinsurance recoverables					3,237
Investment contracts	(821)	(849)		(907)		(2,049)
Claim reserves, short-duration insurance contracts				(325)		(399)
Other	$ (361)	$ (365)		$ (761)		(564)
Other contracts \| Previously reported
Liability for Future Policy Benefit, by Product Segment [Line Items]
Liability for future policy benefits and market risk benefits						$ 3,012
Other contracts \| Change in discount rate assumptions
Liability for Future Policy Benefit, by Product Segment [Line Items]
Effect of changes in cash flow assumptions					0
Other contracts \| Change in cash flow assumptions (effect of insufficient gross premiums) and elimination of negative reserves
Liability for Future Policy Benefit, by Product Segment [Line Items]
Effect of changes in cash flow assumptions					0
Other contracts \| Market risk benefits and other
Liability for Future Policy Benefit, by Product Segment [Line Items]
Effect of changes in cash flow assumptions					$ 269

BUSINESSES HELD FOR SALE AND _3

BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS - Assets Held for Sale Narrative (Details) - Held for sale, not discontinued operation - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Assets of businesses held for sale	$ 1,353	$ 1,374
Liabilities of businesses held for sale	1,953	$ 1,944
Captive industrial insurance subsidiary
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Assets of businesses held for sale	596
Liabilities of businesses held for sale	342
Pre-tax loss on sale	$ 55

BUSINESSES HELD FOR SALE AND _4

BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS - Financial Information for Assets and Liabilities of Businesses Held for Sale (Details) - Held for sale, not discontinued operation - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Assets
Current receivables, inventories and contract assets	$ 527	$ 495
Non-current captive insurance investment securities	578	554
Property, plant and equipment and intangible assets - net	240	232
Valuation allowance on disposal group classified as held for sale	(72)	(17)
All other assets	80	111
Assets of businesses held for sale	1,353	1,374
Liabilities
Progress collections and deferred income	1,101	1,127
Insurance liabilities and annuity benefits	340	358
Accounts payable, equipment project payables and other current liabilities	421	371
All other liabilities	90	87
Liabilities of businesses held for sale	$ 1,953	$ 1,944

BUSINESSES HELD FOR SALE AND _5

BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS - Discontinued Operations Narrative (Details) - USD ($) $ in Millions		3 Months Ended		12 Months Ended
	Jan. 03, 2023	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Spinoff \| GE Healthcare
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Ownership interest disposed of	80.10%
Discontinued operations after disposal, cash collected (paid)		$ 160
Discontinued operations
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Financing receivables held for sale		$ 1,126		$ 1,200
Discontinued operations \| Bank BPH
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Percentage indexed to or denominated in foreign currencies		86%
Financing receivables held for sale		$ 1,126
Pre-tax non-cash charges		175	$ 233
Capital contribution		198		$ 530
Discontinued operations \| GECAS \| AerCap
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Discontinued operations after disposal, cash collected (paid)		(88)
Discontinued operations after disposal, sales of product and services		48
Discontinued operations after disposal, purchases of products and services		$ 67

BUSINESSES HELD FOR SALE AND _6

BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS - Financial Information for Discontinued Operations (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
RESULTS OF DISCONTINUED OPERATIONS
Earnings (loss) from discontinued operations, net of taxes	$ 1,257	$ 101
Assets
Current receivables	245		$ 115
Discontinued operations
RESULTS OF DISCONTINUED OPERATIONS
Total revenues	0	4,361
Cost of equipment and services sold	0	(2,679)
Other income, costs and expenses	(221)	(1,396)
Earnings (loss) of discontinued operations before income taxes	(221)	286
Benefit (provision) for income taxes	1,478	(167)
Earnings (loss) of discontinued operations, net of taxes	1,257	119
Gain (loss) on disposal before income taxes	0	(23)
Benefit (provision) for income taxes	0	5
Gain (loss) on disposal, net of taxes	0	(18)
Earnings (loss) from discontinued operations, net of taxes	1,257	101
Assets
Cash, cash equivalents and restricted cash	1,180		2,627
Current receivables	13		3,361
Inventories, including deferred inventory costs	0		2,512
Goodwill	0		12,799
Other intangible assets - net	0		1,520
Contract and other deferred assets	0		854
Financing receivables held for sale (Polish mortgage portfolio)	1,126		1,200
Property, plant, and equipment - net	69		2,379
All other assets	344		2,109
Deferred income taxes	62		2,528
Assets of businesses held for sale	2,793		31,890
Liabilities
Accounts payable and equipment project payables	102		3,487
Progress collections and deferred income	0		2,499
Long-term borrowings	0		8,273
Non-current compensation and benefits	36		5,658
All other liabilities	1,413		4,556
Liabilities of businesses held for sale	1,551		24,474
Discontinued operations \| Bank BPH
Assets
Financing receivables held for sale (Polish mortgage portfolio)	1,126
Liabilities
Valuation allowance on finance receivables classified as held for sale	889
Litigation reserves	895
Discontinued operations \| Bank BPH \| Bank BPH
Liabilities
Valuation allowance on finance receivables classified as held for sale	645
Discontinued operations \| GE Healthcare
RESULTS OF DISCONTINUED OPERATIONS
Total revenues	0	4,361
Cost of equipment and services sold	0	(2,679)
Other income, costs and expenses	(20)	(1,146)
Earnings (loss) of discontinued operations before income taxes	(20)	536
Benefit (provision) for income taxes	1,479	(150)
Earnings (loss) of discontinued operations, net of taxes	1,459	387
Gain (loss) on disposal before income taxes	0	0
Benefit (provision) for income taxes	0	0
Gain (loss) on disposal, net of taxes	0	0
Earnings (loss) from discontinued operations, net of taxes	1,459	387
Assets
Assets of businesses held for sale	133		28,998
Liabilities
Liabilities of businesses held for sale	279		$ 23,337
Discontinued operations \| Bank BPH & Other
RESULTS OF DISCONTINUED OPERATIONS
Total revenues	0	0
Cost of equipment and services sold	0	0
Other income, costs and expenses	(201)	(250)
Earnings (loss) of discontinued operations before income taxes	(201)	(250)
Benefit (provision) for income taxes	(1)	(18)
Earnings (loss) of discontinued operations, net of taxes	(202)	(268)
Gain (loss) on disposal before income taxes	0	(23)
Benefit (provision) for income taxes	0	5
Gain (loss) on disposal, net of taxes	0	(18)
Earnings (loss) from discontinued operations, net of taxes	$ (202)	$ (286)

INVESTMENT SECURITIES - Narrati

INVESTMENT SECURITIES - Narrative (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Accrued interest, current	$ 490		$ 457
Accrued interest, current, statement of financial position	All other current assets (Note 10)		All other current assets (Note 10)
Debt securities in unrealized loss position, total	$ 20,685		$ 21,482
Debt securities in unrealized loss position, 12 months or more	14,044		3,275
Gross unrealized losses, 12 months or more	(2,344)		(835)
Gross unrealized losses	(2,668)		(3,143)
Net unrealized gains (losses) recorded to earnings	6,040	$ (370)
Proceeds from investment securities sales and early redemptions by issuers	3,008	1,949
Debt securities, realized gain	11	24
Debt securities, realized losses and impairments	(21)
Equity securities without readily determinable fair values	714		614
Fair value adjustments, including impairment	9	18
Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investment securities with a fair value	$ 6,379		$ 6,421
GE Healthcare
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity securities, investment interest (in shares)	90.3
Equity securities, ownership percentage	19.90%
Net unrealized gains (losses) recorded to earnings	$ 6,093	$ 0
AerCap
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity securities, investment interest (in shares)	79.7
Equity securities, ownership percentage	33%
CMBS
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Gross unrealized losses	$ (194)
Asset-backed securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Gross unrealized losses	$ (125)

INVESTMENT SECURITIES - Schedul

INVESTMENT SECURITIES - Schedule of Investment Securities (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Debt and Equity Securities, FV-NI [Line Items]
Current equity, amortized cost	$ 0	$ 0
Current equity, estimated fair value	12,814	7,609
Gross unrealized gains	1,169	781
Gross unrealized losses	(2,668)	(3,143)
Other equity	270	408
Non-current investment securities, amortized cost	39,761	38,388
Non-current investment securities, estimated fair value	38,262	36,027
GE Healthcare
Debt and Equity Securities, FV-NI [Line Items]
Current equity, amortized cost	0	0
Current equity, estimated fair value	7,410	0
AerCap
Debt and Equity Securities, FV-NI [Line Items]
Current equity, amortized cost	0	0
Current equity, estimated fair value	5,404	7,403
Baker Hughes
Debt and Equity Securities, FV-NI [Line Items]
Current equity, amortized cost	0	0
Current equity, estimated fair value	0	207
U.S. corporate
Debt and Equity Securities, FV-NI [Line Items]
Amortized cost, excluding accrued interest	27,760	26,921
Gross unrealized gains	996	675
Gross unrealized losses	(1,781)	(2,164)
Estimated fair value	26,975	25,432
Non-U.S. corporate
Debt and Equity Securities, FV-NI [Line Items]
Amortized cost, excluding accrued interest	2,585	2,548
Gross unrealized gains	26	18
Gross unrealized losses	(243)	(300)
Estimated fair value	2,369	2,266
State and municipal
Debt and Equity Securities, FV-NI [Line Items]
Amortized cost, excluding accrued interest	2,881	2,898
Gross unrealized gains	106	66
Gross unrealized losses	(184)	(241)
Estimated fair value	2,803	2,722
Mortgage and asset-backed
Debt and Equity Securities, FV-NI [Line Items]
Amortized cost, excluding accrued interest	4,623	4,442
Gross unrealized gains	39	21
Gross unrealized losses	(320)	(290)
Estimated fair value	4,341	4,173
Government and agencies
Debt and Equity Securities, FV-NI [Line Items]
Amortized cost, excluding accrued interest	1,641	1,172
Gross unrealized gains	3	2
Gross unrealized losses	(139)	(147)
Estimated fair value	$ 1,504	$ 1,026

INVESTMENT SECURITIES - Contrac

INVESTMENT SECURITIES - Contractual Maturities (Details) $ in Millions	Mar. 31, 2023 USD ($)
Amortized cost
Within one year	$ 1,057
After one year through five years	4,762
After five years through ten years	5,726
After ten years	23,323
Estimated fair value
Within one year	1,052
After one year through five years	4,753
After five years through ten years	5,793
After ten years	$ 22,052

CURRENT AND LONG-TERM RECEIVA_3

CURRENT AND LONG-TERM RECEIVABLES - Schedule of Current Receivables (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Accounts, Notes, Loans and Financing Receivable [Line Items]
Customer receivables	$ 11,123	$ 11,803
Revenue sharing program receivables	1,336	1,326
Non-income based tax receivables	1,190	1,146
Supplier advances	711	691
Receivables from disposed businesses	245	115
Other sundry receivables	393	518
Allowance for credit losses	(787)	(768)
Total current receivables	14,212	14,831
Increase in allowance for credit losses	20
Operating segments \| Aerospace
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total current receivables	7,667	7,784
Operating segments \| Renewable Energy
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total current receivables	2,129	2,415
Operating segments \| Power
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total current receivables	3,940	4,229
Corporate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total current receivables	$ 477	$ 404

CURRENT AND LONG-TERM RECEIVA_4

CURRENT AND LONG-TERM RECEIVABLES - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Accounts, Notes, Loans and Financing Receivable [Line Items]
Sale of current customer receivables	$ 464	$ 347
Gas Power
Accounts, Notes, Loans and Financing Receivable [Line Items]
Sale of current customer receivables	$ 77

CURRENT AND LONG-TERM RECEIVA_5

CURRENT AND LONG-TERM RECEIVABLES - Schedule of Long-term Receivables (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Receivables [Abstract]
Long-term customer receivables	$ 448		$ 457
Supplier advances	279		266
Non-income based tax receivables	236		213
Financing receivables	147		82
Sundry receivables	429		400
Allowance for credit losses	(182)		(183)
Total long-term receivables	1,358		$ 1,236
Sale of long term customer receivables	$ 0	$ 79

INVENTORIES, INCLUDING DEFERR_3

INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Inventory Disclosure [Abstract]
Raw materials and work in process	$ 10,000	$ 9,191
Finished goods	4,223	3,937
Deferred inventory costs	1,975	1,764
Inventories, including deferred inventory costs	$ 16,198	$ 14,891

PROPERTY, PLANT AND EQUIPMENT_3

PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES - Schedule of Property, Plant and Equipment (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
Original cost	$ 26,957	$ 26,641
Less accumulated depreciation and amortization	(16,640)	(16,303)
Right-of-use operating lease assets	1,853	1,854
Property, plant and equipment – net	$ 12,170	$ 12,192
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Property, plant and equipment – net	Property, plant and equipment – net

PROPERTY, PLANT AND EQUIPMENT_4

PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	All other liabilities (Note 15)		All other liabilities (Note 15)
Operating lease liabilities	$ 2,083		$ 2,089
Lease expense	$ 195	$ 227

GOODWILL AND OTHER INTANGIBLE_3

GOODWILL AND OTHER INTANGIBLE ASSETS - Changes in Goodwill Balances (Details) $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($)
Goodwill
Balance at beginning of period	$ 12,999
Currency exchange and other	108
Balance at end of period	13,107
Operating segments \| Aerospace
Goodwill
Balance at beginning of period	8,835
Currency exchange and other	64
Balance at end of period	8,899
Operating segments \| Renewable Energy
Goodwill
Balance at beginning of period	3,201
Currency exchange and other	42
Balance at end of period	3,243
Operating segments \| Power
Goodwill
Balance at beginning of period	144
Currency exchange and other	0
Balance at end of period	144
Corporate
Goodwill
Balance at beginning of period	818
Currency exchange and other	2
Balance at end of period	$ 821

GOODWILL AND OTHER INTANGIBLE_4

GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Goodwill [Line Items]
Goodwill	$ 13,107		$ 12,999
Increase (decrease) in intangible assets	(115)
Intangible assets, foreign currency translation gain	23
Amortization of intangible assets	140	$ 922
Corporate
Goodwill [Line Items]
Goodwill	821		818
Corporate \| Digital
Goodwill [Line Items]
Goodwill	821
Operating segments \| Power
Goodwill [Line Items]
Goodwill	144		144
Non-cash pre-tax impairment charge		$ 765
Operating segments \| Aerospace
Goodwill [Line Items]
Goodwill	8,899		$ 8,835
Operating segments \| Aerospace \| Capitalized software
Goodwill [Line Items]
Addition of intangible assets	20
Operating segments \| Aerospace \| Additive
Goodwill [Line Items]
Goodwill	$ 244

REVENUES - Schedule of Disaggre

REVENUES - Schedule of Disaggregated Revenue (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Disaggregation of Revenue [Line Items]
Total revenues	$ 14,486	$ 12,675
Operating segments
Disaggregation of Revenue [Line Items]
Total revenues	13,638	11,975
Operating segments \| Equipment
Disaggregation of Revenue [Line Items]
Total revenues	5,387	4,792
Operating segments \| Services
Disaggregation of Revenue [Line Items]
Total revenues	8,252	7,183
Operating segments \| Aerospace
Disaggregation of Revenue [Line Items]
Total revenues	6,981	5,603
Operating segments \| Aerospace \| Equipment
Disaggregation of Revenue [Line Items]
Total revenues	1,974	1,654
Operating segments \| Aerospace \| Services
Disaggregation of Revenue [Line Items]
Total revenues	5,007	3,949
Operating segments \| Aerospace \| Commercial Engines & Services
Disaggregation of Revenue [Line Items]
Total revenues	5,194	3,853
Operating segments \| Aerospace \| Military
Disaggregation of Revenue [Line Items]
Total revenues	1,018	1,036
Operating segments \| Aerospace \| Systems & Other
Disaggregation of Revenue [Line Items]
Total revenues	770	714
Operating segments \| Renewable Energy
Disaggregation of Revenue [Line Items]
Total revenues	2,837	2,871
Operating segments \| Renewable Energy \| Equipment
Disaggregation of Revenue [Line Items]
Total revenues	2,311	2,173
Operating segments \| Renewable Energy \| Services
Disaggregation of Revenue [Line Items]
Total revenues	527	698
Operating segments \| Renewable Energy \| Onshore Wind
Disaggregation of Revenue [Line Items]
Total revenues	1,502	1,906
Operating segments \| Renewable Energy \| Grid Solutions equipment and services
Disaggregation of Revenue [Line Items]
Total revenues	824	668
Operating segments \| Renewable Energy \| Hydro, Offshore Wind and Hybrid Solutions
Disaggregation of Revenue [Line Items]
Total revenues	511	297
Operating segments \| Power
Disaggregation of Revenue [Line Items]
Total revenues	3,820	3,501
Operating segments \| Power \| Equipment
Disaggregation of Revenue [Line Items]
Total revenues	1,102	965
Operating segments \| Power \| Services
Disaggregation of Revenue [Line Items]
Total revenues	2,718	2,536
Operating segments \| Power \| Gas Power
Disaggregation of Revenue [Line Items]
Total revenues	2,867	2,489
Operating segments \| Power \| Steam Power
Disaggregation of Revenue [Line Items]
Total revenues	541	636
Operating segments \| Power \| Power Conversion, Nuclear and other
Disaggregation of Revenue [Line Items]
Total revenues	412	377
Corporate
Disaggregation of Revenue [Line Items]
Total revenues	$ 848	$ 700

REVENUES - Remaining Performanc

REVENUES - Remaining Performance Obligation (Details) $ in Millions	Mar. 31, 2023 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligations expected to be satisfied	$ 242,054
Equipment
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligations expected to be satisfied	$ 47,991
Equipment \| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01 \| Performance obligation satisfaction, period one
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation expected to be satisfied (as a percent)	55%
Performance obligations expected to be satisfied, expected timing	1 year
Equipment \| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01 \| Performance obligation satisfaction, period two
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation expected to be satisfied (as a percent)	80%
Performance obligations expected to be satisfied, expected timing	2 years
Equipment \| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01 \| Performance obligation satisfaction, period three
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation expected to be satisfied (as a percent)	97%
Performance obligations expected to be satisfied, expected timing	5 years
Services
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligations expected to be satisfied	$ 194,063
Services \| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01 \| Performance obligation satisfaction, period one
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation expected to be satisfied (as a percent)	12%
Performance obligations expected to be satisfied, expected timing	1 year
Services \| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01 \| Performance obligation satisfaction, period two
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation expected to be satisfied (as a percent)	43%
Performance obligations expected to be satisfied, expected timing	5 years
Services \| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01 \| Performance obligation satisfaction, period three
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation expected to be satisfied (as a percent)	68%
Performance obligations expected to be satisfied, expected timing	10 years
Services \| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01 \| Performance obligation satisfaction, period four
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation expected to be satisfied (as a percent)	83%
Performance obligations expected to be satisfied, expected timing	15 years

CONTRACT AND OTHER DEFERRED A_3

CONTRACT AND OTHER DEFERRED ASSETS & PROGRESS COLLECTIONS AND DEFERRED INCOME - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Capitalized Contract Cost [Line Items]
Increase (decrease) in contract and other deferred assets	$ (368)
Increase (decrease) in progress collections and deferred income due to timing of revenue recognition	461
Revenue recognized included in contract liability	4,468	$ 3,997
Long-term \| Services
Capitalized Contract Cost [Line Items]
Increase (decrease) due to billings	(3,155)
Revenues recognized	2,579
Long-term \| Services \| Aerospace
Capitalized Contract Cost [Line Items]
Net favorable (unfavorable) change in estimated profitability	53
Long-term \| Services \| Power
Capitalized Contract Cost [Line Items]
Net favorable (unfavorable) change in estimated profitability	$ (12)

CONTRACT AND OTHER DEFERRED A_4

CONTRACT AND OTHER DEFERRED ASSETS & PROGRESS COLLECTIONS AND DEFERRED INCOME - Schedule of Contract Assets (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current contract assets	$ 2,244	$ 2,467
Nonrecurring engineering costs	2,542	2,534
Customer advances and other	3,089	3,243
Non-current contract and other deferred assets	5,631	5,776
Total contract and other deferred assets	7,875	8,244
Services \| Long-term
Accounts, Notes, Loans and Financing Receivable [Line Items]
Revenues in excess of billings	7,920	7,766
Billings in excess of revenues	(9,095)	(8,443)
Long-term service agreements	(1,176)	(677)
Services \| Short-term
Accounts, Notes, Loans and Financing Receivable [Line Items]
Other current contract assets	927	799
Equipment
Accounts, Notes, Loans and Financing Receivable [Line Items]
Other current contract assets	2,493	2,345
Operating segments \| Aerospace
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current contract assets	(4,203)	(3,884)
Nonrecurring engineering costs	2,521	2,513
Customer advances and other	2,389	2,519
Non-current contract and other deferred assets	4,910	5,032
Total contract and other deferred assets	707	1,148
Operating segments \| Aerospace \| Services \| Long-term
Accounts, Notes, Loans and Financing Receivable [Line Items]
Revenues in excess of billings	2,603	2,363
Billings in excess of revenues	(7,288)	(6,681)
Long-term service agreements	(4,685)	(4,318)
Operating segments \| Aerospace \| Services \| Short-term
Accounts, Notes, Loans and Financing Receivable [Line Items]
Other current contract assets	456	391
Operating segments \| Aerospace \| Equipment
Accounts, Notes, Loans and Financing Receivable [Line Items]
Other current contract assets	27	42
Operating segments \| Renewable Energy
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current contract assets	1,138	1,063
Nonrecurring engineering costs	19	17
Customer advances and other	0	0
Non-current contract and other deferred assets	19	17
Total contract and other deferred assets	1,157	1,079
Operating segments \| Renewable Energy \| Services \| Long-term
Accounts, Notes, Loans and Financing Receivable [Line Items]
Revenues in excess of billings	0	0
Billings in excess of revenues	0	0
Long-term service agreements	0	0
Operating segments \| Renewable Energy \| Services \| Short-term
Accounts, Notes, Loans and Financing Receivable [Line Items]
Other current contract assets	129	108
Operating segments \| Renewable Energy \| Equipment
Accounts, Notes, Loans and Financing Receivable [Line Items]
Other current contract assets	1,009	955
Operating segments \| Power
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current contract assets	5,032	5,044
Nonrecurring engineering costs	2	4
Customer advances and other	700	724
Non-current contract and other deferred assets	702	728
Total contract and other deferred assets	5,734	5,772
Operating segments \| Power \| Services \| Long-term
Accounts, Notes, Loans and Financing Receivable [Line Items]
Revenues in excess of billings	5,317	5,403
Billings in excess of revenues	(1,807)	(1,763)
Long-term service agreements	3,510	3,640
Operating segments \| Power \| Services \| Short-term
Accounts, Notes, Loans and Financing Receivable [Line Items]
Other current contract assets	66	56
Operating segments \| Power \| Equipment
Accounts, Notes, Loans and Financing Receivable [Line Items]
Other current contract assets	1,457	1,348
Corporate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Current contract assets	277	245
Nonrecurring engineering costs	0	0
Customer advances and other	0	0
Non-current contract and other deferred assets	0	0
Total contract and other deferred assets	277	245
Corporate \| Services \| Long-term
Accounts, Notes, Loans and Financing Receivable [Line Items]
Revenues in excess of billings	0	0
Billings in excess of revenues	0	0
Long-term service agreements	0	0
Corporate \| Services \| Short-term
Accounts, Notes, Loans and Financing Receivable [Line Items]
Other current contract assets	277	245
Corporate \| Equipment
Accounts, Notes, Loans and Financing Receivable [Line Items]
Other current contract assets	$ 0	$ 0

CONTRACT AND OTHER DEFERRED A_5

CONTRACT AND OTHER DEFERRED ASSETS & PROGRESS COLLECTIONS AND DEFERRED INCOME - Progress Collections and Deferred Income (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Capitalized Contract Cost [Line Items]
Current deferred income	$ 550	$ 562
Progress collections and deferred income	16,586	16,216
Non-current deferred income	1,500	1,409
Total Progress collections and deferred income	18,086	17,625
Equipment
Capitalized Contract Cost [Line Items]
Progress collections	6,751	6,511
Other
Capitalized Contract Cost [Line Items]
Progress collections	9,284	9,143
Operating segments \| Aerospace
Capitalized Contract Cost [Line Items]
Current deferred income	216	233
Progress collections and deferred income	5,937	6,047
Non-current deferred income	1,183	1,110
Total Progress collections and deferred income	7,120	7,157
Operating segments \| Aerospace \| Equipment
Capitalized Contract Cost [Line Items]
Progress collections	90	74
Operating segments \| Aerospace \| Other
Capitalized Contract Cost [Line Items]
Progress collections	5,631	5,740
Operating segments \| Renewable Energy
Capitalized Contract Cost [Line Items]
Current deferred income	204	208
Progress collections and deferred income	5,588	5,404
Non-current deferred income	206	183
Total Progress collections and deferred income	5,794	5,586
Operating segments \| Renewable Energy \| Equipment
Capitalized Contract Cost [Line Items]
Progress collections	2,313	2,464
Operating segments \| Renewable Energy \| Other
Capitalized Contract Cost [Line Items]
Progress collections	3,071	2,731
Operating segments \| Power
Capitalized Contract Cost [Line Items]
Current deferred income	12	13
Progress collections and deferred income	4,812	4,527
Non-current deferred income	98	104
Total Progress collections and deferred income	4,910	4,632
Operating segments \| Power \| Equipment
Capitalized Contract Cost [Line Items]
Progress collections	4,349	3,973
Operating segments \| Power \| Other
Capitalized Contract Cost [Line Items]
Progress collections	451	541
Corporate
Capitalized Contract Cost [Line Items]
Current deferred income	119	107
Progress collections and deferred income	249	238
Non-current deferred income	12	12
Total Progress collections and deferred income	262	250
Corporate \| Equipment
Capitalized Contract Cost [Line Items]
Progress collections	0	0
Corporate \| Other
Capitalized Contract Cost [Line Items]
Progress collections	$ 131	$ 131

ALL OTHER ASSET (Details)

ALL OTHER ASSET (Details) - USD ($) $ in Millions	3 Months Ended
ALL OTHER ASSET (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Increase in other non-current assets	$ 412
Increase in equity method and other investments	180
Increase (decrease) in long-term receivables	122
Increase (decrease) in insurance cash and cash equivalents	68
Insurance cash and cash equivalents	$ 687	$ 619

BORROWINGS - Schedule of Borrow

BORROWINGS - Schedule of Borrowings (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Short-term borrowings
Total short-term borrowings	$ 2,262	$ 3,739
Long-term borrowings
Long-term borrowings and lease obligation	20,159	20,320
Total borrowings	22,421	24,059
Other
Long-term borrowings
Long-term borrowings and lease obligation	861	901
Debt issued by GE \| Senior notes
Long-term borrowings
Long-term borrowings	4,653	4,724
Debt assumed by GE \| Senior and subordinated notes
Long-term borrowings
Long-term borrowings	8,383	8,406
Debt issued by GE Capital \| Senior notes
Long-term borrowings
Long-term borrowings	6,262	6,289
Senior notes \| Debt issued by GE
Short-term borrowings
Current portion of long-term borrowings	609	464
Senior notes \| Debt issued by GE Capital
Short-term borrowings
Current portion of long-term borrowings	592	1,188
Senior and subordinated notes \| Debt assumed by GE
Short-term borrowings
Current portion of long-term borrowings	947	1,973
Other
Short-term borrowings
Other	$ 114	$ 115

BORROWINGS - Narrative (Details

BORROWINGS - Narrative (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Non-recourse borrowings of consolidated securitization entities
Guarantor Obligations [Line Items]
Debt assumed by GE upon merger	$ 3,379	$ 5,258

ACCOUNTS PAYABLE AND EQUIPMEN_3

ACCOUNTS PAYABLE AND EQUIPMENT PROJECT PAYABLES - Schedule of Accounts Payable and Accruals (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Payables and Accruals [Abstract]
Trade payables	$ 10,049	$ 10,033
Supply chain finance programs	3,454	3,689
Equipment project accruals	1,109	1,236
Non-income based tax payables	451	441
Accounts payable and equipment project payables	$ 15,063	$ 15,399

ACCOUNTS PAYABLE AND EQUIPMEN_4

ACCOUNTS PAYABLE AND EQUIPMENT PROJECT PAYBLES - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Payables and Accruals [Abstract]
Supplier invoices paid	$ 2,079	$ 1,856

INSURANCE LIABILITIES AND ANN_3

INSURANCE LIABILITIES AND ANNUITY BENEFITS - Narrative (Details) - USD ($) $ in Millions	3 Months Ended			12 Months Ended		21 Months Ended	51 Months Ended
	Mar. 31, 2023	Sep. 30, 2022	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2024	Mar. 31, 2023	Jan. 01, 2021
Disaggregation of Revenue [Line Items]
Insurance revenues	$ 791		$ 764
Net earnings (loss)	7,478		(1,108)
Assets	164,472			$ 188,851			$ 164,472
Gross premium income	214		229	935	$ 967
Interest accretion	435		436	1,735	1,730
Favorable (unfavorable) pre-tax adjustments, net premium ratio				404	408
Unfavorable adjustment, insufficient gross premium				190	58
Policyholder account balance	1,921		2,095	1,964	2,124		$ 1,921
Policyholder account balance, surrender, withdrawal and benefit payments	120		115	441	475
Policyholder account balance, net additions and interest credited	$ 75		$ 81	$ 271	$ 326
Policyholder account balance, crediting rate	3%		6%	3%	6%		3%
Reinsurance recoverables, net	$ 277			$ 255	$ 6,596		$ 277
Reinsurance recoverables, allowances					2,065			$ 2,079
Reinsurance recoverable, credit loss increase, expense, pre-tax		$ 350
Reinsurance recoverable, credit loss increase, expense, after-tax		276
Reinsurance recoverable, incurred but not yet reported claims		2,396
Reinsurance incremental loss (pre-tax)		55
Reinsurance incremental loss (after-tax)		$ 43
Capital contributions to insurance subsidiaries	$ 1,815						$ 13,215
Statutory capital level requirement	300%						300%
Long-term care
Disaggregation of Revenue [Line Items]
Gross premium income	$ 124		$ 123	490	487
Interest accretion	310		306	1,224	1,194
Life
Disaggregation of Revenue [Line Items]
Gross premium income	84		98	415	448
Structured settlement annuities
Disaggregation of Revenue [Line Items]
Interest accretion	115		119	471	491
Forecast
Disaggregation of Revenue [Line Items]
Capital contributions to insurance subsidiaries						$ 1,820
Run-off Insurance Operations
Disaggregation of Revenue [Line Items]
Insurance revenues	791		764	2,957	3,101
Gross profit (loss)	70		106	205	798
Net earnings (loss)	54		$ 84	159	627
Assets	$ 47,981			$ 45,031	$ 56,037		$ 47,981

INSURANCE LIABILITIES AND ANN_4

INSURANCE LIABILITIES AND ANNUITY BENEFITS - Schedule of Investment Contracts, Insurance Liabilities and Insurance Annuity Benefits (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefit reserves	$ 36,876	$ 34,593		$ 48,763
Investment contracts	1,667	1,708		1,857
Other	539	544		950
Total	39,082	36,845		51,570
Long-term care
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefit reserves	26,054	24,256	$ 30,314	34,644
Investment contracts	0	0		0
Other	0	0		0
Total	26,054	24,256		34,644
Structured settlement annuities
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefit reserves	9,349	8,860	10,848	12,328
Investment contracts	846	860		950
Other	0	0		0
Total	10,194	9,720		13,278
Life
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefit reserves	1,045	1,040	$ 1,175	1,301
Investment contracts	0	0		0
Other	178	178		189
Total	1,223	1,218		1,490
Other contracts
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefit reserves	428	437		490
Investment contracts	821	849		907	$ 2,049
Other	361	365		761	564
Total	$ 1,610	$ 1,651		2,158
Claim reserves, short-duration insurance contracts				$ 325	$ 399

INSURANCE LIABILITIES AND ANN_5

INSURANCE LIABILITIES AND ANNUITY BENEFITS - Changes in Future Policy Benefit Reserves (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021	Jan. 01, 2021	Dec. 31, 2020
Present value of expected future policy benefits
Future policy benefit reserves	$ 36,876		$ 34,593	$ 48,763
Less: Reinsurance recoverables, net of allowance for credit losses					$ (7,095)
Net future policy benefit reserves, after reinsurance recoverables					48,856
Long-term care
Present value of expected net premiums
Balance, beginning of year	4,059	$ 5,652	5,652	6,397
Beginning balance at locked-in discount rate	3,958	4,451	4,451	4,822
Interest accrual	53	59	223	241
Net premiums collected	(103)	(113)	(417)	(453)
Effect of foreign currency	0	0	0	0
Ending balance at locked-in discount rate	3,937	4,267	3,958	4,451
Effect of changes in discount rate assumptions	281	696	101	1,201
Balance, end of year	4,217	4,963	4,059	5,652
Present value of expected future policy benefits
Balance, beginning of year	28,316	40,296	40,296	43,974
Beginning balance at locked-in discount rate	27,100	27,425	27,026	27,465		$ 27,745
Interest accrual	363	365	1,446	1,435
Benefit payments	(309)	(274)	(1,152)	(1,058)
Effect of foreign currency	0	0	0	0
Ending balance at locked-in discount rate	27,100	27,425	27,026	27,465
Effect of changes in discount rate assumptions	3,171	7,852	1,290	12,831
Balance, end of year	30,271	35,277	28,316	40,296
Future policy benefit reserves	26,054	30,314	24,256	34,644
Less: Reinsurance recoverables, net of allowance for credit losses	(204)	(5,154)	(171)	(6,473)	(7,036)
Net future policy benefit reserves, after reinsurance recoverables	25,850	25,160	24,085	28,171	30,541
Long-term care \| Beginning balance adjustments, quarterly activity
Present value of expected net premiums
Effect of changes in cash flow assumptions			0	0
Effect of actual variances from expected experience			29	(130)
Adjusted beginning of year balance			3,987	4,321
Present value of expected future policy benefits
Effect of changes in cash flow assumptions			(11)	0
Effect of actual variances from expected experience			30	(130)
Adjusted beginning of year balance			27,046	27,335
Long-term care \| Beginning balance adjustments, annual activity
Present value of expected net premiums
Effect of changes in cash flow assumptions				(9)		(91)
Effect of actual variances from expected experience				(290)		(68)
Adjusted beginning of year balance				4,152		4,663
Present value of expected future policy benefits
Effect of changes in cash flow assumptions				(413)		(509)
Effect of actual variances from expected experience				(320)		(147)
Adjusted beginning of year balance				26,732		27,089
Structured settlement annuities
Present value of expected net premiums
Balance, beginning of year	0	0	0	0
Beginning balance at locked-in discount rate	0	0	0	0
Interest accrual	0	0	0	0
Net premiums collected	0	0	0	0
Effect of foreign currency	0	0	0	0
Ending balance at locked-in discount rate	0	0	0	0
Effect of changes in discount rate assumptions	0	0	0	0
Balance, end of year	0	0	0	0
Present value of expected future policy benefits
Balance, beginning of year	8,860	12,328	12,328	13,531
Beginning balance at locked-in discount rate	8,730	8,978	8,790	9,024		9,163
Interest accrual	115	119	471	491
Benefit payments	(174)	(162)	(671)	(678)
Effect of foreign currency	0	0	0	0
Ending balance at locked-in discount rate	8,730	8,978	8,790	9,024
Effect of changes in discount rate assumptions	619	1,870	70	3,305
Balance, end of year	9,349	10,848	8,860	12,328
Future policy benefit reserves	9,349	10,848	8,860	12,328
Less: Reinsurance recoverables, net of allowance for credit losses	0	0	0	0	0
Net future policy benefit reserves, after reinsurance recoverables	9,349	10,848	8,860	12,328	13,532
Structured settlement annuities \| Beginning balance adjustments, quarterly activity
Present value of expected net premiums
Effect of changes in cash flow assumptions			0	0
Effect of actual variances from expected experience			0	0
Adjusted beginning of year balance			0	0
Present value of expected future policy benefits
Effect of changes in cash flow assumptions			0	0
Effect of actual variances from expected experience			(1)	(3)
Adjusted beginning of year balance			8,789	9,021
Structured settlement annuities \| Beginning balance adjustments, annual activity
Present value of expected net premiums
Effect of changes in cash flow assumptions				0		0
Effect of actual variances from expected experience				0		0
Adjusted beginning of year balance				0		0
Present value of expected future policy benefits
Effect of changes in cash flow assumptions				(23)		58
Effect of actual variances from expected experience				(11)		(11)
Adjusted beginning of year balance				8,990		9,210
Life
Present value of expected net premiums
Balance, beginning of year	4,828	6,622	6,622	7,205
Beginning balance at locked-in discount rate	5,210	5,443	5,443	5,518
Interest accrual	50	52	203	203
Net premiums collected	(73)	(83)	(357)	(392)
Effect of foreign currency	(23)	73	(176)	(9)
Ending balance at locked-in discount rate	5,129	5,487	5,210	5,443
Effect of changes in discount rate assumptions	(149)	396	(381)	1,179
Balance, end of year	4,979	5,883	4,828	6,622
Present value of expected future policy benefits
Balance, beginning of year	5,868	7,923	7,923	8,767
Beginning balance at locked-in discount rate	6,148	6,570	6,247	6,560		6,797
Interest accrual	60	62	243	248
Benefit payments	(138)	(148)	(531)	(638)
Effect of foreign currency	(24)	77	(185)	(10)
Ending balance at locked-in discount rate	6,148	6,570	6,247	6,560
Effect of changes in discount rate assumptions	(123)	488	(380)	1,363
Balance, end of year	6,025	7,058	5,868	7,923
Future policy benefit reserves	1,045	1,175	1,040	1,301
Less: Reinsurance recoverables, net of allowance for credit losses	(57)	(81)	(67)	(87)	(15)
Net future policy benefit reserves, after reinsurance recoverables	$ 988	$ 1,094	973	1,214	$ 1,546
Life \| Beginning balance adjustments, quarterly activity
Present value of expected net premiums
Effect of changes in cash flow assumptions			0	0
Effect of actual variances from expected experience			(35)	2
Adjusted beginning of year balance			5,175	5,445
Present value of expected future policy benefits
Effect of changes in cash flow assumptions			0	0
Effect of actual variances from expected experience			2	19
Adjusted beginning of year balance			$ 6,250	6,579
Life \| Beginning balance adjustments, annual activity
Present value of expected net premiums
Effect of changes in cash flow assumptions				91		191
Effect of actual variances from expected experience				6		(69)
Adjusted beginning of year balance				5,540		5,640
Present value of expected future policy benefits
Effect of changes in cash flow assumptions				120		207
Effect of actual variances from expected experience				40		(43)
Adjusted beginning of year balance				$ 6,720		$ 6,961

INSURANCE LIABILITIES AND ANN_6

INSURANCE LIABILITIES AND ANNUITY BENEFITS - Undiscounted and Discounted Expected Gross Premiums and Benefit Payments (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022	Dec. 31, 2021
Long-term care
Liability for Future Policy Benefit, by Product Segment [Line Items]
Undiscounted, expected future gross premiums	$ 7,924	$ 7,985	$ 8,052	$ 8,173
Undiscounted, expected future benefit payments	64,944	65,217	67,254	67,516
Discounted, expected future gross premiums	5,105	4,918	5,599	6,187
Discounted, expected future benefit payments	30,271	28,316	35,277	40,296
Structured settlement annuities
Liability for Future Policy Benefit, by Product Segment [Line Items]
Undiscounted, expected future benefit payments	19,745	19,936	20,482	20,666
Discounted, expected future benefit payments	9,349	8,860	10,848	12,328
Life
Liability for Future Policy Benefit, by Product Segment [Line Items]
Undiscounted, expected future gross premiums	13,537	13,754	14,676	14,579
Undiscounted, expected future benefit payments	11,800	12,020	12,709	12,702
Discounted, expected future gross premiums	6,104	5,916	7,311	8,275
Discounted, expected future benefit payments	$ 6,025	$ 5,868	$ 7,058	$ 7,923

INSURANCE LIABILITIES AND ANN_7

INSURANCE LIABILITIES AND ANNUITY BENEFITS - Weighted-Average Durations and Interest Rates (Details)	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022	Dec. 31, 2021
Long-term care
Liability for Future Policy Benefit, by Product Segment [Line Items]
Duration (years)	13 years 2 months 12 days	13 years	14 years 7 months 6 days	15 years 6 months
Interest accretion rate	5.50%	5.50%	5.50%	5.30%
Current discount rate	5%	5.60%	4%	3.10%
Structured settlement annuities
Liability for Future Policy Benefit, by Product Segment [Line Items]
Duration (years)	11 years 2 months 12 days	10 years 8 months 12 days	12 years 2 months 12 days	13 years 2 months 12 days
Interest accretion rate	5.40%	5.40%	5.40%	5.50%
Current discount rate	5%	5.50%	4%	3.10%
Life
Liability for Future Policy Benefit, by Product Segment [Line Items]
Duration (years)	5 years 3 months 18 days	5 years	6 years 1 month 6 days	6 years 3 months 18 days
Interest accretion rate	5.10%	4.90%	5.10%	4.80%
Current discount rate	4.80%	5.40%	3.80%	2.60%

POSTRETIREMENT BENEFIT PLANS -

POSTRETIREMENT BENEFIT PLANS - Narrative (Details) $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($) category	Mar. 31, 2022 USD ($)	Jan. 03, 2023 USD ($)
Defined Benefit Plan Disclosure [Line Items]
Number of categories \| category	3
Defined contribution plan costs	$ 77	$ 110
Spinoff
Defined Benefit Plan Disclosure [Line Items]
Postretirement and pension plan benefit obligation			$ 4,000
Continuing operations
Defined Benefit Plan Disclosure [Line Items]
Defined contribution plan costs		79
Principal retiree benefit plans
Defined Benefit Plan Disclosure [Line Items]
Plans income	36	52
Principal retiree benefit plans \| Continuing operations
Defined Benefit Plan Disclosure [Line Items]
Plans income		33
Other pension plans
Defined Benefit Plan Disclosure [Line Items]
Plans income	29	117
Expected employer contributions	100
Other pension plans \| Continuing operations
Defined Benefit Plan Disclosure [Line Items]
Plans income		89
Principal pension plans
Defined Benefit Plan Disclosure [Line Items]
Plans income	271	(143)
Principal pension plans \| GE Supplementary Pension Plan
Defined Benefit Plan Disclosure [Line Items]
Expected employer contributions	230
Principal pension plans \| Continuing operations
Defined Benefit Plan Disclosure [Line Items]
Plans income	271	$ (94)
Retiree health benefits and life insurance
Defined Benefit Plan Disclosure [Line Items]
Expected employer contributions	$ 230

POSTRETIREMENT BENEFIT PLANS _2

POSTRETIREMENT BENEFIT PLANS - Description of Postretirement Benefit Plans (Details) $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($) plan employee
Principal pension plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Number of retirees and beneficiaries covered	115,000
Number of vested former employees	50,000
Number of active employees	16,500
Other pension plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Number of retirees and beneficiaries covered	42,500
Number of vested former employees	29,500
Number of active employees	8,000
Number of U.S. and non-U.S. pension plans \| plan	35
Assets or obligations of U.S. and non-U.S. pension plans, threshold \| $	$ 50
Principal retiree benefit plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Number of retirees and beneficiaries covered	93,500
Number of active employees	15,500

POSTRETIREMENT BENEFIT PLANS _3

POSTRETIREMENT BENEFIT PLANS - Effect on Operations of Pension Plans (Details) - Principal pension plans - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Defined Benefit Plan Disclosure [Line Items]
Service cost for benefits earned	$ 21	$ 49
Expected return on plan assets	(594)	(786)
Interest cost on benefit obligations	474	517
Net actuarial loss amortization	(172)	363
Benefit plans cost	(271)	143
Discontinued operations
Defined Benefit Plan Disclosure [Line Items]
Benefit plans cost	0	49
Continuing operations
Defined Benefit Plan Disclosure [Line Items]
Benefit plans cost	$ (271)	$ 94

CURRENT AND ALL OTHER LIABILI_2

CURRENT AND ALL OTHER LIABILITIES (Details) $ in Millions	3 Months Ended
CURRENT AND ALL OTHER LIABILITIES (Details) $ in Millions	Mar. 31, 2023 USD ($)
Other Liabilities Disclosure [Abstract]
Increase (decrease) in other current liabilities	$ 183
Increase (decrease) in taxes payable	175
Increase (decrease) in sales allowances	135
Increase (decrease) in equipment projects and other commercial liabilities, current	120
Increase (decrease) in derivative liabilities	(195)
Increase (decrease) in other noncurrent liabilities	(125)
Increase (decrease) in equipment projects and other commercial liabilities, noncurrent	$ (181)

INCOME TAXES (Details)

INCOME TAXES (Details)	3 Months Ended
INCOME TAXES (Details)	Mar. 31, 2023	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Effective income tax rate	4.20%	(2.50%)

SHAREHOLDERS' EQUITY (Details)

SHAREHOLDERS' EQUITY (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Beginning balance	$ 34,912
Ending balance	$ 32,823	$ 32,909
Dividends declared per common share (in dollars per share)	$ 0.08	$ 0.08
GE Healthcare
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Reclass from AOCI, net of taxes	$ 195
Accumulated other comprehensive income (loss)
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Beginning balance	(2,272)	$ (4,860)
Ending balance	(3,289)	(4,115)
Currency translation adjustments including noncontrolling interests
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Beginning balance	(5,893)	(4,569)
AOCI before reclass, net of taxes	152	(181)
Reclass from AOCI, net of taxes	2,234	0
Other comprehensive income (loss)	2,387	(181)
AOCI before reclass, taxes	(5)	90
Reclass from AOCI, taxes	(626)	0
Currency translation adjustments including noncontrolling interests \| GE Healthcare
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Reclass from AOCI, net of taxes	2,234
Currency translation adjustments attributable to noncontrolling interests
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Other comprehensive income (loss)	(1)	(4)
Currency translation adjustments
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Other comprehensive income (loss)	2,388	(177)
Ending balance	(3,505)	(4,746)
Benefit plans including noncontrolling interests
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Beginning balance	6,531	3,646
AOCI before reclass, net of taxes	(84)	54
Reclass from AOCI, net of taxes	(2,235)	186
Other comprehensive income (loss)	(2,319)	240
AOCI before reclass, taxes	(13)	25
Reclass from AOCI, taxes	(594)	55
Benefit plans including noncontrolling interests \| GE Healthcare
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Reclass from AOCI, net of taxes	(2,030)
Benefit plans attributable to noncontrolling interests
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Other comprehensive income (loss)	(2)	2
Benefit plans
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Other comprehensive income (loss)	(2,317)	238
Ending balance	4,214	3,884
Investment securities and cash flow hedges
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Beginning balance	(1,927)	5,172
AOCI before reclass, net of taxes	718	(2,993)
Reclass from AOCI, net of taxes	(12)	(5)
Other comprehensive income (loss)	706	(2,998)
Ending balance	(1,222)	2,174
AOCI before reclass, taxes	188	(801)
Reclass from AOCI, taxes	0	1
Long-duration insurance contracts
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Beginning balance	(983)	(9,109)
AOCI before reclass, net of taxes	(1,793)	3,682
Other comprehensive income (loss)	(1,793)	3,682
Ending balance	(2,776)	(5,427)
AOCI before reclass, taxes	$ (477)	$ 979

SHAREHOLDERS' EQUITY - Narrativ

SHAREHOLDERS' EQUITY - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares outstanding	2,795,444		5,795,444
Redemption of GE preferred stock	$ 3,000	$ 0
Common stock, shares outstanding	1,088,960,029		1,089,107,878
Series D Preferred Stock \| Preferred stock
Accumulated Other Comprehensive Income (Loss) [Line Items]
Redemption of GE preferred stock	$ 3,000

EARNINGS PER SHARE INFORMATIO_2

EARNINGS PER SHARE INFORMATION (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Diluted
Earnings (loss) from continuing operations	$ 6,242	$ (1,224)
Preferred stock dividends and other	(145)	(52)
Earnings (loss) from continuing operations attributable to common shareholders	6,097	(1,276)
Earnings (loss) from discontinued operations	1,257	88
Net earnings (loss) attributable to GE common shareholders	$ 7,354	$ (1,188)
Total average equivalent shares (in shares)	1,089	1,100
Employee compensation-related shares (including stock options) (in shares)	8	0
Total average equivalent shares (in shares)	1,097	1,100
Earnings per share from continuing operations (in dollars per share)	$ 5.56	$ (1.16)
Earnings (loss) per share from discontinued operations (in dollars per share)	1.15	0.08
Net earnings (loss) per share (in dollars per share)	$ 6.71	$ (1.08)
Potentially dilutive securities (in shares)	38	43
Basic
Earnings (loss) from continuing operations	$ 6,248	$ (1,224)
Preferred stock dividends and other	(145)	(52)
Earnings (loss) from continuing operations attributable to common shareholders	6,103	(1,276)
Earnings (loss) from discontinued operations	1,257	88
Net earnings (loss) attributable to GE common shareholders	$ 7,360	$ (1,188)
Earnings per share from continuing operations (in dollars per share)	$ 5.60	$ (1.16)
Earnings (loss) per share from discontinued operations (in dollars per share)	1.15	0.08
Net earnings (loss) per share (in dollars per share)	$ 6.76	$ (1.08)
Preferred Share Redemption
Preferred share redemption, excise tax	$ (30)

OTHER INCOME (LOSS) - Schedule

OTHER INCOME (LOSS) - Schedule of Other Income (Loss) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Licensing and royalty income	$ 34	$ 57
Unrealized gain (loss)	6,040	(370)
Realized and unrealized gain (loss)	5,906	(206)
Other net interest and investment income (loss)	186	93
Other items	(48)	82
Total other income (loss)	$ 6,081	$ 49
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal, Statement of Income or Comprehensive Income [Extensible Enumeration]	Total other income (loss)	Total other income (loss)
Other (income) loss
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Equity method income	$ 0	$ 38
GE Healthcare
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Unrealized gain (loss)	6,093	0
AerCap
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Realized and unrealized gain (loss)	(195)	(1,736)
Baker Hughes
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Realized and unrealized gain (loss)	$ 10	$ 1,515

OTHER INCOME (LOSS) - Narrative

OTHER INCOME (LOSS) - Narrative (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Sales of retained ownership interests	$ 2,025	$ 1,302
GE Healthcare
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Equity securities, investment interest (in shares)	90.3
Equity securities, ownership percentage	19.90%
AerCap
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Equity securities, investment interest (in shares)	79.7
Equity securities, ownership percentage	33%
Sales of retained ownership interests	$ 1,808
Baker Hughes
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Sales of retained ownership interests	$ 216

RESTRUCTURING CHARGES AND SEP_3

RESTRUCTURING CHARGES AND SEPARATION COSTS - Restructuring and Other Charges (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	$ 161	$ 48
Restructuring and other charges cash expenditures	137	127
Cost of equipment/services
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	36	27
SG&A
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	125	25
Other (income) loss
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	0	(3)
Operating segments \| Aerospace
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	4	5
Operating segments \| Renewable Energy
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	65	6
Operating segments \| Power
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	19	34
Corporate
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	72	3
Workforce reductions
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	66	13
Plant closures & associated costs and other asset write-downs
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	82	26
Acquisition/disposition net charges and other
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	$ 12	$ 9

RESTRUCTURING CHARGES AND SEP_4

RESTRUCTURING CHARGES AND SEPARATION COSTS - Changes in Restructuring Liability (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Restructuring Reserve [Roll Forward]
Beginning balance	$ 977	$ 825
Additions	86	9
Payments	(87)	(115)
Effect of foreign currency and other	0	(9)
Ending balance	976	710
Restructuring reserve	976	710
Discontinued operations
Restructuring Reserve [Roll Forward]
Ending balance	64
Restructuring reserve	64
Post-employment severance benefits
Restructuring Reserve [Roll Forward]
Ending balance	353	322
Restructuring reserve	$ 353	$ 322

RESTRUCTURING CHARGES AND SEP_5

RESTRUCTURING CHARGES AND SEPARATION COSTS - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	$ 161	$ 48
Restructuring and other charges cash expenditures	137	127
Separation costs	205	99
Payments for restructuring costs	87	115
Non-cash asset impairment, accelerated depreciation and other charges
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	75	39
Employee workforce reduction and contract related charges
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	86	9
Separation costs
Restructuring Cost and Reserve [Line Items]
Separation costs	205	99
Payments for restructuring costs	204	3
Restructuring, incurred net tax expense (benefit)	56	24
Separation costs \| Discontinued operations
Restructuring Cost and Reserve [Line Items]
Separation costs	20	20
Payments for restructuring costs	85
Restructuring, incurred net tax expense (benefit)	$ (4)	$ (4)

FINANCIAL INSTRUMENTS - Assets

FINANCIAL INSTRUMENTS - Assets and Liabilities Not Carried at Fair Value (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Liabilities
Investment contracts	$ 1,667	$ 1,708	$ 1,857
Carrying amount (net)
Assets
Loans and other receivables	2,427	2,557
Liabilities
Borrowings	22,421	24,059
Investment contracts	1,667	1,708
Estimated fair value
Assets
Loans and other receivables	2,275	2,418
Liabilities
Borrowings	21,586	22,849
Investment contracts	$ 1,736	$ 1,758

FINANCIAL INSTRUMENTS - Fair Va

FINANCIAL INSTRUMENTS - Fair Value of Derivatives (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Derivative [Line Items]
Gross Notional	$ 63,925	$ 57,898
All other assets
Derivative asset, statement of financial position	All other assets (Note 10)	All other assets (Note 10)
Gross derivatives	$ 1,208	$ 1,275
Netting and credit adjustments	(756)	(821)
Net derivatives recognized in statement of financial position	$ 452	$ 454
All other liabilities
Derivative liability, statement of financial position	All other liabilities (Note 15)	All other liabilities (Note 15)
Gross derivatives	$ 980	$ 1,241
Netting and credit adjustments	(755)	(820)
Net derivatives recognized in statement of financial position	225	420
Derivatives accounted for as hedges
Derivative [Line Items]
Gross Notional	4,648	5,112
All other assets
Gross derivatives	138	132
All other liabilities
Gross derivatives	100	146
Derivatives accounted for as hedges \| Currency exchange contracts
Derivative [Line Items]
Gross Notional	4,648	5,112
All other assets
Gross derivatives	138	132
All other liabilities
Gross derivatives	100	146
Derivatives not accounted for as hedges
Derivative [Line Items]
Gross Notional	59,277	52,786
All other assets
Gross derivatives	1,071	1,143
All other liabilities
Gross derivatives	880	1,095
Derivatives not accounted for as hedges \| Currency exchange contracts
Derivative [Line Items]
Gross Notional	58,595	51,885
All other assets
Gross derivatives	917	946
All other liabilities
Gross derivatives	871	1,082
Derivatives not accounted for as hedges \| Interest rate contracts
Derivative [Line Items]
Gross Notional	30	43
All other assets
Gross derivatives	0	0
All other liabilities
Gross derivatives	0	1
Derivatives not accounted for as hedges \| Other contracts
Derivative [Line Items]
Gross Notional	652	858
All other assets
Gross derivatives	154	197
All other liabilities
Gross derivatives	$ 9	$ 13

FINANCIAL INSTRUMENTS - Fair _2

FINANCIAL INSTRUMENTS - Fair Value Hedges, Narrative (Details) - USD ($) $ in Millions	Mar. 31, 2023	Mar. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Cumulative amount of fair value hedging adjustments	$ 1,226	$ 1,931
Cumulative amount of fair value hedging on discontinued hedging relationships	1,226	2,011
Hedged liability	$ 8,817	$ 15,636

FINANCIAL INSTRUMENTS - Effects

FINANCIAL INSTRUMENTS - Effects of Derivatives on AOCI (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Derivative [Line Items]
Gain (loss) recognized in AOCI, cash flow hedges	$ 28	$ (47)
Gain (loss) recognized in AOCI, net investment hedges	(62)	112
Foreign currency debt
Derivative [Line Items]
Carrying value designated as net investment hedges	$ 3,398	$ 3,934

FINANCIAL INSTRUMENTS - Cash Fl

FINANCIAL INSTRUMENTS - Cash Flow and Net Investment Hedges, Narrative (Details) $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($)
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Pre-tax gain (loss) included in AOCI related to cash flow hedges of forecasted transactions	$ (25)
Loss expected to be transferred to earnings as an expense	$ 8
Maximum term of hedged forecasted transactions	12 years

FINANCIAL INSTRUMENTS - Effec_2

FINANCIAL INSTRUMENTS - Effects of Derivatives on Earnings (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Total revenues	$ 14,486	$ 12,675
Interest Expense	269	387
SG&A	2,142	2,725
Other	16,810	9,823
Revenues
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) reclassified to earnings	1	3
Fair Value Hedges
Total effect of derivatives not designated as hedges	2	1
Interest Expense
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) reclassified to earnings	(2)	(7)
Fair Value Hedges
Hedged items		78
Derivatives designated as hedging instruments		(87)
Total effect of fair value hedges		(9)
Total effect of derivatives not designated as hedges	0	0
SG&A
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) reclassified to earnings	0	0
Fair Value Hedges
Total effect of derivatives not designated as hedges	115	(105)
Other
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) reclassified to earnings	(2)	(32)
Fair Value Hedges
Total effect of derivatives not designated as hedges	(58)	(66)
Currency exchange contracts \| Revenues
Fair Value Hedges
Total effect of derivatives not designated as hedges	2	1
Currency exchange contracts \| Interest Expense
Fair Value Hedges
Total effect of derivatives not designated as hedges	0
Currency exchange contracts \| SG&A
Fair Value Hedges
Total effect of derivatives not designated as hedges	76	(68)
Currency exchange contracts \| Other
Fair Value Hedges
Total effect of derivatives not designated as hedges	(47)	(81)
Interest rate, commodity and equity contracts \| Revenues
Fair Value Hedges
Total effect of derivatives not designated as hedges		1
Interest rate, commodity and equity contracts \| Interest Expense
Fair Value Hedges
Total effect of derivatives not designated as hedges	0
Interest rate, commodity and equity contracts \| SG&A
Fair Value Hedges
Total effect of derivatives not designated as hedges	39	(37)
Interest rate, commodity and equity contracts \| Other
Fair Value Hedges
Total effect of derivatives not designated as hedges	$ (11)	$ 15

FINANCIAL INSTRUMENTS - Counter

FINANCIAL INSTRUMENTS - Counterparty Credit Risk, Narrative (Details) - Counterparty credit risk - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Derivative [Line Items]
Exposure to counterparties including interest net collateral, excluding embedded derivatives	$ 325	$ 306
Net amount	$ 170	$ 365

VARIABLE INTEREST ENTITIES (Det

VARIABLE INTEREST ENTITIES (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Variable Interest Entity [Line Items]
Assets	$ 164,472	$ 188,851
Liabilities	131,649	153,938
Consolidated VIE
Variable Interest Entity [Line Items]
Assets	404	401
Liabilities	192	206
Unconsolidated VIEs
Variable Interest Entity [Line Items]
Assets	6,088	5,917
Unconsolidated VIEs \| Energy Financial Services
Variable Interest Entity [Line Items]
Assets	1,462	1,481
Unconsolidated VIEs \| Insurance
Variable Interest Entity [Line Items]
Assets	$ 4,411	$ 4,219

COMMITMENTS, GUARANTEES, PROD_2

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES - Commitments (Details) $ in Millions	Mar. 31, 2023 USD ($)
Investment Commitments
Long-term Purchase Commitment [Line Items]
Commitments	$ 3,966
Run-off Insurance Operations
Long-term Purchase Commitment [Line Items]
Commitments	3,868
Run-off insurance operations, unconsolidated VIE investment commitment
Long-term Purchase Commitment [Line Items]
Commitments	3,761
Aerospace \| Financial Assistance
Long-term Purchase Commitment [Line Items]
Commitments	$ 2,390

COMMITMENTS, GUARANTEES, PROD_3

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES - Guarantees (Details) $ in Millions	Mar. 31, 2023 USD ($)
Guarantee of indebtedness of others \| Discontinued operations
Guarantor Obligations [Line Items]
Maximum exposure	$ 76
Indemnification agreement, TSA \| Discontinued operations \| GE HealthCare
Guarantor Obligations [Line Items]
Guarantee obligations, liability	70
Indemnification agreement, TMA \| Discontinued operations \| GE HealthCare
Guarantor Obligations [Line Items]
Guarantee obligations, liability	47
Indemnification agreement, TMA \| Continuing operations \| GE HealthCare
Guarantor Obligations [Line Items]
Guarantee obligations, liability	49
Other indemnification agreements \| Discontinued operations
Guarantor Obligations [Line Items]
Maximum exposure	706
Related reserves	76
Other indemnification agreements \| Continuing operations
Guarantor Obligations [Line Items]
Maximum exposure	520
Other indemnification agreements \| Continuing operations \| GE HealthCare
Guarantor Obligations [Line Items]
Guarantee obligations, liability	$ 78

COMMITMENTS, GUARANTEES, PROD_4

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES - Product Warranties (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Liability for product warranties	$ 1,932	$ 1,960

COMMITMENTS, GUARANTEES, PROD_5

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES - Alstom Legacy Matters (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Alstom Legacy Matters
Loss Contingencies [Line Items]
Loss contingency accrual	$ 420	$ 455

COMMITMENTS, GUARANTEES, PROD_6

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES - Bank BPH (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Discontinued operations
Related Party Transaction [Line Items]
Financing receivables held for sale	$ 1,126	$ 1,200
Discontinued operations \| Bank BPH
Related Party Transaction [Line Items]
Percentage indexed to or denominated in foreign currencies	86%
Financing receivables held for sale	$ 1,126
Bank BPH \| Bank BPH
Related Party Transaction [Line Items]
Estimate loss	$ 1,540

SEGMENT OPERATIONS (Details)

SEGMENT OPERATIONS (Details) - USD ($) $ in Millions	3 Months Ended
SEGMENT OPERATIONS (Details) - USD ($) $ in Millions	Mar. 31, 2023	Mar. 31, 2022
Segment Reporting Information [Line Items]
Total revenues	$ 14,486	$ 12,675
Revenues, V%	14%
Interest and other financial charges	$ (269)	(387)
Non-operating benefit income (cost)	385	105
Benefit (provision) for income taxes	(271)	(29)
Preferred stock dividends and other	(145)	(52)
Earnings (loss) from continuing operations attributable to GE common shareholders	6,103	(1,276)
Earnings (loss) from discontinued operations attributable to GE common shareholders	1,257	88
Net earnings (loss) attributable to GE common shareholders	7,360	(1,188)
Operating segments
Segment Reporting Information [Line Items]
Total revenues	$ 13,638	11,975
Revenues, V%	14%
Segment profit (loss)	$ 987	538
Segment profit (loss), V%	83%
Operating segments \| Aerospace
Segment Reporting Information [Line Items]
Total revenues	$ 6,981	5,603
Revenues, V%	25%
Segment profit (loss)	$ 1,326	908
Segment profit (loss), V%	46%
Operating segments \| Renewable Energy
Segment Reporting Information [Line Items]
Total revenues	$ 2,837	2,871
Revenues, V%	(1.00%)
Segment profit (loss)	$ (414)	(434)
Segment profit (loss), V%	5%
Operating segments \| Power
Segment Reporting Information [Line Items]
Total revenues	$ 3,820	3,501
Revenues, V%	9%
Segment profit (loss)	$ 75	63
Segment profit (loss), V%	19%
Corporate
Segment Reporting Information [Line Items]
Total revenues	$ 848	700
Revenues, V%	21%
Segment profit (loss)	$ 5,456	(1,419)
Corporate \| Energy Financial Services
Segment Reporting Information [Line Items]
Interest and other financial charges	(12)	(16)
Benefit (provision) for income taxes	51	47
Segment reconciling items
Segment Reporting Information [Line Items]
Interest and other financial charges	$ (257)	(371)
Interest and other financial charges, V%	31%
Non-operating benefit income (cost)	$ 385	105
Benefit (provision) for income taxes	(322)	(76)
Preferred stock dividends and other	$ (145)	$ (52)